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I lie pulmonary imnuinopalliology of parainfluenza type 3 (I'l V-3) infection in sheep was investigated
firstly by isolating ttic virus from field cases of sliccp pneumonia, secondly by experimentally reproducing the
disease with the isolated vims and finally try studying changes in lymphocytes subsets and alveolar
macrophages, induced by HI V-3 in vivo and in vitro.
Throe ovine virus isolates (270-7, 390-10 and 430-7) were obtained and characterised, as l'IV-3.
according to virus morphology, transmission electron microscopy (I HM); cylopalhic cll'ccl (CI'H);
hacmagglutination, of guinea pig erythrocytes; physicochcmical properties; serological crossrcaclivity with
anliscra raised against l'IV-3; and reactivity with monoclonal antibodies to l'IV-3 structural proteins, that
crossrcact with human and bovine strains.
flic ability of the virus to induce respiratory disease was investigated by experimental inoculation of
ovine l'IV-3 isolate, 270-7 in colostrum deprived lambs Clinical, pathological, bacteriological and virological
studies were carried out on days 2. 3, 3 and 7 post infection (p i ), l itis I'l V-3 ovine strain was able to induce
clinical disease, llistopathological findings were interstitial pneumonia with hyperplasia of bronchiolar
associated lymphoid tissue (HALT), degenerative bronchiolar epithelium with lymphocyte inlillration, areas of
atelectasis and increased alveolar septa thickness due to proliferation of type II pncmnocytcs, lymphocytes,
macrophages and later to Itbrosis. lire large number of lymphocytes, particularly on days 5 and 7 pi,
combined with the minimal to moderate cytolvsis of antigen bearing cells suggests that l'IV-3-induced
pulmonary disease has an inuuunopathological component. l'IV-3 particles were detected more frequently in
bronchiolar epithelium cells than in alveolar septal cell This was correlated with changes of these cell
populations in lung lesions, delected by iminunohistochemislry.
Alter 7 days p i . virus-induced changes in the leukocyte composition of the lungs were detected using
a panel of rnAbs (o ovine lymphocytes and macrophages. Changes in lung tissue were detected by
inununohistology and changes in lungwash llnid (LWH) bv llowcylomctry. Association lie I ween lung cells and
virus particles was investigated by double immunoslaining. The differential cell count of LWIf from l'IV-3
infected animals was characterised by a significant increase (pet).03) in lymphocytes and neutrophils.
Lymphocy te phcnolyping showed a significant decrease (pet).05) of C'1711 cells, a significant increase (p<0.05)
oT CDK1 cells and a significant inversion (pcO.OO I) or the (171 '/COS1 ratio. Immunoslaining of I'l V-3 infected
lung sections showed a remarkable increase of lymphocy tes, particularly in HALT, and most cells were CD81.
flic number of macrophages increased in peribronchial and alveolar septa and some were positive lor I'l V-3
particles.
Cultures of peripheral blood monocylc-dcrivcd macrophages (MUMf) and alveolar macrophages
(AMf) were established, file ability of l'IV-3 lo inlccl these cells was studied by CI'H, and virus particle
immtmoslaining. Viral replication was detected by TliM and scanning electron microscopy (SBM). l'IV-3
induced lytic CI'H'w ith inlracyloplastnic eosinophilic inclusion Ixidics and syncy tia formation. I'HM revealed
virus budding al the cell membrane, lilamcntous cytoplasmic inclusions and clusters of pleomorphic viral
particles in the extracellular space.
flic expression of MIIC class I and MIIC class II molecules, which is associated willt antigen
presenting function, was studied alter in vitro inlccl ion of MUM and AM with I'l V-3. UK and IX) Ml It.' class
II expression was moderately high (60-80%) on noninl'cclcd fresh monocytes and AM but, allcr 3 days in
culture the expression of this molecules was dramatically reduced lo 5%. Stimulation with y-llrN was able to
promptly restore MIIC class II expression in cultured noninfcclcd MUM arid AM. This did not occur alter I'l V-
3 infection. The expression of MIIC class I molecules was not significantly all'cctcd (p>0,05) by culture or
I 'I V-3 infection.
flic phagocytic activity of macrophages lor IT fC-lnbcllcd/nnlibody-coalcd sheep red blood
cclls(SRUC) alter I'l V-3 infection decreased significantly (p< ().()3) alter .3 days p i.
PGS/ABST/94
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PNEUMONIC AREAS FROM LAMBS AFTER 7 DAYS P.I. WITH
OPIV-3 270-7.
FIGURE 5.4 IMMUNOSTAINING OF CD8+ T LYMPHOCYTES IN FROZEN
LUNG SECTIONS OF INTERSTITIAL PNEUMONIC AREAS FROM
LAMBS AFTER 7 DAYS P.I. WITH OPIV-3 270-7.
FIGURE 5.5 IMMUNOSTAINING OF MOS IN FROZEN LUNG SECTIONS OF
INTERSTITIAL PNEUMONIC AREAS FROM LAMBS AFTER 7
DAYS P.I. WITH OPIV-3 270-7.
FIGURE 5.6 PIV-3 INFECTED AMO DETECTION BY DOUBLE
IMMUNOSTAINING (SA-HRP/IAP) IN FROZEN LUNG SECTIONS
OF INTERSTITIAL PNEUMONIC AREAS FROM LAMBS AFTER 7
DAYS P.I. WITH OPIV-3 270-7.
FIGURE 6. 1 MONOCYTE-DERIVED MACROPHAGE (MDMO) CELL
CULTURES.
















FIGURE 6.3 MONOCYTE-DERIVED MACROPHAGES (MDMOS) AND
ALVEOLAR MACROPHAGES (AMOS) CULTURED IN GELATIN-
COATED FLASKS OR PLATES WERE INOCULATED WITH OPIV-3
270-7 (1 TICD50/CELL) AFTER 5 DAYS AND 3 DAYS IN CULTURE,
RESPECTIVELY.
FIGURE 6. 4 TIME DEPENDENT EFFECT ON ADHERENCE (A) AND VIABILITY
(B) OF OPIV-3 INFECTED AND MOCK-INFECTED AMO,
FIGURE 6.5 TIME DEPENDENT RELEASE OF INFECTIOUS OPIV-3 FROM
EQUAL NUMBERS (6.4X104 CELLS/WELL) OF MDMOS AND
AMOS.
FIGURE 6.6 TIME DEPENDENT RELEASE OF INFECTIOUS OPIV-3 FROM
LYMPHOCYTES CULTURES STIMULATED AND NON-
STIMULATED WITH CON A (0.5|J.g/WELL).
FIGURE 6. 7 TIME DEPENDENT RELEASE OF INFECTIOUS OPIV-3 FROM AMO
CULTURES STIMULATED AND NON-STIMULATED WITH CON A
(0.5|Xg/WELL).
FIGURE 6. 8 TIME DEPENDENT RELEASE OF INFECTIOUS OPIV-3 FROM AMO
(6.4 X104/WELL) CULTURES PLUS LYMPHOCYTES (2X105/WELL)
STIMULATED AND NON-STIMULATED WITH CON A
(0.5|ig/WELL). DATA REPRESENT THE AVERAGE TCID50/ML ±SD
FROM FIVE DIFFERENT EXPERIMENTS.
FIGURE 6. 9 FREQUENCY HISTOGRAMS SHOWING DETECTION OF OPIV-3
PARTICLES ON LYMPHOCYTE AND AMO CELL SURFACES BY
FLOW CYTOMETRY.
FIGURE 6.10 IMMUNOSTAINING OF T LYMPHOCYTE SUBSETS CD4+ AND
CD8+ IN LYMPHOCYTE ROSETTES WITH OPIV-3 270-7
INFECTED AMOS. AUTOLOGOUS LYMPHOCYTES (2X106
CELLS/ML) WERE ADDED TO AMOS (AFTER 3 DAYS P.I. WITH
OPIV-3 270-7.
FIGURE 6.11 TIME DEPENDENT EXPRESSION OF HN ANTIGEN IN OPIV-3 270
INFECTED MDMOS AND AMO DETECTED BY FLOW
CYTOMETRY.
FIGURE 6.12 FREQUENCY HISTOGRAMS SHOWING DETECTION OF THE
VIRAL ANTIGEN HN EXPRESSED ON THE CELL SURFACE AND
IN THE CYTOPLASM, OF MDMOS AND AMOS INFECTED WITH
OPIV-3 270-7, BY FLOW CYTOMETRY.
FIGURE 6.13 TRANSMISSION ELECTRON MICROSCOPY (TEM) OF MDMO
AND AMO CELL CULTURES HARVESTED AT 24, 48 AND 72
HOURS POST INOCULATION WITH OPIV-3 270-7.
FIGURE 6.14 FLOW CYTOMETRY DISPLAYS FOR "LIVE GATING" OF AMOS















FIGURE 6.15 FREQUENCY HISTOGRAMS SHOWING MDMO AND AM<D
PHENOTYPIC CHANGES IN CULTURE.
FIGURE 6.16 EXPRESSION OF OVINE VPM32 TISSUE MO MARKER BY
MONOCYTE-DERIVED MACROPHAGES (MDMOS) IN CULTURE.
FIGURE 6.17 FREQUENCY HISTOGRAMS SHOWING CHANGES IN LFA-3
EXPRESSION BY MDMOS IN CELL CULTURE.
FIGURE 6.18 FREQUENCY HISTOGRAMS SHOWING CHANGES IN CD1
EXPRESSION BY AMOS IN CELL CULTURE.
FIGURE 7. 1 EXPRESSION OF MHC CLASS II MOLECULES IN AMOS IN TISSUE
CULTURE.
FIGURE 7.2 FREQUENCY HISTOGRAMS SHOWING THE EFFECT AFTER 2
DAYS OF 7-IFN TREATMENT ON THE MHC MOLECULE
EXPRESSION OF MDMOS IN CULTURE.
FIGURE 7.3 FREQUENCY HISTOGRAMS SHOWING THE EFFECT AFTER 2
DAYS OF 7-EFN TREATMENT ON THE MHC MOLECULE
EXPRESSION OF AMOS IN CULTURE.
FIGURE 7.4 FREQUENCY HISTOGRAMS SHOWING THE EFFECT AFTER 2
DAYS OF 7-IFN TREATMENT ON THE MHC MOLECULE
EXPRESSION OF MDMOS INFECTED FOR 5 DAYS WITH OPIV-3.
FIGURE 7.5 FREQUENCY HISTOGRAMS SHOWING THE EFFECT AFTER 2
DAYS OF 7-IFN TREATMENT ON THE MHC MOLECULE
EXPRESSION OF AMOS INFECTED FOR 5 DAYS WITH OPIV-3.
FIGURE 7. 6 FREQUENCY HISTOGRAMS SHOWING THE EFFECT OF THE OPV-
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BFK bovine foetal kidney
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CD cluster of differentiation
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Parainfluenza virus type 3 (PIV-3) is an ubiquitous respiratory pathogen of both
humans and animals with a worldwide distribution (Chanock & Mcintosh, 1990). The
antigenically related human and bovine strains (Ito et al., 1987) are important causes
of bronchitis, bronchiolitis and pneumonia in their respective hosts (Brysson et al.,
1983; Van Wyke Coelingh et al., 1990). PIV-3 is often a factor in causing
pneumonia in sheep (Davies et al., 1977; Robinson, 1983).
Severe clinical respiratory disease and pneumonia are commonly associated with
bacterial infection. However, the attempts to produce pneumonia in sheep with
bacteria only have met with variable success. Pasteurella haemolytica is commonly
isolated from pneumonic sheep lungs, but attempts to experimentally produce the
disease with this microorganism alone has not been successful (Davies et al., 1986).
However, experiments in which lambs have been inoculated with combinations of
PIV-3 and Pasteurella haemolytica consistently induced severe clinical respiratory
disease (Wells et al., 1978; Davies et al., 1981; Davies et al., 1986; Cutlip &
Lehmkuhl, 1982).
Viral respiratory tract disease is a consequence of mechanical and biochemical injury
to epithelial cells and alveolar macrophages (Jakab & Warr, 1983). The lytic effect on
epithelial cells leaves a denuded respiratory tract. This also results in impairment of
the mucociliary escalator system and reduced surfactant levels (Slauson et al., 1989).
Viral impairment of the biochemically mediated killing by macrophages has been
thought to enhance bacterial growth and colonization of the respiratory tract (Slauson
et al., 1987). As a result, in the most severe cases there is secondary bacterial
infection, pneumonia and death (Welliver & Ogra, 1988). PIV-3 in cattle transiently
suppresses pulmonary antibacterial defences by causing dysfunctions in the alveolar
macrophage phagocytic system (Hesse & Toth, 1983; Liggit et al., 1985; Brown &
Ananaba, 1988).
Lung pathology induced by human PIV-3 in rats is not associated with the period of
time when there is maximum virus proliferation, but rather with the period of time of
rapidly declining virus titres and the expression of the antiviral immune response in the
lungs (Porter et al., 1991). This temporal relationship suggests that lesions of
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interstitial pneumonia caused by PIV-3 might be secondary to the antiviral immune
response rather than a direct effect of virus replication. PIV-3 infection is restricted
primarily to the respiratory tract where both macrophages and respiratory epithelium
are infected (Chanock & Mcintosh, 1990). Thus, virally infected macrophages may be
an important source of infectious vims or soluble mediators which can enhance or
suppress lymphocyte response and function.
The purpose of this work was to study the role of PIV-3 in sheep pneumonia and
aspects of the host immune response. Ovine PIV-3 isolates were obtained from field
cases of sheep pneumonia. Their antigenic relationship with bovine and human PIV-3
was characterised with monoclonal antibodies. Changes in lung macrophage and
lymphocyte populations were studied in experimentally induced interstitial pneumonia.
The association of vims particles with these cell populations was examined both in
vivo and in vitro. The effect of productive infection on macrophage phagocytic
capacity and cell phenotype was studied in vitro.
1.1 Parainfluenza virus type 3 (PIV-3) infection
1.1.1 Epidemiological and clinical aspects of PIV-3 infection
Antibodies to PIV-3 and isolation of the vims have been reported in several species
(Brako et al., 1984). In humans, respiratory syncytial vims (RSV) and PIV-3 are
responsible for severe viral respiratory tract disease leading to hospitalization of
infants and children (Murphy et al., 1994).
Transmission of parainfluenza vimses is by direct contact or by large droplet spread;
however, the vimses do not persist long in the environment. The high rate of infection
early in life, coupled with the frequency of reinfection, suggests that these vimses
spread readily from one individual to another. PIV-3 is the most efficient
parainfluenza vims in this aspect. There is no evidence that infection is transmitted
from humans to animals or vice versa (Chanock & Mcintosh, 1990).
The PIV-3 predominantly induces respiratory problems in lambs but it may also affect
adult sheep (Lehmkuhl & Cutlip, 1983; Berrfos et al., 1987). The symptoms include
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high body temperature, anorexia, apathy, nasal discharge, respiratory distress, sniffing
and coughing (Cutlip & Lehmkuhl, 1982; Lehmkuh! & Cutlip, 1983).
In humans other clinical problems have been associated with PIV-3 infections. This
virus has been isolated from the cerebral spinal fluid (CST) from children and adults.
All had lever and signs of meningitis and eventually recovered (Craver el al., 1993).
1.1.2 Pathology of PIV-3 infection
Gross lesions in the upper respiratory tract include hyperaemia of the nasal and
turbinate mucosae and small amounts of exudate in nasal passages. In lungs red areas
of consolidation are found in the apical lobes. Histopathological examination shows
hyperplasia of the bronchial epithelium, acidophilic cytoplasmic inclusions and
peribronchial accumulation of lymphocytes with a few PMNs. Also an intense
accumulation of lymphocytes and macrophages (M<|)s) within interalveolar septa along
with proliferation of pneumocytes type II and libroblasts can be seen. In the alveolar
space there are M<|)s and epithelial cells (Stevenson & More, 1970; Berrios et al.,
1991).
1.1.3 Classification of Parainfluenza type 3 virus(PIV-3)
PIV-3 belongs to the Paramyxoviridae family which includes many pathogens of
clinical importance for humans and animals. The Paramyxoviridae family has been
classified into three genera: Paramyxovirus, Morbillivirus and Pneumovirus. This
classification is based on the detection of the viral glycoproteins neuraminidase and
haemagglutinin. The Paramyxovirus genus includes the mumps virus, parainfluenza
viruses types 1 to 5 and many others of which Sendai virus, Simian 5 and Newcastle
disease virus are the most characteristic. The Morbillivirus genus contains the
measles, canine distemper and rinderpest viruses which do not show neuraminidase
activity. The third genus, Pneumovirus, includes the human respiratory syncytial virus
and also those affecting cattle and mice. They lack both neuraminidase and
haemagglutinin activity (Bishnu e( al., 1990; Galinski, 1991).
The development of gene technology and specific reagents, such as monoclonal
antibodies (mAbs), has facilitated a new understanding of the Paramyxoviridae.
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Genetic sequencing of paramyxovirus genes lias given new insight into the
interrelationship between members of the Paramyxoviridae and increased the
understanding of the evolutionary diversity of these viruses (Vainionpaa et al., 1989).
Based on sequence homology between corresponding genes, Spriggs et al., (1987)
divided the Paramyxoviridae into three distinct groups. The first group consists of
the Sendai, parainfluenza type 3, measles and canine distemper viruses. The second
group contains the simian virus 5 and the Newcastle disease virus. The third group
includes the respiratory syncytial virus (RSV).
The paramyxoviruses infect a large variety of mammals and birds, but the individual
virus types are very host-specific, and symptoms caused by each virus differ largely.
Symptoms can vary from an asymptomatic infection to nearly 100% mortality.
(Vainionpaa et al., 1989).
Other biological characteristics of P1V-3 correspond to its ability to agglutinate
erythrocytes from guinea pigs, sheep, cattle, pigs, goats, mice, rabbits, monkeys and
humans (group O) (Leunen & Welleman, 1966; Nguyen-Ba-Vy, 1967b). Maximum
haemagglutinating titres are achieved with guinea pig erythrocytes at 25°C for
parainfluenza vims type 1 and 3.
It has been demonstrated that parainfluenza viruses are inactivated by ether,
chloroform, UV and extreme pH. On other hand, they show variation in their
susceptibility to the temperature of 56°C, for example some strains are destroyed
within 20 minutes while others resist for 8 hours (Nguyen-Ba-Vy, 1967b).
PIV-3 multiplies in primary cell culture systems of bovine, ovine and monkey foetal
kidney cells and in some cell lines (Chanock et a!., 1958; Reisinger et al., 1959;
More, 1966; St George, 1969; Hawthorne et al; 1982; Lehmkuhl & Cutlip, 1982;
Batungbacal & Scott, 1982; Pfeffer et al., 1983). It has also been reported that some
strains of bovine PIV-3 (BPIV-3) proliferate in testicle cells (Nguyen-Ba-Vy, 1967b).
On the other hand, some strains can be replicated in embryonated eggs that are
inoculated via the amnion (Andrewes et a/., 1978).
The cytopathic effect (CPE) that has been observed in cell cultures inoculated with
PIV-3 is characterised by the appearance, after 48 hours, of large round cells with
increased refractability. This effect extends progressively to the whole monolayer with
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consecutive cell degeneration and finally the complete destruction of the cell culture.
This may occur after 3 to 5 days post infection (Dennett et at., 1973). Some strains
have the ability to produce, in some cell culture systems, a CPE that includes syncytia
formation and the presence of inclusion bodies that are mostly intracytoplasmic and
eosinophilic (Fenner et al., 1987a,b).
1.1.4 Virus genome and virus structural proteins
Characterisation of the virus antigenic structure is necessary in order to understand
the initiation of infection, virus interaction with immune cells and variations in virus
strains. The present understanding of the antigenic structure of Paramyxoviruses has
been largely derived irom the use of mAbies. Gene technology now offers the
possibility to analyze and compare antigenic structures of immunologically important
proteins at the molecular level as the complete sequences of paramyxovirus genes are
known (Vainionpaa et at., 1989). The majority of paramyxoviruses are monotypic,
but strain variations may occur as in human PIV-3 (Van Wyke Coelingh el al., 1990).
Paramyxoviruses are pleomorphic, enveloped RNA viruses that replicate in the
cytoplasm and are released by budding through the host cell plasma membrane. The
size of the virion varies between 100 and 300 nm in diameter. The genome is a single-
stranded, nonsegmented RNA molecule with a molecular weight (MW) of about
4.6-7 xlO6 daltons (Vainionpaa et ah, 1989). The genome of human parainfluenza
virus type 3 (FiPlV-3) is a single negative-sense RNA strand (vRNA) that is 15,463
nucleotides in length (Dimock & Collins, 1993). It contains a set of six or more genes
covalently linked in tandem, that serve as a template for transcription of six unique
mRNAs that encode six structural proteins named nucleocapsid (N), phosphoprotein
(P), matrix protein (M), fusion protein (F), haemagglutini-neuraminidase protein (HN)
and large protein (L) (Elango el at., 1986). The genome is surrounded by a
nucleoprotein (NP) in the form of a filamentous, herringbone-like nucleocapsid core,
which also contains the two minor proteins, L and P. The MW of the NP protein for
PIV-3 is 66,000 (Kingsbury el at., 1978; Ray et at., 1985; Vainionpaa et at., 1989;
Bishnu & Galinski, 1990). These proteins are analogous to those from other
paramyxovirus (Spriggs & Collins, 1987; Panigrahi et at., 1987). A schematic model
of a paramyxovirus is shown in Figure 1.1. A transmission electron microscopy
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(THM) photograph of a PIV-3 particle is shown in Fig. 1.2. Some characteristics of
the structural proteins are presented in Table 1.1.
According to Chanock and Mcintosh (1990) the characteristics of PIV-3 structural
proteins are as follows:
• Protein N is abundant and is a structural protein of the nucleocapsid and is tightly
complexed with genomic RNA. The carboxy terminus is located outside the
nucleocapsid, where it is available for interaction in RNA synthesis or
nucleocapsid packaging. The more basic and hydrophobic amino-tenninal region
probably interacts with RNA.
• Protein P is also located in the nucleocapsid where it is a component of the RNA-
polymerase complex. It is phosphorylated and a component of viral transcriptase.
It also appears to be mobile on the nucleocapsid and in clusters with protein L.
• Protein M is located on the inner aspect of viral envelope. It is the basic molecule
involved in maturation and assembly of virions in infected cells.
• Protein F is located on the surface of viral envelope and mediates viral
penetration, haemolysis and syncytium formation. It serves as a major protective
antigen that elicits neutralizing and fusion-inhibiting antibodies. Protein F is
synthesized as an inactive precursor Fo, which is activated by proteolytic cleavage
into disulfide-linked subunits Fj and F2.
• Protein HN is located on surface of the viral envelope and takes part in virus
attachment and both haemagglutination and neuraminidase activities. It serves as a
major protective antigen that elicits neutralizing and neuraminidase inhibiting
antibodies. HN is a type II glycoprotein that is inserted into the membrane by a
hydrophobic region.
• Protein L is located in the nucleocapsid and forms a crucial part of the virus
specific RNA dependent RNA-polymerase activity. It is the least abundant protein
produced during infection. Immunogold-labelling indicates that L molecules are
distributed in clusters along nucleocapsids isolated from infected cells, suggesting
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FIGURE 1.1 A schematic representation of a paramyxovirus virion. H(N),
hemagglutinin (neuraminidase) glycoprotein; F, fusion glycoprotein; RNP,
ribonucleoprotein; M, matrix (membrane); P, phosphoprotein; N, nucleoprotein; L,
large protein.
FIGURE 1. 2 Transmission electron microscopy (TEM) of a OPIV-3 virion detected
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that it acts co-operatively in viral RNA synthesis together with protein P which is
also associated in clusters with protein L.
The nucleocapsid structure is surrounded by a lipid-rich envelope containing virus-
specific projections (peplotners). The projections are comprised of two glycoproteins,
HN and F. They are anchored to the virus membrane by the hydrophobic portion of
the molecule. They are synthesised in the rough endoplasmic reticulum and
transported through the smooth membranes and Golgi's apparatus in a similar fashion
as other transmembrane proteins (Elango el at, 1986). HN and F glycoproteins are
important in the establishment of protection against the disease produced by the virus
(Vainionpaa, et at, 1989; Klippmark et at, 1990).
HN protein has six antigenic sites non-topographically overlapped; each one of them
contains multiple epitopes. Three of these antigenic sites (A, B, and C) are recognised
by mAbs that neutralise viral activity and inhibit the haemagglutination. The role of
the other three sites have not been identified yet. Similarly, mAbs against protein F,
detect eight different antigenic sites on this protein (Rydbeck, et at, 1986; Van Wyke
Coelingh el ai, 1990).
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Only limited antigenic variations are observed among BPIV-3 strains isolated from
different geographical areas and at different times. HN protein of human P1V-3 also
has relative antigenic stability, in contrast to the antigenic variability of F protein (Van
Wyke Coelingh et al., 1988; Shioda et at, 1988). The human and bovine strains share
neutralising epitopes, but show different antigenic characteristics. The differences
between both strains are located predominately in HN protein (Ray & Compans,
1986; Klippmark et al., 1990). However, there is no information available on the
antigenic relation between bovine and ovine strains.
Although BPIV-3 is clearly distinct from RPIV-3 they are antigenically closely
related (Abinanti et at, 1961). The human and bovine P1V-3 1IN glycoproteins share
two neutralizing epitopes in antigenic site A, whereas three neutralizing epitopes are
shared on the F glycoproteins (Coelingh et al., 1986). These two epitopes of HN, as
well as two out of the three of F, are completely conserved among HPIV-3 isolates.
The other third epitope of F is slightly less conserved (97%). Bovine and human PIV-
3 also exhibit significant conservation of amino acid sequence; homology of the N, P,
and M proteins varies from 62% to 86%. Homology of the F and HN surface
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glycoproteins is 80% and 77%, respectively (Zuku et al., 1987). This makes BPIV-3 a
candidate to induce resistance to HPIV-3 as it has been demonstrated in
experiments with cotton rats (Coelingh el al., 1987).
1.1.5 Pathogenesis and virus replication
The infection of host cells by PI V-3 begins through the action of two glycoproteins
from the virion surface named proteins HN and F. They play a fundamental role in
virus adsorption and penetration to the target cell and they present the main
immunogenic determinants that are essential for evoking an immune response against
the infection. (Rydbeck et al., 1988).
After protein HN binds to the sialic acid contained in host cell receptors, protein F
promotes the fusion of the virion envelope with the host cell membrane. This allows
the entrance of the viral RNA into the cytoplasm to start the virus replication. Protein
F is also responsible for the fusion of infected with non infected cells during late viral
replication resulting in the appearance of syncytia in vivo and in vitro (Van Wyke
Coelingh & Tierney, 1989; Moscona & Peluso, 1993a). This event also requires the
participation of protein HN (Ebata et al., 1991). Syncytia formation in either CV-1 or
HeLa cells requires the recombinant expression of both F and HN glycoproteins from
the HPIV-3 (Hemingway et al., 1994). Syncytia formation occurs at the end of the
replication cycle, when some changes to the cell membrane take place. The speed of
syncytia formation is in relation to high or low multiplicity of infection ( Fenner et al.,
1987a).
Protein M has been implicated in the establishment or maintenance of a persistent
viral infection. The role for the other proteins has not yet been clarified (Vainionpaa
etai, 1989).
The negative sense RNA vims genome cannot function directly as a mRNA but must
be first transcribed into positive-stranded RNA with viral RNA-dependent RNA-
polymerase. The viral proteins N, P, and L are required for this activity (Vainionpaa et
al., 1989). The viral RNA is translated to full-size proteins on host cell ribosotnes.
The fusion protein is synthesized as the inactive precursor F0 and later cleaved to the
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final form by host-cell-specific proteases. Glycoproteins are translated on the rough
endoplasmic reticulum and transported to the cell surface via the Golgi complex and
glycosylated during the transportation (Sato et al., 1988). P1V-3 replicates in the
cytoplasm and is released by budding through the host-cell plasma membrane.
It has been described for Orthomyxovirus and Paramyxovirus that the host cell
membrane receptor involved in infection is a neuraminic acid. As these receptors are
ubiquitous on the cell surface of ditferent species they can not be considered as
determinant factors for virus tissue tropism or host range affinity (Moscona & Peluso,
1992). The cell receptors for PIV-3 are found in different cell types including lung
epithelial cells, lymphocytes, monocytes, M<|)S and neurones (Vainionpaa et al., 1989).
Evidence has been presented that the receptor requirements for an HP1V-3 particle to
infect a cell are different from those for fusion between cells. By treating infected cells
in culture with various doses of neuraminidase, Moscona & Peluso (1992)
demonstrated that the virus spreads from cell to cell in the complete absence of cell to
cell fusion.
The protein F of PIV-3 involved in fusion exists as a precursor and is activated when
it is cleaved by host cell proteases located probably on cell membrane surface. The
cleavage occurs in the N terminal of the polypeptide in a region that shows homology
for Paramyxovirus (Chopin & Scheid, 1980). ). Although the assembly of the virions
occurs normally without this cleavage, the produced virus particles are not infectious.
If the infected cell does not have the right protease, the released virus particles are not
infectious, leading to a self-limited infection and reduced pathological consequences.
Therefore, the susceptibility of a cell to become infected by this virus is determined by
the presence of specific proteases together with complex interactions of the virus
structure, host cell receptors, cell metabolism and virus replication (Potgieter, 1986).
On the other hand, failure to cleave the F protein may also be a contributing factor in
the establishment of virus persistence (Moscona & Peluso, 1991).
Virus infections efficiently disaipt the functions of the infected cells. Lytic infection by
paramyxoviruses generally leads to rapid destruction and death of the host cells.
Adsorption of paramyxoviruses to the cell membrane alters the membrane fluidity and
permeability. This leads to an increase in cytosolic calcium (Dyer et al., 1994).
Another mechanisms of cell damage is the apparearence of hydrophobic pores on the
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plasma membrane, which leads to leakage of ions and low-molecular-weight
compounds with subsequent loss of cellular functions (Vainionpaa et al., 1989).
The epithelial cells of the respiratory tract are first infected after PIV-3 invasion;
however, alveolar macrophages (AM<|)s) can also become infected at this stage. The
involvement of AM<J)s has important consequences for the pathogenesis of respiratory
tract viral disease (Stauber & Weston, 1984).
Some studies carried out in vitro have demonstrated that virus parainfluenza type I
replicates more efficiently in cell cultures of pneumocytes type II than in cell cultures
of M<[>s (Castleman, et al., 1989).
The loss of epithelial cells from the respiratory tract along with the impairment of
mucocilliary movement and a good growth media represented by the exudate
promotes the colonisation and growth of bacteria (Davies, et al., 1977; Babiuk et al.,
1988).
1.1.6 Replication in macrophages
In pulmonary tissue, apart from antibody and cell mediated immunity, the lung cell
defence is derived from the action of AM<}>s complemented by the influx of monocytes
and PMNs from peripheral blood (Polgieter, 1986). The respiratory tract disease
induced by PIV-3 is regarded as a consequence of both mechanical and biochemical
injuries to epithelial cells and also to AM(J)s. This can lead in the most severe cases to
secondary bacteria infection, pneumonia and death.
The AM(f> has a critical role in lung resistance to bacteria colonisation, which can take
place after the AM(f) has been affected. This can be a direct consequence of viral
replication in this cell or a result of immune mediated cytotoxicity towards virus
infected M(j)s (Davies et al., 1986).
Not only can the number of M(j>s be reduced by PIV-3 infection but also some
functions of this cell type can be impaired. The evidence suggests that such M<j)s have
suppressed immunological and non-immunological activities related to membrane
receptor binding, Fc receptor mediated phagocytosis, non-specific receptor
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phagocytosis, phagosome-lysosome fusion, intracellular bacteria degradation and
killing (Hesse & Toth, 1983; Davies et al., 1986; Slauson, et al., 1987).
BPIV-3 inhibits oxygen-dependent bacterial killing by phagocytes, a key pulmonary
defence mechanism, thus predisposing the host to intrapulmonary bacterial
superinfection (Dyer et al., 1994). The changes in the production of reactive oxygen
species and the release of TxB2 by AM<j>s could account for damage to the airways
and bronchial hyperresponsiveness often seen after viral infection. BPIV-3 inhibits 02~
generation in AM<f>s. The haemagglutinin activity is the essential viral factor required
in the inhibition of 02" production by BPIV-3. Increases in cytosolic calcium and
activity of PKC signal NADPH oxidase assembly and 02~ production in phagocytic
cells. Treatment of AM<j>s with BPIV-3 selectively and significantly depress the Ca-
dependant PKC activity (Henricks et a/., 1993).
1.1.7 Immune response
Clinical disease and immunization with paramyxoviruses generally induces permanent
protective immunity. For example, infection with either measles or mumps viruses
results in lifelong immunity against re-infection (Julkunen, 1984; Ray & Compans,
1986). However, in the case of PIV-3 re-infection occurs with considerable frequency
during infancy and early childhood (Chanock & Mcintosh, 1990). Even in the
presence of circulating neutralizing antibodies adults have been shown to be
susceptible to re-infection. It appears that infection with PIV-3 does not result in the
establishment of a protective immune response (Sieg et al., 1994).
The antibody response in natural PIV-3 infection is directed against both the surface
and internal components of the virion (Kasel et al., 1984). In fact all viral proteins are
antigenic and immunogenic but the glycoproteins are most important for eliciting
antibody response. The protective antibody response is directed against HN and F
proteins. Protein HN is the major immunogenic molecule responsible for the induction
of neutralizing antibodies. This protein has four different antigenic sites with variable
epitopes (Van Wyke Coeling et al., 1990).
Primary infection usually induces a greater antibody response to the HN protein. Re¬
infection is often required to stimulate a high level of serum antibody to F protein.
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The relative effectiveness of HN and F antibodies in preventing infection has been
studied both in vivo and in vitro. Tissue culture studies suggest that F antibodies may
be more important because they can neutralize virus infection and prevent cell-to-cell
spread by cell fusion. HN antibodies can only neutralize virus infectivity of free
virions. However, evaluation of vaccinia virus-PIV-3 glycoprotein recombinants in
cotton rats indicated that infection by a recombinant which expressed PIV-3 HN,
induced more effective immunity than a recombinant which expressed PIV-3 F
(Spriggs et al., 1987).
Production of non-functional local antibodies, as well as poor F antibody response
may explain why re-infection with PIV-3 occurs with considerable frequency during
infancy and early childhood (Chanock & Mcintosh, 1990).
It has been demonstrated that humoral immune mechanisms can destroy PIV-3
infected host cells in the presence of antibody and complement (Hussain & Mohanty,
1984). Paramyxovirus antigens activate the complement pathway not only as
immunocomplexes but also via direct activation of the alternative pathway. Strains
with higher neuraminidase activity have a greater capacity to activate the complement
pathway than strains with lower levels of activity. Activation of the alternative
pathway may be an important mechanism of early host response before the immune
system has had enough time to mount a specific response and it may contribute to the
immunopathogenesis of paramyxovirus infection (Edwards et al., 1986)
The importance of cytotoxic T cells in recovery from PIV-3 infection has not been
formally established. Nevertheless, it is likely that this form of cell-mediated immunity
is important in the recovery process because type 3 virus infection or children with
profound T-cell deficiency can lead to fatal giant-cell pneumonia (Chanock &
Mcintosh, 1990).
Immunity against PIV-3 seems to be limited. It has been reported and demonstrated
that infection reoccurs within short time intervals. There is no vaccine available to
prevent the disease in humans, nevertheless several attenuated VPI-3 vaccines have
been used in cattle and sheep with favourable results ( Well et al., 1976; Lehmkuhl &
Cutlip, 1983; Morein et al., 1983; Ray et al., 1985). Since this virus causes severe
disease, in early infancy, vaccines must be effective in the presence of maternal
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antibodies. Currently, several strategies for immunization against this vims are being
explored including peptide vaccines, subunit vaccines, vectored vaccines,, live
attenuated vims vaccines (Murphy et ah, 1994), chimeric glycoproteins (Homa et ah,
1993) and microencapsulated vims particules (Ray et al., 1993).
Immunopathology can result from the induction of inappropriate immune responses.
The paramyxovirus F glycoprotein acquires its fusion activity following cleavage by a
host protease in the membrane of the infected cell. The F protein is responsible for
penetration of virions into cells, spread from cell to cell and formation of syncytia.
Formaldehyde-inactivated vaccines fail to elicit anti-F antibodies. If vaccinees are
subsequently infected, their immune systems fail to control the spread of the vims.
This allows large amounts of viral antigen to be produced which react with non-
neutralising anti-HN antibodies and give immunopathological changes (Choppin &
Scheid, 1980). This provides something of a warning against the possible dangers of
inactivated vaccines (Mims & White, 1984).
Cells infected with paramyxoviruses release soluble material such as vims envelope
glycoproteins which can produce immunopathological reactions. They also secrete
interferon (IFN) and tumour necrosis factor alpha (TNF-a), particularly when they
are mononuclear phagocytes (Vainionpaa et ah, 1989).
1.1.8 Viral Immunosuppression
Inhibition of the oxygen-dependent bactericidal function of AM<j)s and disturbances in
signal transduction by PIV-3 may contribute to the immunosuppression and bacterial
superinfection accompanying viral respiratory disease (Dyer et ah, 1994).
HPIV-3 is a major cause of disease in infants. It also has a striking potential to
reinfect individuals throughout their lives, suggesting that HPIV3 does not induce
lifelong immunity; however, the operative mechanism for the failure to prevent
reinfection is not known. Productive infection of T lymphocytes requires cell
activation and results in a marked inhibition of proliferation. Furthermore, exposure
to thei vims, even without overt expression of viral proteins as detected by
immunohistology, profoundly alters the functional capacity of the T cells. The
mechanism has not been elucidated however, it is possible that viral proteins interact
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with cellular proteins that mediate proliferative responses, thereby inhibiting their
function. Alternatively, the presence of the virus may induce the secretion of an
inhibitory cytokine, such as transforming growth factor B. Productive viral infection
cannot explain the marked functional alteration in the HPIV-3 exposed T cells since
detectable viral protein synthesis as detected by immunohistology was not required for
profound inhibition of T cell proliferation (Sieg et al., 1994). The ability of the virus
to regulate T-lymphocyte function may play an important role in the failure of the
virus to induce lifelong immunity (Sieg et al., 1994). This may also contribute to
immunosuppression (Sieg et al., 1994).
1.1.9 Persistent viral infection
In this type of viral infection the virus persists inside the host cell as either a complete
or incomplete virus particle. In some cases the persistent viral infection is enhanced by
interfering defective particles (Barret & Dimmock, 1986; Murphy et al. 1987), which
are unable to replicate in absence of standard virus. Such particles not only interfere
with the normal virus replication but also expand themselves. They are also involved
in the establishment and maintenance of persistently infected tissue cultures (Murphy
etal., 1987).
The persistent virus can be either replicative (productive infection) or non replicative
(non-productive infection). However, during the non replicative stage some
suppressed genes can be reactivated and lead to a new replicative phase (Barret &
Dimmock, 1986; Swoveland, 1991).
Persistent viral infections can be associated with chronic and recurrent signs of
disease; reduced host immune reponse by immunosuppressive virus; immune response
against infected cells or tissues; and production of pathogenic immune complexes.
Such immune complexes can localize in vascular and basal membranes. This leads to a
serious damage of these structures, resulting sometimes in death due to
glomerulonephritis (Povey, 1986).
It is considered that PIV-3 infection is confined to the lower respiratory tract during
the course of disease. However, PIV-3 has been associated in vivo with persistent
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viral infection in dogs (Everman et al., 1980) and in humans (Mills et al., 1981;
Goswan et al., 1984).
Cells persistently infected with HPIV-3 have also been obtained in vitro. This has
been achieved by inoculating tissue cultures at high multiplicity of infection, with high
levels Of neuraminidase present in the inocula. This produces a rapid destruction of
sialic acid from cell suface which prevents the cell fusion and the appearance of CPE
(Wechsler et al., 1985; Moscona & Pelusso, 1991a). Persistent infection of these cell
cultures have been associated with the presence of one or more viral defective-
interfering (DI) particles in addition to standard viral genomes (Moscona & Peluso,
1993b).
Cell cultures persistently infected with PIV-3 characteristically do not present
cytopathic effect (CPE), but maintain the viral infection within the system. These cells
will show cytopathic effect when new non-infected cells are added to the tissue
culture (Moscona & Peluso, 1991a). Furthermore, it has been demonstrated that cells
persistently infected with PIV-3 fuse only with non-infected cells (Wechsler et al.,
1985; Moscona & Peluso, 1991b).
Studies of RNA recovered from cell cultures persistently infected with PIV-3 indicate
the existence of a mutational hyperreactivity at the 3' terminal of the viral genome
(Murphy et al., 1991).
1.2 Defence mechanisms of the respiratory system
1.2.1 Aerodynamic filtration
The anatomic design of the respiratory tract, with multiple sites of turbulence and
bifurcation, is effective in limiting the penetration of larger particles to the upper
respiratory tract. Particles of 10 p.m or greater usually precipitate in the upper
respiratory tract, while particles between 2 and 10 flm are usually trapped in the
bronchial tree. Smaller particles may reach the terminal airways and alveoli or may be
inhaled and exhaled without deposition. The particle size in which aerolized virus
enters the lung is an important determinant of the outcome of infection (Welliver &
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Ogra, 1988). During the course of local immunization studies with respiratory viruses,
it was observed that large viral particles (100 |im in diameter) precipitate and induce
antibody responses in the nasopharynx, with little or no antibody response occurring
in the lower respiratory tract. On the other hand, aerolized antigen particles 1.5 |im in
diameter produce little or no nasopharyngeal antibody response but are quite
effective in inducing antibody responses in the lower portions of the tracheal tree
(Waldman & Ganguly, 1974). This pattern of dispersion of droplets may have some
significance in infection of a given host. Intranasal inoculation of virulent influenza
virus into mice allowed for spread of the virus to the trachea and lungs over three to
five days but was rarely lethal. Mice in which the total respiratory tract was
inoculated, almost uniformly developed fatal pneumonia (Yetter et al., 1980).
1.2.2 Mucociliary transport
Particles that settle anywhere in the respiratory system tract above the alveoli are
subject to clearance by the mucociliary transport system. Particles precipitate on
mucous plaques and are swept up to the posterior pharynx by the sweeping action of
ciliated respiratory epithelial cells. These ciliated cells are present from the terminal
bronchi to the larynx (Yates, 1988). Individuals with defects in ciliary motion are
particularly prone to respiratory infections. Viral infections, cigarette smoke and other
agents may have a ciliostatic effect that renders the host more susceptible to infection
(Welliver & Ogra, 1988).
1.2.3 Polymorphonuclear Neutrophils (PMNs)
PMNs are replete with enzymes and oxidants that could damage either microbial
pathogens or lung tissue. It has been shown in vitro that PMNs adhere better to virus-
infected cells than to non-infected monolayers (Faden et al., 1984). Immune
complexes containing viruses can activate oxidative pathways of PMNs (Kaul et al.,
1981), although the importance of this mechanism in pathogenesis of viral diseases is
unknown (Welliver & Ogra, 1988). Finally, in the presence of complement, PMNs




Complement may assist in the lysis of virus-infected cells through a number of
different mechanisms. Antibody-dependant neutralization of paramyxoviruses is
enhanced by the presence of complement. Also virus-infected cells are capable of
activating both complement pathways (Welliver & Ogra, 1988). PMN leukocytes are
capable of lysing virus-infected cells in the presence of complement (Kaul et al.,
1984). Wether or not complement itself can lyse virus-infected cells is unclear
(Welliver & Ogra, 1988).
1.2.5 Interferon (1FN)
LFNs are potentially important agents in resistance to viral infection. Exogenously
administered a-IFN was shown to have a prophylactic efficacy against rhinovirus
upper respiratory infections (Hayden et al., 1986). However, in some cases 1FN
seems to restrict the spread of virus but does not play a principal role in eradication
of infection (Welliver & Ogra, 1988). Most studies to this time have evaluated
lymphocyte y-IFN production in viral infections. RSV appears to be a relatively poor
producer of y-IFN either from lymphocytes or M<))s (Roberts, 1982). In contrast,
influenza virus (Roberts, 1982) and P1V-3 (Towsend & Williams, 1988) appear to be
potent stimulators of lymphocytic y-IFN.
1.2.6 Antibodies
The development of local antibody in the respiratory tract to a number of viruses has
been investigated. From the nasopharynx to the bronchiolar level, the principal
antibody isotype in humans appears to be IgA (Welliver & Ogra, 1988). Strong
clinical and experimental evidence is available indicating that the antibody in the
respiratory tract is the result of local antibody synthesis in the bronchiolar associated
lymphoid tissue (BALI), with a clear contribution from gut-associated lymphoid
tissue (Bienenstock & Befus, 1980). In general, naturally acquired respiratory viral
infections or immunization by the mucosal route appear to be the most effective
means of inducing secretory IgA antibody responses in the respiratory mucosa.
However, secretory IgA antibody responses in the respiratory tract may be observed
following parenteral inoculation with influenza virus (Waldman et al., 1973).
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While IgA is the predominant immunoglobulin isotype in the upper respiratory tract,
IgG antibody becomes progressively more predominant in the lower parts oF the
respiratory tract, become at least equal to concentrations of IgA in the major bronchi
and probably predominating over IgA in the alveoli (Reynolds, 1986). IgGl appears
to be the predominant isotype and is much more common than IgG2. lgG3 and IgG4
are found in still smaller quantities. IgGl and IgG2 are present in the respiratory tract
as a result of transudation from serum, while lgG3 and lgG4 are probably synthesized
locally (Merrill et al., 1985). Deficiencies of individual IgG subclasses in the human
may be seen alone or in conjunction with IgA deficiency and may predispose to more
severe illness, in comparison to IgA deficiency alone (Bjorkander et al., 1985).
In ruminants in contrast to other species secretory IgA is a relatively minor
component in mucosal surface. Complement-fixing IgG I is the major immunoglobulin
and it is derived almost exclusively from blood serum (Lascelles & McDonnell, 1974).
1.2.7 Natural Killer (NK) cells
NK cells are present in abundance at mucosal surfaces. These cells exhibit HLA-
unrestricted cytotoxic activity against cells infected with a number of types of
pathogens, including viruses (Welliver & Ogra, 1988). Thestudy of the role of NK
cells in recovery from viral respiratory infection has been focused in infection with
influenza virus. Their role in PIV-3 infection remains unclear. Natural killer cell
response is enhanced after influenza virus infection in mice (Wyde et al., 1977).
Nevertheless, "nude" mice, which have NK cell activity but are T-cell deficient,
exhibit minimal pulmonary infiltration, no tissue destruction in the lungs, and an
increased tendency toward dissemination of influenza virus to the brain in comparison
to immunologically competent litter mates (Wyde el al., 1977).
1.2.8 Lung macrophages
As the respiratory tract is continuously exposed to organisms or particles of the
inhaled air, there is a need for appropriate defence mechanisms to prevent injurious
and infebtious processes. In the upper and central respiratory tract (nasopharynx,
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trachea and large bronchi), mechanisms such as sneezing, coughing and mucociliary
clearance contribute to a large extent to particle removal. By contrast, the distal
airways (bronchioles) and the alveoli are devoid of these mechanisms. Therefore, most
of the clearance of small inhaled particulate material and microorganisms reaching the
periphery of the lung relies on the phagocytic system (Sibille & Reynolds, 1990). The
contribution of phagocytes to lung host defence is well illustrated by the high
frequency of pneumonia observed in severely neutropenic patients or in cases of lung
M<j> dysfunction (Reynolds, 1985). In addition to their defensive role, PMNs and
AM(J)s have been implicated in injurious processes associated with both acute and
chronic pulmonary diseases (Sibille & Reynolds, 1990).
According to Sibille & Reynolds (1990) the M<|) can interact with other cells and
molecules through the release of numerous secretory products (Table 1.2) and the
expression of several surface receptors (Table 1.3). This strongly supports a central
role for pulmonary M()>s. In the normal lung, M<|)s are resident cells, whereas PMNs
are almost absent. However, in certain conditions, PMNs can accumulate within the
lung structures interacting with M<j)s (Figure 1.3).
Although all Mqs share the same precursor (the circulating monocyte) and share some
functions, each type appears to have different characteristics (Sibille & Reynolds,
1990). For example, lung M<j)s are the only M<j>s living in aerobic conditions and this
environment is likely to influence the behavior of these phagocytes (Sibille &
Reynolds, 1990). Pulmonary macrophages are both phenotypically and functionally
diverse, even within a single compartment. These differences may reflect the stage of
differentiation from blood precursors, but more likely reflect the environment and
physiological roles of phagocytes in distinct locations. Important membrane molecules
that determine the function of macrophages include complement, Fc, mannose and
scavenger receptors, as well as class I and II MHC, adhesion and other signaling
molecules (reviewed by Lipscomb et al, 1995).
According to Brain (1988) different kinds of M(j)s can be recognized in the lung.
They include alveolar, interstitial, intravascular and airways M()>s.
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TABLt 1. 2 Major products released by alveolar macrophages.
Cytokines
lnterleukin-1 alpha and beta
lnterleukin-6
Tumor necrosis (actor
Alpha and gamma interferon
Colony-stimulating growth factors
Transforming growth factor-beta



















Prostaglandins (E„ D,p 6-keto-PGF-1-alpha and F2-alpha)
Lipoxygenase metabolites
5-hydroxyeicosatetraenoic acid





























Taken from Sibille & Reynolds (1990).
TABLE 1.3 Surface ligands on alveolar macrophages.
Proteins
Immunoglobulins A, G,.4, E
Ferritin, transferrin
Lactoferrin
Complement fragments C3, C5a
Major histocompatibility complex type II molecules: la-like antigen
Hormones
Glucocorticoids









Peptides and phorbol esters
FMLP, PMA
Lectin-binding molecules
Manose fucose receptor (163-kQ mannose receptor)
Glucose receptor
80-kD surface protein




* These receptors have been described in monocytes and tissue macrophages but not yet in alveolar
macrophages.






















FIGURE 1. 3 Interaction between alveolar macrophages (AMiJis) and polymorpho¬
nuclear neutrophils (PMNs) in the lung. Upon stimulation by various stimili, AM<(>s
release either chemotactic factors or inhibitory factor for PMNs. These factors will
either attract PMNs from the capillary lumen to the alveolar space or prevent PMN
migration to the alveoli. Once in the alveolar lumen, the PMNs can be activated by
various factors, including AM(|)-derived monokines and bioactive lipids. AM(j>s can
also inhibit PMN activity through the release of mediators such as PGE2. Secretory
products released by both AM<()s and PMNs are likely to influence defense and injury
processes.
r
FIGURE 1. 4 Transmission electron microscopy of sheep lung tissue showing a
vacuolated AM<|) in the alveolar space but attaching to the alveolar wall (A). A closer
view shows numerous intracytoplasmic vacuoles (v) and granules (g). The nucleus is
irregular with aggregated chromatin. Augmentation x3,350 (A) and xl0,000 (B).
 
1.2.8.1 Alveolar Macrophage (AM§)
Among the different kinds of pulmonary M<J)s the AM()) is the best characterised and
most extensively studied, because it can be easily recovered by bronchoalveolar lavage
(BAL). The AM0 is the resident phagocyte of the alveolar space (Fels & Cohn 1986).
As illustrated by the electron microscopy photograph in Figure 1.4, the AM({) is
characterised by a lobulated nucleus and a vacuolated cytoplasm containing numerous
mitochondria and electron dense secondary lysosomes. The AM(j) represent a
population morphologically and functionally heterogeneous (Sibille & Reynolds,
1990). The size of the cells varies from 12 (im (similar to monocytes) to 40 |im
(often multinucleated cells) (Cohen & Cline, 1971). Taking advantage of these size
differences and using gradients of colloidal silica or of concentrated bovine serum
albumin solutions, AM(J> have been separated into different subpopulations (Shellito &
Kaltreider, 1984; Chandler et al., 1986). The membrane receptor expression and cell
functions, such as phagocytosis and mediator release, have been shown to vary among
these different populations. The distribution of AM(J>s among the different
subpopulations varies according to disease states. For example, in acute inflammation,
an increased number of small, monocyte-like M<()s is observed, whereas chronic lung
disorders are associated with an increase in larger, more mature M<j)s (Brannen &
Chandler, 1988).
Particles reaching the alveoli are cleared principally by AMtjis. These cells are capable
of phagocytosis and enzymatic degradation of subtances, may transport substances
out of the lung and may activate other immunologic components of the lung defence
system (Welliver & Ogra, 1988). Suppression of AM*) function would certainly be
expected to predispose individual to more severe respiratory disease, and M(()s secrete
numerous products that certainly could damage the lung (Sibille & Reynolds, 1990).
AM(j)s appear to be able to function as accessory or effector cells in immune reactions
and are also capable of initiating the inductive phase of humoral and cellular immune
responses by presenting antigens to specific B and T-lymphocytes (Chandler et al.,
1986; Fels & Cohn, 1986). However, most studies support the concept that AM<Jis are
poor antigen presenting cells (APCs) for priming T cells even when they express high
levels of class II MHC (Holt, 1979; Toews et al., 1984; Lipscomb et al., 1986). This
diverse group of cells is now best understood in the context of lung immunity as
phagocytes and as regulators of both immunity and nonspecific inflammation (Holt,
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1986). The bulk of evidence indicates that lung macrophages are unlikely APCs in the
initiation of primary immune responses (reviewed by Lipscomb et al, 1995).
However, they may have a role in stimulating recently primed T cells like other class
II MHC-positive cells of many types (Steinman, 1991; Croft, 1994). The major role of
AM(j)s seems to be to phagocytose and remove potentially dangerous particulates and
soluble antigens from the alveoli and to inhibit local lung immune responses. AM<j)-
suppressive activity is important to prevent the development of hypersensitivity
reactions previewed by Lipscomb et al, 1995). Mechanisms utilized by populations of
AM(j)s to suppress immune responses have been reported in several animal species.
They include PGE2 production in dogs (Demenkoff et al., 1980), inhibition of
receptor-induced intracellular calcium in humans (Yarbrough et al., 1991), TGF(3
(Lipscomb et al., 1993) and nitric oxide (Holt et al., 1993) secretion in mice.
1.2.8.2 Interstitial macrophages
Interstitial M<j)s are located in the connective tissue of the lung and, in contrast with
AM<j)s, are not directly exposed to airborne particles. Interstitial M<|)s are obtained
from minced lung explants but are not recovered by BAL (Bowden & Adamson,
1972). Despite some similarities with AM(j)s (phagocytosis, release of oxygen radicals
and presence of Fc-gamma-receptor), interstitial M<|)s have an increased ability to
replicate and to synthesize DNA in vitro compared to AM<|)s (Lehnert et al., 1985).
They are most effcient in stimulating the T lymphocyte response against antigens
(Holian & Scheule, 1990).
1.2.8.3 Intravascular macrophages
In addition to AM<j)s and interstitial M<J)s, pulmonary M<f>s resident in intravascular
structures have been identified in several animal species (pigs, sheep, cats and
humans), but not in rodents (Warner et al., 1986; Dehring & Wismar, 1989). These
cells are morphologically different from blood monocytes and adhere firmly to the
endothelial cells. Through their clearance function, pulmonary intravascular Mt(>s may
play an important role in the pathogenesis of oedema with acute lung inflammation
induced by sepsis. Whether pulmonary intravascular M(j)s originate from bone marrow
cells and attach to the lung endothelium, or from interstitial or AM(J)s and migrate
21
back towards the capillary lumen, still remains to be determined (Sibille & Reynolds,
1990).
1.2.8.4 A irways macrophages
M<j)s are also present in large and small airways. Some of these airway M<|)s are likely
to correspond to AM<|>s transported by the mucociliary escalator. However, a certain
number 'of these airway M<j>s appear to be resident cells of the airways, adhering
tightly to the epithelial cells. They could help in the removal of debris present in the
large airways (Brain et al., 1984).
1.2.9 Dendritic cells
Also a loosely adherent mononuclear cell present in human lung tissue specimens, but
not in BAL, has been characterised (Nicod et al., 1987). This cell is morphologically
similar to a dendritic cell (DC), does not express Fc-gamma-receptor and
demonstrates a lower phagocytic activity, but a higher T lymphocyte-stimulating
accessory function than do AM<|>s. These pulmonary DC have also been identified
more recently in rat (Holt et al., 1992; Havenith et al., 1993). DCs form an
interdigitating network in the airway epithelium similar to the network described for
skin Largerhans cells (Holt, 1993). In humans intraepithelial DCs are particularly
dense in the trachea and gradually diminish in concentration as the airways branch.
DCs also exist in the connective tissue surrounding bronchi and bronchioles, in
perivascular connective tissue, in alveolar septa, in the pleura and in very small
numbers in alveolar spaces (van Haarst et al., 1994). Like DCs from other sites, lung
DC constitutively express both class I and 11 MF1C, are light density, loosely adherent,
poorly or nonphagocytic and demonstrate long processes both in tissue sections and
in cell suspensions (Nicod et al., 1987). Lung DCs tail to express pan T, natural killer
(NK) cell, B cell and many macrophage markers (reviewed by Lipscomb et al, 1995).
1.2.10 Lymphocytes
The lymphocyte system of the lung is capable of functioning independently of, as well
as interacting with, the systemic lymphocyte system. According to Welliver & Ogra
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(1988) the lymphocytic tissue of the lung can be loosely organized into four general
types:
• Lymph nodes, which are predominandy found along the upper respiratory tract to
the hyla.
• The bronchus-associated lymphoid tissue (BALT) which is concentrated in the
areas of bronchial and bronchiolar bifurcations.
• Interstitial lymphocytic nodules.
• Free lymphocytes in both the parenchyma and air spaces.
Interaction with the systemic immune system most probably occurs in the BALT.
Lymphocytes from systemic circulation may enter the lung here and be dispersed
along the lamina propia, while lung lymphocytes seem to enter the systemic
circulation in this area (Welliver & Ogra, 1988).
Considerable evidence has accumulated demonstrating the development of virus-
specific cytotoxic T-lymphocytes after viral infections. The development of T-cells
with cytotoxic activity specific for influenza virus-infected cells appears to be the
critical factor in restricting influenza virus infection to the respiratory tract and
eradicating the infection. Passive transfer of immune spleen cells, which were obtained
30 days after infection in mice and restimulated with virus infected cells, enabled mice
to recover from pneumonia due to influenza without causing an increase in influenza-
specific antibody titres. In contrast, immune spleen cells that were not restimulated
enhanced antibody titers but did not aid in recovery from primary pneumonia (Wells et
ai, 1981 a,b). There is evidence that the cytotoxic T-cell response to influenza virus
infection may also contribute to the pathogenesis of disease. Immunocompetent mice
have more pulmonary lesions than nude mice following infection with influenza virus
(Wyde et al., 1977).
The pathways of antigen processing that result in binding of peptides to MHC class I
or class II molecules are different. The description of a cytosolic pathway for MHC
class I and an endosomal pathway for MHC class II processing and presentation
characterises these differences. Whereas proteins added externally to cells are usually
processed in the endosomal pathway, biosynthesis of viral proteins (endogenous
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proteins) within cells favours presentation by the cytosolic pathway (Rotzschke et al.,
1990). In general but not exclusively CD8+ and CD4+ T cells have a division of tasks:
CD8+ CTLs control intracellular pathogens whereas CD4+ helper T cells help to
eradicate extracellular pathogens by cooperation with B cells and by release of
cytokines (Leist et al., 1987). After infection, a virus has achieved control over the
cellular protein synthesis machinery. Then presentation of antigenic viral proteins via
the cytosolic pathway is clearly favoured. However, even after endogenous synthesis
of viral proteins, presentation by MHC class II molecules is not absolutely excluded.
Furthermore, after release from infected cells, viruses and viral proteins have to be
considered as exogenous sources of antigen. Whether extracellular viral proteins
represent a major factor for the generation of an efficient immune response depends
on the productivity of the viral infection in a given tissue (Koszinowski et al., 1991).
Paramyxoviruses are enveloped RNA viruses that replicate in the cytoplasm and are
released by budding through the host cell plasma membrane (Vainionpaa et al., 1989).
Enveloped viruses are thought to enter cells by two mechanisms: by fusion with the
cell membrane or by receptor mediated endocytosis followed by fusion with the
vesicle (Nagai et al., 1983). These type of viral entry should be able then to load both
the MHC class I and the MHC class II pathway of processing and presentation. As a
consequence both CD4+ and CD8+ T cell subpopulations are expected to be
stimulated to contribute to protection against viral infection or to exacerbation of
disease. However, PIV-3 fuses directly with the plasma membrane at neutral pH
without activating endocytic vesicle formation (Chopin & Sheid, 1980).
The degree to which CD8+ T-cell induction and function is independant of CD4+
Th cell activity apparently varies between viral infections. The clearance of mouse
hepatitis virus from the central nervous system follows a pattern that suggests the
CD8+ T cells are the main effectors, but need CD4+ help (Williamsom & Stohlman,
1990). This finding is consistent with the hypothesis that CD4+ T cells are critical for
the provision of cytokines to help CD8+ T cells differentiate and proliferate. However,
in influenza A virus infection neither the recruitment of CD8+ T cells to lymphoid
tissue nor their localization to the site of virus growth is substantially dependant on a
primed CD4+ helper population. Furthermore, CD4+-depleted mice clear influenza A
virus from the lungs, and the frequency of antiviral CTL precursors is not reduced




When CD8' response is precluded due to a lack of CDS' T cells or an alteration in the
presenting MHC molecules the result also seem to vary according to the type of viral
infection. In lymphocytic choriomeningitis virus (LCMV)-infected mice this situation
leads to persistent infection, which clearly indicates that CD81 T cells are critical for
clearance (Pircher et al., 1990). This is different however, for murine cytomegalovirus
(MCMV). Athough in the immunocompetent mouse protective immunity to MCMV
is clearly a function of the CD8' subset, these cells are dispensable for virus control in
long-term CD8' depleted mice (Jonjic et al., 1990). In these mice, CD4' T cells have
an antiviral function that is absent in fully immuncompetent mice.
1.2.11 Cytokines
1. 2.11.1 Macrophage derived cytokines
Among the cytokines secreted by M<|)s IL-1 a and (3 and TNF-a are believed to play
an important role in inflammatory reactions, according to both in vitro and in vivo
studies (Dinarello et al., 1986). The activities of these cytokines on different cells are
numerous. The actions of IL-1 and TNF-a often ovelap (Nathan, 1986). Both IL-1
and TNF-a are secretory products of AM<j>s and this secretion appears to be increased
in AM<|>s from patients with sarcoidosis (Hunninghake, 1984; Bachwich et al., 1986)
Because sarcoidosis is a granulomatous disease perpetuated by activated M<{>s and T
lymphocytes accumulating in the lung interstitium and alveoli, the increased IL-1
release may induce the recruitment of T-lymphocytes and their activation, whereas
TNF-a may be responsible for monocyte differentiation and release of IL-1 (Thomas
& Hunninghake, 1987). The large variety of actions of these two cytokines on
lymphocytes, M<|)s, endothelial cells, PMN, fibroblasts and tumour cells suggests that
both IL-1 and TNF-a are likely implicated in infectious, inflammatory and tumoricidal
processes (Le & Vilcek, 1987).
In addition to IL-1 and TNF-a, AMijis produce fibroblast growth factors in vitro. In
particular the AM<j)-derived fibroblast growth factor (AMDGF) is able to induce
fibroblast proliferation in vitro (Bitterman et a/., 1986). Among factors promoting
fibroblast growth, fibronectin, a glycoprotein present in extracellular matrix and
implicated in cell surface interactions, is known to be released by human AM((>s
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(Rennard et al., 1983). Furthermore, AM<j>s release inhibitory factors for both
fibroblast growth and IL-1 (Elias et al., 1990).
M<|)s from different sources have been found to release IL-6. This factor has a broad
spectrum of biological activities, including the induction of fever, acute phase proteins
and growth and differentiation of T and B cells (Wong & Clark, 1988). Other
polypeptide hormones released by AM<|)s include platelet derived growth factor
(PDGF)t transforming growth factor-beta (TGF-[3) and alpha and gamma-interferon
\ 5
(a and y-lFN) (Elias et al., 1990). This secretion of a and y-IFN have potentially
important implications in modulating the antiviral and immune activities of AM<J>s
(Sibille & Reynolds, 1990).
1.2.11.2 Lymphocyte derived cytokines
There is growing evidence that cytokines delivered locally by T cells can contribute to
selective virus elimination. This is achieved by direct antiviral effects and a
combination of indirect effects involving specific as well as non-specific effector cells.
When tested at the clonal level, mouse CD4 T cell clones fall into two main groups,
Thl and Th2. Thl clones synthesize IL-2 and y-IFN, whereas Th2 clones synthesize
1L-4, IL-5, IL-6 and IL-10 (Mosmann & Cofffnan, 1989). CD8' CTLs synthesize a
range of cytokines similar to those that are synthesized by Thl and CD41 CTLs.
CD4' and CD8' CTLs may operate in vivo by direct cytolysis and by the local release
of cytokines such as y-IFN. In view of the fact that a major effect of y-IFN is the
upregulation of MHC class II gene expression, an enhanced antigen presentation by
MHC class 11 molecules, in combination with the induction of an antiviral state in
neighbouring cells, could potentiate the effects of CD4' T cells in vivo (Kottonen-
Corish etal., 1990).
There is no report of vims control by Th2 cells. Th2 cells produce among other
cytokines IL-10, which inhibits the synthesis of y-IFN by Thl cells (Pearce et al.,
1991). Thus, Th2 cells that synthesize IL-10 may be envisaged to counteract the
antiviral function of virus-specific CD41 and CD8' CTLs, both of which produce y-
IFN (Mosmann & Coflfnan, 1989).
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1.3 AIMS OF THE THESIS
The frequency of infection by PIV-3 virus in sheep, determined by serological tests, is
quite high in the south of Chile (68%) where it is seems to produce severe cases of
pneumonia in association with Pasterurella haemolytica (Berrios et a!., 1987;
Riedemann ei al., 1990). However, no isolations of this virus from field cases of sheep
pneumonia has yet been reported.
This study deals with the isolation of a OPIV-3 strain from field cases of sheep
pneumonia, from the South of Chile and the experimental reproduction of lung
lesions corresponding to viral pneumonia. This will allow the characterisation of
histological lesions and changes in cell populations, associated with immune response,
that occur during replication of OPIV-3 in lung tissue. The ability of the virus to
infect lymphocytes and monocytes/macrophages will be study in vitro, as well as the
effect of infection on phenotype and functional properties of monocytes/macrophages.
Specific objectives
• To isolate and characterise OPIV-3 from field clinical cases of sheep pneumonia in
Chile.
• Toi reproduce and characterise lung lesions of viral pneumonia through the
experimental inoculation of colostrum deprived lambs with OPIV-3.
• To detect the presence ofPIV-3 particles in situ in association with lung lesions of
experimental interstitial pneumonia.
• To detect the presence of OPIV-3 particles in association with lymphocytes and
macrophages recovered by lung wash (LW) from animals with experimental
interstitial pneumonia.
• To investigate the capacity of OPIV-3 to establish a productive infection in
lymphocytes, monoeytes-derived macrophages and alveolar macrophages in vitro.
• To characterise ultrastructural changes of monocytes-derived macrophages and
alveolar macrophages during replication of OPIV-3 in vitro.
• To characterise phenotypic changes of monocytes-derived macrophages and
alveolar macrophages during replication of OPIV-3 in vitro.
• To evaluate alterations in the phagocytic capacity of monocytes-derived
macrophages and alveolar macrophages during replication of OPIV-3 in vitro.
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2. MATERIALS AND METHODS
All chemicals were supplied by SIGMA Chemical Co., Poole, Dorset, England or
BHD Ltd., Poole, England unless otherwise stated. Tissue culture plasticware was
supplied by GIBCO BRL, Paisley, Scotland. Universals and centrifuge tubes were
supplied by Bibby Ltd., Stirling, Scotland.
2.1 Cell cultures for virus isolation
I
2.1.1 Culture of ovine skin fibroblasts (OSF)
Ovine skin fibroblasts (OSF) derived from biopsies as detailed in Bird et al. (1993),
were cultured in Dulbecco's modified Eagle's medium (GIBCO, BRL) containing 2
mM-L-glutamine, 100U penicillin per ml, 100 pg streptomycin per ml and 10% FCS
at 379C, 5% C02.
Cell cultures were detached using 0.05% (w/v) trypsin in 0.02% (w/v) EDTA in PBS
and transferred into other tissue culture flasks in a 1:3 proportion.
2.1.2 Ovine foetal kidney (OFK) and bovine foetal kidney (BFK) cells
Primary and secondary OFK and BFK monolayer cultures were used for the isolation
and characterisation of OPIV-3 isolates. These cells were derived from biopsies as
detailed in Berrfos et al. (1991). OFK and BFK cultures were all negative to the
presence of bovine diarrhoea vims (BDV) and respiratory sincitial virus (RSV) by
ELISA. They were also used for the passage of the vims, used as inocula in the
experimental infection of lambs. Cells were grown in Eagle's Essential Minimum
Media (MEM, Sigma Chemical Co USA) supplemented with 2 mM-L-glutamine,
0.08% sodium bicarbonate, 100 units/ml penicillin, 1 OOpg/ml streptomycin, 10%




2.1.3 Freezing and thawing of cells
1 to 2 xlO6 cells per ml, in an ice-cold mixture of 90% FCS/10% DMSO and were
frozen slowly by placing the cells in a polystyrene box filled with cottonwool at -70^
overnight. Then the vials were transferred to liquid nitrogen. To resuscitate frozen cell
lines, an aliquot was warmed quickly at 372C, gradually diluted with warm DME/10%
FCS and then centrifuged at 350 xg for 5 minutes. The cell pellet was resuspended in
DME/10% FCS, incubated for 5 minutes at 37SC and then pelletted again. Finally, the
cells were resuspended in DME/10% FCS and transferred into 25cm2 tissue culture
flasks.
2.2 Animals
2.2.1 Animals for virus isolation
I
Sheep that arrived at different times from the south of Chile to a slaughter house in
Santiago showing clinical signs of respiratory disease including coughing, rapid
respiration, anorexia, nasal discharge and fever, were selected for virus isolations
attemtps. They were taken to the Animal Pathology Department of University of
Chile, in Santiago for necropsy. Lung samples were taken for virus isolation,
bacteriological examination and histopathology. Standard bacteriological procedures
were used to isolate and identify bacteria and mycoplasms from the lung.
2.2.2 Animals for experimental infection
Ten lambs were obtained at birth and deprived of colostrum. They were bottled-fed 3
times daily on 300ml of warmed cow's milk supplemented twice daily with a
commercial oral solution of streptomycin sulphate and neomycin sulphate.
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2.2.3 Rabbit for OPIV-3 antisera production
New Zealand adult rabbits (Bioterio del Institute de Salud Publica de Chile,
Santiago, Chile), clinically healthy and free from antibodies to PIV-3 were used to
raise polyconal sera against the PIV-3 isolated in this study from clinical cases of
sheep respiratory disease (see 4.1.1.1.)
2.3 Antibodies
All sera were heat-inactivated at 569C for 30min. Antibody titres for PIV-3 were
determined by a microtitre serum-virus neutralization test (Lehmkuhl and Cutlip,
1982).
• BPIV-3 reference antisera kindly supplied by Dr. Neil Watt (Edinburgh
University, Veterinary Pathology Department, Field Station, Edinburgh, UK).
• BPIV-3 reference antisera raised against a bovine strain named La Pintana 84
(Berrfos et al., 1990) kindly supplied by Dr. Patricio Berrfos ( Laboratorio de
Virologfa, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile,
Santiago, Chile).
• OPIV-3 antisera raised against the ovine isolate named 270-7 (Berrfos et al.,
1991) raised in New Zealand rabbits ( Laboratorio de Virologfa, Facultad de
Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santiago, Chile).
• Murine monoclonal antibodies anti HPIV-3 proteins that have cross reactivity
with the same proteins of BPIV-3 (Klippmark et al., 1990). They were kindly
supplied by Dr. Robert Rydbeck, Virology Departament, Karolinska Institute,
Stockholm, Sweden (see Table 2.1).
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TABLE 2. 1 Monoclonal antibody panel anti HPIV-3 and grouping according
epitopes*












* = according to Rydbeck et al„ (1986)
**= a different group indicates that the Mab recognizes different epitope
• FITC, HRP and alkaline phosphatase conjugated antibodies against rabbit IgG
(Scottish Antibody Production Unit, Law Hospital, Carluke, Lanarkshire,
Scotland) and against mouse IgG (Sigma Chemical Company, St. Louis, MO,
USA).
2.4 Reference PIV-3 strains
• Bovine strain of PIV-3 kindly supplied by Dr. Neil Watt (Edinburgh University,
Veterinary Pathology Department, Field Station, Edinburgh, UK).
• Bovine strain of PIV-3 named La Pintana 84 (Berrfos et al., 1990) kindly
supplied by Dr. Patricio Berrfos (Laboratorio de Virologfa, Facultad de Ciencias
Veterinarias y Pecuarias, Universidad de Chile, Santiago, Chile).
• Ovine strain of PIV-3 named Moredun kindly supplied by Dr. Peter Nettleton




2.5 Flow cytometry and analysis of cytometric data
Flow cytometry is an analytical technique which in a population of continuously
flowing fluorochrome labelled cells permits accurate quantitation of various
parameters of individual cells, such as the distribution according to their sizes and
fluorescence intensities. Data on these parameters can be stored and analysed in a
computer. In this work, flow cytometric acquisition of fluorescein isothiocyanate
(FITC) labelled cell data was carried out using a fluorescence-activated cell analyser,
FACScan (Becton Dickinson, Mountain View, CA, U.S.A.). The Consort 30
programme was used in the acquisition, storage and analysis of the single colour flow
cytometric parameters of the labelled sheep cells. In each case data was derived by
analysing 10,000 cells (or events) per sample. The cytometer configurations were
calibrated and set using negative control cells stained with normal mouse serum
(NMS) and the appropriate immunoconjugates. FITC fluorescence (520 nM) emission
was detected with the photomultiplier tube voltage set at 555 mV. Forward (FSC)
and side or 90 degree (SSC) light scatter amplifications were linear and set at E00 and
326 respectively, while FITC amplification was logarithmic (all 256 channels). Using
dot plot (Figure 2.1a) cells (lymphocytes or monocyte/macrophages) were "live-
gated" for acquisition and analysis while cell debris, dead cells, red blood cells (RBCs)
and were excluded on the basis of FSC and SSC parameters (Figure 2.1b,c). FSC,
SSC and fluorescent data were plotted as frequency histograms with the log
fluorescent intensity presented on the x-axis and the frequency of cell numbers
presented on the y-axis (Figure 2. Id).
2.6 Immunofluorescence and immunohistochemistry
2.6.1 Indirect immunofluorescence
Cells or sections mounted on coverslips were immediately placed in fresh 24well
tissue culture plates and rinsed twice in buffer PBS and then fixed for 5 minutes at
4°C in buffer PBS containing 80% cold acetone. They were rinsed twice in rinsing
buffer PBS containing 0.5% bovine serum albumin (BSA), 0.01M sodium azide and
0.05% 'fween 20. Next step was to incubate at 4°C for 30 minutes with the same
buffer plus 1% normal mouse serum or normal rabbit serum according to the nature of
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FIGURE 2. 1 Flow cytometry of lung wash fluid (LWF) for live gating of
lymphocytes and macrophages (M(|)s) using forward (FSC) and side (SSC) angle light
scatter.
A. Dot plot display (ungated) of a negative control sample of fresh LWF showing the
distribution of distinct cell populations (RBC= red blood cells; Ly= lymphocytes;
M(f)= macrophages) based on their physical characteristics.
B. Exclusion of dead cells, RBC, granulocytes and lymphocytes by "live gating" the
macrophages.
C. Frequency histogram display of the "live gated" macrophages.
D. Exclusion of dead cells, RBC, granulocytes and macrophages by "live gating" the
lympocytes.
the primary antibody used. Then the buiTer was removed and they were incubated
with 50pl of anti PIV-3 rabbit polyclonal sera or mouse monoclonal antibody at 4°C
for 60 minutes. After this, the primary antibody was removed and they were given
three washes in rinsing buffer for 10 minutes each time with constant shaking . They
were incubated for 30 minutes at 4°C with 50pl of a 1:100 dilution in rinsing buffer of
the second FITC conjugated antibody anti-rabbit IgG or anti-mouse IgG according to
the nature of the primary antibody. The secondary antibody was removed and they
were given three washes in rinsing buffer for 10 minutes each time with constant
shaking. Finally, the coverslips were removed and mounted on slides with buffer PBS
containing 10% glycerol. The reactivity was immediately observed and photographed
under UV microscope (Nikon Labophot II).
2.6.2 Indirect immunoperoxidase
Cells or sections mounted on coverslips were immediately placed in fresh 24well
tissue culture plates and rinsed twice in buffer PBS and fixed for 5 minutes at 4°C in
buffer teS containing 80% cold acetone. They were rinsed twice in buffer PBS and
endogenous peroxidase activity was blocked by incubating in PBS 1% hydrogen
peroxide for 30 minutes at 4°C. Then they were rinsed twice in rinsing buffer PBS
containing 0.5% bovine serum albumin (BSA), 0.01 M sodium azide and 0.05%
Tween 20. Next step was to incubate at 4°C for 30 minutes with the same buffer plus
1% normal mouse serum or normal rabbit serum according to the nature of the
primary antibody used. Then the buffer was removed and they were incubated with
50pl of anti PIV-3 rabbit polyclonal sera or mouse monoclonal antibody at 4°C for 60
minutes. After this, the primary antibody was removed and they were given three
washes in rinsing buffer for 10 minutes each time with constant shaking . They were
incubated for 30 minutes at 4°C with 50 pi of a 1:200 dilution in rinsing buffer of the
second HRP conjugated antibody anti-rabbit IgG or anti-mouse IgG according to the
nature of the primary antibody. The secondary antibody was removed and they were
given three washes in rinsing buffer for 10 minutes each time with constant shaking.
I'he reactivity was visualized by incubating for 5 minutes in 50 pi of PBS containing
0.1% diaminobenzidine (DAB) and 0.02% hydrogen peroxide. The reaction was
stopped by washing in distilled water and then enhanced with 1% osmium tetra oxide
for 1 minute. Coverslips were washed in distilled water and placed briefly in
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hematoxylin for nuclei counterstaining, dehydrated in alcohol cleared in xylol and
finally mounted for observation under light microscopy.
2.6.3 Indirect alkaline phosphatase
The coverslips removed from infected and control culture cells were immediately
placed in fresh 24well tissue culture plates and rinsed twice in buffer PBS and then
fixed for 5 minutes at 4°C in buffer PBS containing 80% cold acetone. They were
rinsed twice in buffer Tris/saline (1/10 of 0.5 M Tris-Cl pfl 7.6 0.15 M/Saline
solution) containing 0.5% bovine serum albumin (BSA), 0.01M sodium azide and
0.05% Tween 20. Next step was to incubate at 4°C for 30 minutes with the same
buffer plus 1% normal mouse serum or normal rabbit serum according to the nature of
the primary antibody used. Then the buffer was removed and they were incubated
with 50 pi of anti-PIV-3 rabbit polyclonal sera or mouse monoclonal antibody at 4°C
for 60 minutes. After this, the primary antibody was removed and they were given
three washes in rinsing buffer for 10 minutes each time with constant shaking . They
were incubated for 30 minutes at 4°C with 50 pi of a 1:30 dilution in rinsing buffer of
the second AP conjugated antibody anti-rabbit IgG or anti-mouse IgG according to
the nature of the primary antibody. The secondary antibody was removed and they
were given three washes in rinsing buffer for 10 minutes each time with constant
shaking. The reactivity was visualised by incubating for 15 minutes in 50 pi of freshly
made developing solution prepared by mixing 9.8ml of 0.1 M Tris-Cl (ptt 8.2), 2mg
of Naphthol AS-MX Phosphate dissolved in 0.2ml Dimethylformamide and 10 mg
Fast Red TR Salt. The reaction was stopped by washing in distilled water and then
coverslips were placed briefly in hematoxylin for nuclei counterstaining, and finally
mounted in Farrant's mounting media for observation under light microscopy.
2.6.4 Double-immunostaning (SA-HRP/1AP) for PIV-3 particles and cell
markers
Double-immunostaining was carried out in frozen as well as in formalin fixed sections.
Frozen sections cut 8pm thick and mounted on round glass coverslips were placed in
24 well tissue culture plates, air dried at least for 30 minutes and then fixed for 5
minutes at 4°C in buffer PBS containing 80% cold acetone, then processed for double
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immunostaining. Formalin fixed, paraffin embedded sections were cut 5 pm thick and
mounted on round glass coverslips. They were dewaxed, rehydrated in alcohol and
then rinsed twice in buffer PBS before being processed for double immunostaining.
Double immunostaining was performed in a humid chamber in two stages according
to the method described by Braun et al. (1991). In the first stage (detection of OPIV-
3 antigens by SA-HRP) the endogenous peroxidase activity was blocked by
incubating in PBS 1% hydrogen peroxide for 30 minutes at 4°C. Then the sections
were rinsed twice in rinsing buffer PBS containing 0.5% bovine serum albumin
(BSA), 0.01M sodium azide and 0.05% Tween 20. The next step was to incubate at
4°C for 30 minutes with the same buffer plus 1% normal rabbit serum in a humid
chamber at room temperature. Then the buffer was removed, by three washes in
rinsing buffer for 10 minutes each time with constant shaking, and the sections were
incubated with 50gl of anti PI V-3 rabbit polyclonal sera at 4°C for 1 or 2 hours at
room temperature. After washing as before, second incubation was carried out with
biotinylated goat anti-rabbit IgG (Sigma) diluted 1:200 in buffer for 2 hours at room
temperature. The third incubation after washing was performed with horseradish
peroxidase (HRP) conjugated avidin (Sigma) 5pm/ml in 0.05 M Tris/NaCl-buffer, pH
7.6 for 1 hour at room temperature. Sections were stained with 0.5mg/ml 4-chloro-l-
naphtol (4CN)/0.005% hydrogen peroxide for 30 minutes. Positive reaction was
detected by the appearance of a blue colour. The reaction was stopped by washing in
distilled water, and then enhanced with 1% osmium tetra oxide for 1 minute. In the
second stage (detection of cell markers by IAP) the sections were rinsed twice in
buffer Tris/saline (1/10 of 0.5 M Tris-CI pH 7.6 0.15 M/Saline solution) containing
0.5% BSA, 0.01 M sodium azide and 0.05% Tween 20. The next step was to incubate
at 4°C for 30 minutes with the same buffer plus 1% normal mouse serum. Then the
buffer was removed and they were incubated with mouse monoclonal antibody SBU-
T4, SBU-T8 or VPM32 at 4°C for 60 minutes. After this, the primary antibody was
removed and they were given three washes in rinsing buffer for 10 minutes each time
with constant shaking . They were incubated for 30 minutes at 4°C with 50pl of a
1:30 dilution in rinsing buffer of the second AP conjugated antibody anti-mouse IgG.
The secondary antibody was removed and they were given three washes in rinsing
buffer for 10 minutes each time with constant shaking. The reactivity was visualised
by incubating for 15 minutes in 50pl of freshly made developing solution prepared by
mixing 9.8m! of 0.1 M Tris-CI (pFI 8.2), 2mg of Naphthol AS-MX Phosphate
dissolved in 0.2ml Dimethylfonnamide and 10 mg Fast Red I R Salt. Positive staining
I
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was detected by the appearance of a red colour. The reaction was stopped by washing
in distilled water and then coverslips were placed briefly in methylene green for
nuclei counterstaining, and finally mounted in Tarrant's mounting media for
observation under light microscopy.
2.7 Isolation of OPIV-3 Chilean strains
Samples from clinical cases of sheep pneumonia were processed to isolate OVPI-3.
For this, 0.1ml of obtained inoculum, from either nasal swabs or lung samples, was
inoculated into 3 flasks (per sample) containing subconfluent OFK cells in Eagle's
Essential Minimum Media (MEM, Sigma Chemical Co. USA) supplemented with
5% foetal calf serum (FCS, Sigma Chemical Co. USA), 0.08% sodium bicarbonate,
200 units/ml penicillin, lOOug/ml streptomycin. As negative controls tissue cultures
were inoculated with samples processed from normal lungs and as positive control
tissue cultures were inoculated with OPIV-3 reference strain. Virus isolation was
based upon the following procedures:
2.7.1 Titration of virus infectivity
The virus infectivity was determined according to titration of cytopathic effect (CPE),
haemadsorption and haemagglutination of guinea pig erythrocytes.
For infectivity titrations serial tenfold dilutions of virus were added in aliquots of
0.01ml to tissue culture flasks. Adsorption was allowed to proceed for 30 minutes at
37°C prior to overlaying with maintenance medium. On the 4th or 5th following days
the infected cultures were examined for haemadsorption and cytopathic effect.:
2.7.1.1 Haemadsorption test
The end point was taken as the highest initial dilution of virus giving detectable
haemadsorption of 1% guinea pig erythrocytes suspension following incubation at
4°C for 30 minutes. The titre was expressed as the number of tissue culture infective
doses (TCID5o) per 0.1ml.
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2.7.1.2 Cytopath ic Effect (CPE)
The inoculated cell cultures were examined under an inverted light microscope each
day alter infection to detect the presence of virus induced CPE. The inocula were
subpassaged twice ifno CPE developed after 5-7 days of incubation.
CPE was further investigated by placing cells in 24 well tissue culture plates with
sterile 13 mm diameter round glass cover slips. They were removed at different times
post inoculation and fixed in methanol for 5 minutes. Then they were stained with
hematoxylin-eosin (H/E) and mounted to observe CPE including inclusion body
formation.
2.7.1.3 HHemagglutination (HA) test
I
Material harvested from infected OFK cell culture was used as the source of
haemagglutinin (Sever, 1962). The tests were performed in U shaped bottom well
microtitre plates. Haemagglutinating activity was titrated using 0.2 ml volumes of a
two-fold dilution series of haemagglutinin and an 0.5% suspension of guinea pig
erythrocytes. The plates were kept at room temperature for 40 minutes and the end
points were read by the sedimentation pattern method. The titre was expressed as the
highest initial dilution of haemagglutinin causing complete agglutination of the
erythrocytes. The dilution was considered to contain 1 haemagglutinating unit (HA
unit) per 0.2 ml.
2.7.2 Electron microscopy
For negative staining, infected cultures with over 70% CPE were frozen and thawed
once and the resulting lysate was processed. Lysates were precleared by
centrifugation at 1,500 x g for 30 minutes. The supernatant was centrifuged at
100,000 x g for 2 hours and the pellet was resuspended in PBS pH 7.2. The negative
staining was done with 2% phosphotungstic acid on 400 mesh grids covered with
Formbar. The observation and photography was carried out in a transmission electron
microscope Zeiss EM 109.
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Thin sections for electron microscopy were prepared from monolayers of OFK cell
cultures. Infected cells were harvested at 24, 48 and 72 hours post inoculation. They
were inoculated with virus and processed according to Cutlip & Laird (1976). The
cell monolayers were removed from the tlasks with a rubber policeman, centrifuged
at 120 x g for 5 minutes and resuspended and lixed in glutaraldehyde 2.5% in
cacodylate buffer 0.2 M pH 7.4. After 2 rinses in cacodylate buffer for 30 minutes
each, the cells were postfixed for 30 minutes in 1% osmium tetraoxide in cacodylate
buffer and again rinsed twice in buffer. After fixation and after rinsing the cells were
pelleted by centrifiigation at 120 x g for 5 minutes. Fixed cells were embedded in 2%
agar by centrifugation at 1,300 x g at 40°C lor 10 minutes. Pellets thus formed were
cut into 1 to 2mm samples and dehydrated in a graded series of ethanol. Then, they
were cleared in 3 changes of propylene oxide for 8 minutes each and finally in a
solution containing 50% propylene oxide and 50% epoxy resin (Epon 812, Shell
Chemical Company, Kansas City Mo ). Later, they were embedded overnight in a
solution 1:10 propylene oxide/epoxy resin and then for 24 hours only in epoxy resin
and hardened at 50°C for 72 hours. Sections were cut on an ultramicrotome (Sorval
MT2 B), stained with lead citrate for 15 minutes and uranyl acetate for 5 minutes
according to Bryson el a/.(1983) and examined with an electron microscope (Model
200, Phillips Electronics, NY)
2.7.3 Physical and biochemical virus characterisation
2.7.3.1 pH sensitivity
Buffer solutions pH 3.0, 7.0 and 9.0 were prepared, then 10-fold virus dilutions were
made with them to be incubated at 40°C for 15 minutes, finally the extreme pi Is were
neutralized by adding NaOH or ITCl 0.25M.





Sodium citrate 1.37 g
Citric acid 1.12 g
Distilled water up to 100 ml
• pH 7.0
Sodium phosphate 0.742 g
Disodium phosphate 0.542 g
Distilled water up to 100 ml
. pH 9.0
Sodium borate 3.607 g
Boric acid 0.034 g
Distilled water up to 100 ml
2.7.3.2 Lipid solvents sensitivity
Ether: The sensitivity to ether was performed according to a method described by
Andrewes & Horstman (1949). The vims was suspended in 20% v/v ether in culture
media, the control was suspended in 20% v/v Puck's saline solution A. The tubes
were hermetically closed and taken to 40°C for 24 hours and shaken
constantly. Then, ether was removed by evaporation and the vims suspension was
stored at -70°C until titration.
I
Chloroform: The sensitivity to chloroform was assessed following the method
described by Feldman & Wang (1961). Briefly, to 1ml of vims suspension was
added 0.5ml of chloroform. Simultaneously, a control was prepared with 0.5ml of
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Puck's saline solution A. The tubes were gently shaken for 10 minutes at room
temperature.
In order to eliminate the chloroform the virus suspensions were centrifiiged at 12 x g
for 5 minutes. The chloroform and virus separate in different bands, so this allowed
the virus to be collected and kept frozen at -70°C until titration.
2.7.3.3 Trypsin sensitivity
The sensitivity to trypsin was performed according to a method described by Gresser
& Enders (1961). 1%, 0.5% and 0.25% solutions of trypsin were prepared with
Puck's saline solution A. Then 1 ml of vims suspension was mixed with 1ml of the
trypsin dilution. Tubes were incubated at 37°C in a thermoregulated bath for 60
minutes. Trypsin was inactivated by adding 1% cold foetal calf serum.
As controls, 1 ml virus suspension was mixed with 1 ml of Puck's saline solution A.
Then they followed the same procedure.
2.7.3.4 Heat sensitivity
Test tubes were previously wanned up to 56°C and to each of them 0.5ml of vims
suspension was added and immediately taken to a thermorregulated bath at 56°C.
Each tube was removed from the thermoregulated bath at different times (0, 5, 10, 20
and 30 min), and then transferred to an ice box and finally stored frozen at -70°C
until titration.
2.7.4 Serological identification
2.7.4.1 Anti P/V-3 sera production
Anti P1V-3 sera was raised in rabbit immunized with the virus isolates described in
this study. Two rabbits were used for each vims isolate, they were free of anti PIV-3
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antibodies as determined by III test before immunization. Each rabbit was given four
inoculations containing 1ml of virus suspension with an infective titre of1075 TICD50
for isolate 271-7, 10s 5 for isolate 390-10 and 106'9 for isolate 410-7. Each of the
four inoculations was given as follows: the first one via the subcutaneous route with
complete Freund's adjuvant (Dilco Laboratories Detroit Michigan,USA.); the
second one via intramuscular and the third and tour ones via intraperitoneal. Each
inoculation was given with a week interval.
Ten days alter the last inoculation the rabbits were bled to obtain the sera. All sera
was inactivated at 56°C for 30 minutes and stored at -70°C until titration. Non
specific haemaggultination inhibition factors were eliminated by mixing and incubating
the sera with 25% caolin for 30 minutes at room temperature. Then, the sera were
centrilliged at 1,500 x g for 10 minutes. The supernatant was treated for
heteroagglutinin elimination with a suspension of 5 % guinea pig erythrocytes for one
hour.
As a reference the following anti PIV-3 sera was used:
• anti bovine PIV-3 sera raised with strain La Pintana 84 (Berrios et at, 1990),
kindly supplied by Dr. Patricio Berrios (Lab. Virologia, Facultad de Ciencias
Veterinarias y Pecuarias. Universidad de Chile);
• anti bovine PIV-3 sera supplied by Dr. Neil Watt (Veterinary Pathology
Department, Edinburgh University, Edinburgh, UK); and anti ovine PIV-3 sera
supplied by Dr. Peter Nettleton (Moredun Institute, Edinburgh, UK.)
Prior to testing the serum samples were diluted twofold in MEM and heat inactivated
at 56°C for 30 minutes.
2.7.4.2 Haemagglutination Inhibition (HI) test
For serum HI antibody titrations 0.2m! of serial-two fold dilutions of serum were
mixed with 0.2 ml of a dilution of haemagglutinin containing 4 HA units and
incubated for 60 minutes, then 0.2 ml of a 0.5% suspension of guinea pig erythrocytes
was added and incubated for 40 minutes. The plates were kept at room temperature
for 60 minutes and the end points were read again by the sedimentation pattern
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method. The HI antibody titre of the serum was taken as the highest initial dilution of
serum which affected complete inhibition of haemagglutination.
2.7.4.3 Sero-neutralization (SN) test
All samples were tested in triplicate, using twofold dilutions (from 1:2 to 1:512) in a
microtitriation procedure (Lehmkuhl & Gough, 1977). The test virus (100 median
tissue culture infective doses, TCID50) was added to each well. The serum-virus
mixture was incubated for I hour at room temperature before the addition of 0.05ml
of appropriate cells, at concentrations calculated to allow the immediate formation of
monolayers. The plates were incubated in a C02 incubator at 37°C. The plates were
read 2-3 days later. The serum-virus neutralization titres were the highest dilution of
serum in which 50% of the wells were protected from the viral CPE.
2.7.5 Immunofluorescence and immunocytochemistry
Immunocytochemistry was carried out in infected cell cultures in order to detect virus
particles with the polyclonal sera and also with anti human PIV-3 virus monoclonal
antibodies. OFK cells were placed in tissue culture 24 well plastic microplates
(Corning Glass Works. Corning NY 1483 I) containing glass round sterile coverslips
measuring 13 mm diameter. Each well received 1 ml of Eagle's MEM with 5%
foetal calf serum and containing 105 cells. They were incubated for 48 hours at 37°C
and then inoculated with 0.1ml of virus suspension under study at a multiplicity of
infection (m.o.i.) of 0.1. The virus was absorbed at 37°C for 60 minutes. The virus
suspension was removed and 1 ml of culture media was added and incubation at
37°C followed. Wells in separate microplates were inoculated with tissue culture
media and kept as negative controls. Separate microplates wells were infected with
the reference virus as positive controls.
The coyerslips were removed after 24, 48 and 72 hours post inoculation to be
processed for immunostaining by immunofluorescence, indirect immunoperoxidase
and indirect immuno-alkaline-phosphatase staining as described in sections 2.6.1,
2.6.2 and 2.6.3, respectively.
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2.7.6 Detection of viral antigens by flow cytometry
Detection of viral antigens expressed on the cell surface and in the cytoplasm was
carried out by flow cytometry. The presence of OPIV-3 antigens on the surface of
infected cells was detected by indirect immunofluorescence carried out in rhesus
tubes. Infected and mock-infected cells were cultured and harvested as described
before then blocked with PBA (PBS containing 0.1% BSA and 0.01% sodium azide)
including 2% NRS and 2% NMS for 30 minutes at 0°C. The cells were further
incubated with anti OPIV-3 sera or mAbs anti IIPIV-3 antigens (see table 2.1) at 0°C
for 40 minutes, washed three times with PBA and then incubated with FITC-
conjugated anti-mouse IgG F(ab')2 1:50 dilution (Dakopatts, Ltd.) at 0°C for another
twenty minutes. After three washes with PBA, cells were fixed with 1%
paraformaldehyde in PBS and analyzed by flow cytometry. In order to detect viral
antigen, the infected and mock-infected cells were fixed in 80% methanol in PBS
before blocking and incubation with antibodies, according to method described by Lee
(1994). Cells were gated according to FSC and SSC parameters. The reactivity of the
antibodies was analyzed by flow cytometry using a Becton-Dickinson FACScan with
Consort 30 version F Software. Normal mouse serum (1:500 dilution) stained cells
were set up as background staining controls. The percentage of positive cells and
mean of fluorescence intensity (MF) were determined by using Lysis Version 1.62 and
Consort 30 version F Software.
2.8 Experimental interstitial sheep pneumonia
2.8.1 OPIV-3 270-7 inoculation of experimental Iambs
The ovine isolate of PIV-3 named 270-7 (see 4.1.1.1) was isolated (Laboratorio de
Virologia, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile,
Santiago, Chile) and described in this study. This strain was used for the experimental
inoculation of colostrum-deprived lambs at the sixth passage in OFK cells grown in
Eagle's medium containing 0.5% foetal calf serum. The titre was 107 2 TCIDSo per ml
Fourteen lambs were obtained at birth and colostrum-deprived. They were bottled-fed
3 times daily on 300ml of warmed cow's milk supplemented twice daily by oral
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administration of a commercial solution of streptomycin sulphate and neomycin
sulphate. Serum samples were obtained from each lamb before inoculation and at
necropsy and stored at -70°C. After three days they were divided into two groups.
Eleven lambs were inoculated with 5ml tissue culture fluid containing the virus; 2ml
were given intranasally and 3ml transtracheally. For intratracheal inoculation a 16
gauge hypodermic needle was inserted into the mid-cervical section of the trachea
under local anaesthesia; a polythene catheter (20 cm x 1 mm external diameter) was
then passed into the trachea to deposit the inoculum in the thoracic part of the trachea
while the lamb was being held horizontally. Three control lambs, housed separately,
received a similar amount of cell culture fluid from non-inoculated cell cultures. The
lambs were observed daily for clinical response. Three lambs were euthanized and
necropsied on post-inoculation day (PID) 3, three on day 5 and five on day 7. The
control lambs were euthanized and necropsied on PID 8. Rectal temperatures were
taken daily from birth. Nasal samples were collected daily with sterile swabs for
isolations of virus beginning from birth. Lung tissues were taken for attempts to
isolate virus and bacteria at necropsy.
2.8.2 OPIV-3 recovery and identification
Nasal swabs during experiment and lung tissues after necropsy were collected for
virus isolations. Nasal secretions or 0.5cm? of lung tissue, minced in Eagle's minimal
essential medium, were inoculated on triplicate tissue culture flasks of subconfluent
OFK cells. The medium was supplemented with 5% foetal calf serum (FCS), 100 pg
gentamycin sulfate and 10 pg of amphotericin B per ml. The flasks were observed
daily for the onset of viral cytopathic effect. Virus in the 3rd to 6th passages were
used for further studies. Cultures for virus isolations were incubated for 14 days,
frozen and thawed, subpassaged and incubated for a further 14 days before they were
considered to be negative.
2.8.3 Bactcriologic examination
Standard bacteriological procedures were used to isolate and identify bacteria and
mycoplasmas from nasal secretions and lung. Samples of the lung were homogenized
to give a 10% suspension in Hank's balanced salt solution (HBSS) containing 0.1%
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yeast extract and 0.5% lactoaibumin hydrolysatc (HYL). Nasal swabs were collected
into 2 ml of HYL . Duplicate 0.1 ml volumes of each dilution were spread on plates of
7% sheep blood agar and the number of bacteria colonies was determined after
overnight incubation at 37°C.
Samples for mycoplasma isolations were stored frozen at -70C until processing.
Mycoplasma broth (BHS-L) and mycoplasma-agar (BHS-A) were prepared as
described by Carmichael et a/.(1972). They were thawed and agitated vigorously
then the fluid was passed through a 0.65jj.m membrane filter to remove gross bacterial
contamination. Serial ten fold dilutions of the filtered material were prepared in 1.8 ml
volumes, of (BHS-L) pH 7.8 and in BHS-L containing lOmg/ml arginine pH 7.0. The
dilutions were incubated for 10 days at 36°C and the titre was recorded as the highest
dilution of sample material showing a pll change and expressed as colour changing
units (c.c.u.)/0.2 ml of sample. Isolates were identified by colony morphology on
(BHS-A) and growth inhibition with specific antiserum.
2.8.4 Serology
Serum samples were collected from all sheep at the beginning of the experiments and
before necropsy. Prior to testing, the serum samples were diluted twofold in MEM
and heat inactivated at 56°C for 30 minutes.
Neutralization tests: Antibody titres to PIV-3 were determined on paired serum
samples from the lambs, using a microtitration serum-virus neutralization test
(Lehmkuhl & Gough, 1977). All samples were tested in triplicate, using twofold
dilutions (from 1:4 to 1:512) in a microtitriation procedure. The test virus (100
median tissue culture infective doses, TCID50) was added to each well. The serum-
virus mixture were incubated for 1 hour at room temperature before the addition of
0.05ml of appropriate cells, at concentrations calculated to allow the immediate
formation of monolayers. The plates were incubated in a CO incubator at 37°C. The
plates were read 2-3 days later. The serum-virus neutralization titres were the highest
dilution of serum in which 50% of the wells were protected from the viral CPE.
All sera were inactivated at 56°C for 30 minutes. Serum neutralisation (SN) tests
were carried out by mixing serial two fold dilutions of serum with an equal volume of
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virus at a dilution calculated to contain 100 TC1D50. The mixtures were incubated at
18°C for 1 hour before inoculation of 4 OFK cell cultures per dilution. End points
were determined by haemadsorption on the 4th day of incubation. The titre was
expressed as the highest dilution of serum preventing growth of virus in 50% of tubes.
Haemadsorption inhibition test were performed as described by Davies et al.{ 1982).
Sera for haemagglutination inhibition (HI) tests were adsorbed with guinea pig
erythrocytes and titrated as described before (see 4.2.1.2.3.). The HI antibody titre
was expressed as the highest initial dilution of serum which completely inhibited
aggutination by 4 units of virus. The source of haemagglutinin was tissue culture fluid
harvested from OFK cell cultures 5 days after infection.
2.8.5 Histopathology of lung lesions
Samples for lung histopathology were taken from each pneumonic and control lungs.
They were fixed in buffered 10% formalin with calcium carbonate. Tissues were
formalin fixed and paraffin embedded according to standard techniques (Lopez et al.,
1982). 5pm sections were obtained with a conventional rotatory microtome Minot
Leitz (Wetzler) and mounted on slides with egg albumin. Mounted sections were
dried and then deparaffined in xylol, rehydrated in alcohol and stained. Then they
were dehydrated in alcohol, cleared in xylol and mounted.
• Histological stains (Lopez et al., 1982):
- Hematoxilin-eosin for general morphology
- Van Gieson staining for identification of fibrosis(colagen type I)
- Giemsa staining for identification of infiltrative leucocytes
I
2.8.6 Immunofluorescence and iminunohistochemistry
Lung samples were taken for imtnunostaining from each pneumonic and control
lambs. They were labelled and placed in plastic bags and immediately immersed in
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liquid nitrogen. The frozen samples were then transferred and stored at -709C until
being cut with a crystotat (Lipshaw MFG. Co. Detroit 10, Michigan, USA). The 8(im
frozen sections were mounted on round coverslips previously covered with 1%
polylysine and then air dried for at least 30 minutes. Sections were processed
according to method described by Bancroft (1975). Briefly, they were fixed in 80%
cold acetone (-202C) in buffer PBS and then processed for immunostaining by
immunofluorescence, indirect immunoperoxidase, indirect immunoalkaline-
phosphatase staining and double-immunostaning as described in sections 2.6.1, 2.6.2,
2.6.3 and 2.6.4, respectively.
2.9 Monocyte-derived macrophages (M/JMt{)j and alveolar
macrophage (AM<t>J cultures
2.9.1 Gelatin-plasma coated flasks or plates
Gelatin coated flasks or plates were prepared according to the method described by
Jones et al. (1989). 2.5 ml or 0.5 ml of 2% sterile gelatin was added to each 25cm2
tissue culture flask or well (of a 24 well plate), respectively. After 1 hr incubation at
372C, the excess gelatin was removed and the plates were dried in a 37eC incubator.
The dried flasks or plates could be stored at room temperature until they were used.
Immediately before use they were incubated with autologous plasma for 30 min at
37QC. The plasma was removed and the flasks or plates were washed twice with PBS.
These pre-treated flasks or plates were then ready for the culture of MDMtj) or AM<j).
2.9.2 Mkmocyte-derived macrophage (MDM<}>) isolation and culture
Blood was collected in heparin-containing tubes (10 U/ml of blood). Buffy coat cells
were obtained by centrifugation of the heparinized blood at 1,250 xg for 15-20
minutes at room temperature. Autologous plasma was collected and used in the
preparation of gelatin-plasma coated flasks or plates. The buffy coat was diluted in
sterile phosphate buffered saline (PBS=0.85% NaCl, 0.02% Kcl, 27mM Na2HPC>4,
1.5 mM KH2P04, pH 7.2), overlaid on lymphoprep (Nyegaard, Oslo, Norway) and
then centrifuged at 1,200 xg for 20 minutes at room temperature. Peripheral blood
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mononuclear cells (PBMC) were harvested at the interface and then washed three
times (500 x g for 5 minutes) with PBS. The PBMC were finally resuspended in
RPMI-1640 medium containing 2 mM L-glutamine, 20 mM HEPES (N-2-
hydroxyethylpiperazine-N-2-ethane-sulphonic acid), 100 U penicillin per ml, 100 p.g
streptomycin per ml and 5 xlO"1 M 2-mercaptoethanol (2-ME) (RPMI) with 10%
foetal calf serum (FCS) and 10% normal lamb serum (NLS) (Gibco) (RPMI/10%
FCS/10%NLS).
The PBMC were counted and the concentration adjusted to 5 xlO6 cells per ml. Then
0.5 ml, 5 ml or 15 ml of the cell suspension was plated into each well (of 24 well
2 2*
plates), 25 cm or 75 cm flasks, respectively. The cells were incubated from 1 hour to
overnight at 372C, 5% C02, depending on the experiment. The non-adherent cells
were washed off with warm RPMI/2% FCS. Fresh RPMI/10% FCS/10% NLS was
added for continuous culture. The culture medium was changed every 5 days. After 5
to 7 days of culture most non-adherent lymphocytes could be removed as above and
the cultured adherent monocyte-derived M(j)s (MDM(j>) were usually confluent. Over
95% of these adherent cells were non-specific-esterase (NSE) positive.
After 7 days in culture, normal cultured MDM<j) showed proliferation and some
detached and became suspended in the supernatant. The suspended cells could be
passaged to other flasks where they became adherent.
2.9.3 Lymphocyte isolation in culture
PBMC from buffy coat were obtained and fractionated in lymphoprep (Nyegaard,
Oslo, Norway) as described in section 2.9.2. Then lymphocytes were separated from
adherent cells. Briefly, PBMC to be depleted of adherent cells were resuspended in
lymphocyte complete RPMI-1640, containing 20% FCS. These cells were incubated
in gelatin-coated prewarmed polystyrene flasks for 3 hrs. at 37QC, 5% C02. Non
adherent cells were aspirated and the cycle repeated. Following the second incubation
lymphocytes were aspirated, washed and resuspended in lymphocyte complete RPMI-
1640 medium containing 2 mM L-glutamine, 20 mM HEPES, 100 U penicillin per ml,
100 |ig streptomycin per ml and 5 xlO"1 M 2-mercaptoethanol (2-ME) (RPMI) with
10% FCS (Gibco). Lymphocytes were resuspended to a concentration of 2 xl06
cells/ml.
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2.9.4 Alveolar macrophage (AM<{)) isolation and culture
Lungs were collected from normal healthy sheep. AM(j> were obtained by lung
washing (LW) with cold Hank's balanced salt solution (HBSS) according to method
described by Mayer & Lam (1984). Firstly, the thoracic cavity was opened and the
trachea, lungs and heart dissected out as a single package, with the upper part of the
thrachea clumped shut to avoid entrance of blood into the lungs. The exterior of this
package was carefully washed with PBS at 37°C to eliminate any remaining blood.
Secondly, the lumen of the trachea was opened and aproximately 50ml of HBSS at
37°C were injected to reach every lobe. The trachea was clamped off and the lungs
gently shaken for several minutes. The fluid was drained into a container and the same
procedure was repeated ten to fifteen times. Finally, after removing the floating cell
debris and mucus at the top of the cell suspension, the collected fluid was pelleted by
centrifugation at 250 x g at 4°C for 10-20 minutes, depending on the volume of LW
fluid. Cell pellets were washed with RPMI/2% FCS three times. The cell number was
counted and adjusted to 5 xlO5 cells per ml in RPMI/20% FCS. Specimens
contaminated with blood were not used. Five ml of cell suspension were seeded into
25cm2 flasks and then incubated at 37°C, 5% CO2. Non-adherent cells were removed
3-4 hours later and the flasks re-fed with fresh medium. The purity of AM(J> cultures
was over 95% as determined by NSE staining. AM<j) were cultured in a similar manner
to monocytes but with RPMI/20% FCS.
In order to harvest adherent MDM<j> or AM<j>, cultures were washed twice with PBS
once and 2.5 ml of 5mM F,DTA in PBS was added to 25cm2 flasks. After 2-5 minutes
incubation the flasks were knocked to dislodge the cells and a rubber policeman was
used to scrape off any adherent remaining cells. The cells were washed once with
warm RPMI/2 %FCS and then used.
2.9.5 Non-specific esterase (NSE) staining
Cytospin smears or cell cultures on glass coverslips were stained for NSE according
to Hudson and Hay (1989). Then cells were fixed in cold 45% v/v formaldehyde, 25
% v/v acetone in 0.1 M phosphate buffer (pH 6.6) for 40 seconds. The fixed cells
were washed in running water and the nuclei were counterstained with 0.4%
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methylene green for 5 minutes. Cells were classified as positive by the appearance of a
brown colour.
2.9.6 Giemsa staining
Fibroblasts were fixed in a cold methanol/acetone mixture (1:1) for 5 minutes and
then treated with 1 % dichromate for 30 minutes. The treated cells were further fixed
with the cold methanol/acetone mixture for 5 minutes. The cells were stained with
Giemsa's solution (2-fold dilution made fresh) for 5 minutes. The stained cells were
washed in mnning water, air-dried and then mounted in DPX. Macrophages were
stained as above but after washing in water they were incubated in Giemsa's buffer
(0.1 M acetic acid, 0.2 M disodium hydrogenphosphate pH 5.75) for 5 minutes,
washed and mounted.
2.10 infection of Monocyte-derived macrophage (MDM<j>) and alveolar
macrophage (AM*)) cultures with OPIV-3
MDMt)) and AM(|) were cultured in 25 cm2 flasks and infected with OPIV-3 270-7
virus at 1 TCID50 per cell on days 5 and 3 of culture, respectively. Then infected and
mock-infected cells were harvested on different days post inoculation by treatment
with 5mM EDTA in PBS.
2.10.1 Transmission electron microscopy (TEM) of OPIV-3 infected monocyte-
derived macrophage (MDMt))) and alveolar macrophage (AMtj)) cultures
MDMcj) and AM<|) cultured in 75cm were infected with OPIV-3 270-7 as described.
On days 1 to 7 p.i. infected and mock-infected cells were gently scraped off the flask
surface with a rubber policeman. The cells were washed once with PBS and then
immediately fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) at 4eC for
2 hours. The fixed cells were washed with cacodylate buffer and then post-fixed in 1%
Osmium tetraoxide for 1 hour at 4eC. The cells were dehydrated through a gradient of
acetone and then embedded in araldite. Ultrathin sections (60nm) were cut and stained
with uranyl acetate and lead cytrate. The stained sections were examined under a
TEM Philips 400 electron microscope.
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2.10.2 Phenotypic analysis of monocyte-derived macrophage (MDM())) and
alveolar macrophage (AM<j>) cultures by flow cytometry
2.10.2.1 Indirect immunofluorescence staining for flow cytometry
Cultured MDM()), AMcj) or fresh peripheral blood monocytes were washed twice with
PBA (PBS containing 0.1% BSA and 0.01% sodium azide). Then they were aliquoted
into Rhesus tubes at lx 105 cells per tube. Cells were pelleted by centrifugation at 250
x g for 3 minutes, 0-C and then resuspended in 25 |ll of primary antibody (mouse
monoclonal antibody) for 40 minutes at 0eC. As a control of staining, cells were
incubated with NMS or NRS (1:500 dilution) as primary antibodies. The panel of
monoclonal antibodies used is shown in Table 2.2. The cells were washed three times
in cold PBA including 2% NRS and 2% NMS and then incubated with 25 |ll of anti-
mouse or anti-rabbit (according to primary antibody) IgG F(ab')2 1:50 dilution
(Dakopatts, Ltd.) for 20 minutes at 20QC. After 3 washes in cold PBA cells were
resuspended in 200 (il of PBA and immediately analyzed by flow cytometry. Cells
were gated according to FSC and SSC parameters on M<j> or lymphocyte areas. The
reactivity of the antibodies was analyzed by flow cytometry using a Becton-
Dickinson FACScan with Consort 30 version F Software. Normal mouse serum
(l:50(j dilution) stained cells were set up as background staining controls. The
percentage of positive cells and mean of fluorescence intensity (MF) were determined
by using Lysis Version 1.62 and Consort 30 version F Software.
2.10.3 Effect of OPIV-3 infection on monocyte-derived macrophage (MDM<{))
and alveolar macrophage (AM<j>) phagocytic capacity
MDM(|) and AM0 were cultured in 24 well plates. The cultured MDM(|) were infected
with OPIV-3 270-7 at 1 TCID50 per cell on days 3, 5, 7 and 9 of culture. The
phagocytic assay was performed on day 10 of culture.






























































2.10.3.1 Opsonization of sheep red blood cells (SRBC)
FITC-labelled SRBC were opsonized by a sub-haemagglutinating dilution (1:40 in
PBS) of anti-SRBC serum developed in rabbits1. SRBC were incubated with this
antiserum for 30 minutes at 37QC. The opsonized SRBC were washed twice with
PBS and then resuspended to 1% in RPMI/2% FCS.
2.10.3.2 FIT'C-labelling of sheep red blood cells (SRBC)
The method described by Tuijman et al.( 1990), was used to FITC-conjugate SRBC.
A 5% suspension of SRBC in microtube was washed 3 times with PBS using a
microcentrifuge (Sanyo) at 3,000 r.p.m. for 2 minutes. The SRBC were incubated
with FITC at a final concentration of 100 (ig/ml in PBS for 30 minutes at 379C. The
FITC labelled SRBC were washed twice in PBS and then opsonized with a pooled
antiserum.
2.10.3.3 Rosetting ofopsonized SRBC with monocyte-derived macrophages
(MDM(f>s) and alveolar macrophage (AM(f>s) in culture.
The rosette method consists in coupling specific proteins to the surface of
erythrocytes. The red blood cells act simply as inert support and the added protein
provides the specificity for all binding. Sheep erythrocytes, coated with
immunoglobulins, by addition of rabbit anti SRBC serum, will form rosettes with
sheep M(j)s that carry Fc receptors.
1 xlO6 AM(J)s in 100 (il were pipetted into Rhesus tubes and incubated with 100 (il of
1% suspension of antibody coated FITC-conjugated SRBC in PBS. After being spun
at 1,500 rpm for 5 minutes, the mixed cell suspension was incubated for 10 minutes at
room temperature and then resuspended and analyzed by flow cytometry.
1
Kindly given by Dr. John Hopkins, Veterinary Pathology Department, Edinburgh University.
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2.10.3.4 Phagocytosis of opsonized SRBC by cultured monocyte-derived
, macrophages (MDM(J)s) and alveolar macrophage (AM<j)s)
MDM(J) and AM<j) were cultured in 24 well plates and infected with OPIV-3 270-7 as
described in section 2.7.7. The cultures were washed with RPMI/2% FCS to remove
non-adherent cells. Assays were then undertaken on adherent cells. The cell cultures
were fed with 250 pi RPMI/2% FCS containing 50 pi of FITC-opsonized-SRBC and
incubated for 1 hour at 372C, 5% CO2.
Non-ingested SRBC were removed with PBS and any of them remaining on the cell
surfaces of the macrophages was lysed hypotonically. This was earned out by adding
distilled water for 30 seconds. The isotonicity of the medium was restored by the
addition of x2 PBS.
The M(]) cultures were treated with 5mM EDTA in PBS for five minutes and then
gently scraped off with a rubber policeman. The cells were transferred into rhesus
tubes, washed with PBA and immediately processed for flow cytometry analysis.




ISOLATION OF PARAINFLUENZA TYPE 3 VIRUS FROM SHEEP: LUNG
PATHOLOGY, VIRUS ISOLATION AND VIRUS CHARACTERISATION
I
3.1 INTRODUCTION
Parainfluenza virus type 3 (PIV-3) is one of the most widespread cause of interstitial
pneumonia and it has been isolated in different countries around the world, including
Great Britain (Hore, 1966). The virus is generally associated with benign respiratory
disease. However, PIV-3 infection has been demonstrated to predispose animals to
acquiring pneumonia produced by bacteria such as Pasteurella haemolytica,
Corynebacterium sp. and rickettsias (Davies et al., 1977, 1986; Sharp et al., 1978;
Yates, 1988). Also, it can increase the severity of bacterial pneumonia (Yates, 1988).
In humans, almost two-thirds of infants can be infected with this virus in the first year
of life; 92% of the children are infected at least once with human PIV-3 (HPIV-3) by
two years of age and 37% have been infected more than once. Most of the lower
respiratory tract disease associated with HPIV-3 infection is found during the first
infection (Glezen et al., 1984).
Reports on PIV-3 affecting sheep (OPIV-3) from various parts of the world, have
included viral isolations and antibody surveys. OPIV-3 has been isolated, from the
lungs of sheep that had pneumonia, in the United Kingdom (Hore & Stevenson,
1969), in the U.S.A. (Lehmkhul & Cutlip, 1982), Canada (Ditchfield, 1966),
Australia (St.George, 1969), New Zealand (Carter & Hunter, 1970), and Argentina
(Epstein, B. 1974) among many other countries. In addition, viral antibodies to
OPIV-3 have been detected in 80% of sheep in France, 90% in South Africa, 32.5%
in Iran, 15.6% in Egypt, 53% in Britain, 60% in Nigeria and 40.9% in India (Brako
et al., 1984). These are the results from the haemagglutination inhibition (HI) test.
These numbers would probably be found to be higher with the virus neutralization test
which is more sensitive than HI (St. George, 1971). These results indicate that OPIV-
3 virus infection is widespread throughout the world.
Different PIV-3 strains have been identified in human and cattle producing respiratory
tract disease (Klippmark et al., 1990) and their antigenic relationship has been
investigated (Ray & Compans, 1986). Strains of this virus have also been identified in
sheep (Ditchfield 1966; St George 1969; Carter & Hunter, 1970; Epstein, 1974;
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Davies et al., 1977; Sharp et al., 1978; Lehmkuhl & Cutlip, 1982), however, the
antigenic relation between ovine and the human or bovine strains is not clear.
The frequency of infection by OPIV-3 virus in sheep, determined by serological tests,
seems to be quite high in Chile (68%), particularly in central and southern areas of the
country (Berrfos et al., 1987; Riedeman, et al., 1990). Here infection produces
economic losses because of treatment costs incurred, delayed sale and death. PIV-3
has been isolated from cattle (Berrfos et al., 1990), but there are no reports on
isolations from sheep.
PIV-3 causes clinical disease in cattle and sheep, independent of its role in leading to
secondary bacterial infections of the respiratory tract. In calves and lambs infection is
marked by fever, lacrymation, serous nasal discharge, depression, dyspnea and
coughing. Many animals may exhibit minimal clinical signs, but some may develop
interstitial pneumonia. In the latter cases, lesions consisting of inflammatory
consolidation are usually present only in the anterior lobes of the lungs. Because of
the variety of agents that can cause these kinds of clinical and pathological
manifestations, etiological diagnosis can only be achieved by virus isolation from nasal
swabs or postmortem material. Virus isolation is usually done in cell cultures of
bovine origin and vims is identified serologically by immunofluorescence,
haemagglutination inhibition or virus neutralization (Fenner, 1987a,b).
The objective of this work was to isolate and characterise OPIV-3 from field cases of
sheep pneumonia in Chile. The infectivity of the viral isolates was titrated in order
to use them in experimentally reproducing respiratory disease in sheep. This allowed
the production of pathological lung material, for studies on the immune cell response




3.2.1 Isolation of ovine PIV-3 from clinical cases
Ten sheep, from southern areas in Chile, showing respiratory disease symptoms were
necropsied and samples from nasal secretions and lung lesions were taken for OPIV-3
isolation. Viral isolates were obtained from three animals and identified as 430-7,
392-10 and 270-7. These three viral isolates showed the same characteristics as
described for PIV-3.
The animals showed similar symptoms including increased respiratory rate, mouth
breathing, mucopurulent rhinitis, anorexia and some weight loss.
3.2.2 Pathology
3.2.2.1 Gross pathology findings:
Gross lesions consisted of well demarcated, homogenous red or red-gray foci of
consolidation scattered in all lobes but affecting in particular the anteroventral lung
areas. Atelectasis was generally observed at the margins of the anterior lobes. In cases
392-10 and 430-7 a few small pulmonary abscesses were found with associated
fibrous pleural adhesions. Most consolidated areas were dark red, slightly depressed,
rounded or irregular in shape from 1 to 5cm in diameter. A fibrinopurulent exudate
was present in nasal mucosa of sheep 430-7 (data not shown).
3.2.2.2 Histopathology findings:
Common microscopic lesions included diffuse subacute interstitial pneumonitis and
secondary bronchopneumonia. There was bronchial and bronchiolar epithelium
damage with swollen, defoliating and necrotic cells. Areas of consolidation were
present in the parenchyma, due to extensive proliferation of septal cells and M<])S. A
variable degree of peribronchial and peribronchiolar lymphocyte and M(j) accumulation
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was present in all lungs (Fig.3.la). A marked bronchiolar associated lymphoid tissue
(BALT) hyperplasia was frequently observed. These lymphoid structures were
surrounded by both atelectasis and emphysema (Fig.3.1b). Sometimes, bronchioles
and small bronchi were occluded by necrotic debris and PMN infiltration (Fig.3.1c).
In addition, perivascular lymphocytes cuffs were often observed. More severe lesions
were found in cases 392-10 and 430-7 and consisted of areas of necrosis, focal
abscessation, perivascular fibrosis and pleural inflammation and fibrosis (Fig. 3. Id).
3.2.2.3 Bacteriologyfindings
Material from lung specimens was inoculated into 5ml amounts of infusion broth and
into 7% sheep blood agar, then incubated overnight at 37°C. Broth cultures were sub-
cultured to blood agar the following day and suspected colonies of Pasteurella
haemolytica were detected in samples from two lungs (392-10 and 430-7) and
subcultured for further examination. Isolates of Pasteurella haemolytica biotype A,
serotype 2 were obtained from these two lungs, according to the method described by
Biberstein & Thompson (1966). No Pasteurella spp was isolated from the third lung
(270-7). Mycoplasma was not detected in any of these three cases of sheep
pneumonia.
3.2.2.4 Serology
Antibody titres to PIV-3 were determined in serum samples from the lambs (270-7,
392-10 and 430-7), taken before necropsy, using a microtitration serum-virus
neutralization test (Lehmkuhl & Gough, 1977). A reference strain of OPIV-31 and its
antiserum, were used to carry out the test. The three lambs 270-7, 392-10 and 430-7
had positive SN titres of 640, 320 and 320, respectively.
1 Ovine isolate of PIV-3 named Moredun kindly supplied by Dr. Peter Nettleton (Moredun Institute,
Edinburgh, UK)
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FIGURE 3. 1 Formalin fixed and paraffin embedded tissue sections of pneumonic
lungs taken from lambs 270-7, 392-10 and 430-7.
a) A marked accumulation of
mononuclear cells with lymphocytes
(L) and M(|)s is observed around the
bronchioles (B) in lamb 270-7. H/E
stain. Magnification xlOO.
c) Necrotic cell debris and PMNs (P)
occluding the lumen of a small
bronchiole. Intense accumulation of
lymphocytes (L) around and beneath
the epithelium in lamb 430-7. Giemsa's
stain. Magnification xlOO.
b) Hyperplasia of bronchiolar
associated lymphoid tissue (BALT)
(arrow) surrounded by emphysema (E)
and atelectasis (A) in lamb 270-7.
Giemsa's stain. Magnification x40.
d) Pleural inflammation with an
accumulation of lymphocytes (L) and a
marked increase in thickness due to





3.2.3.1 Inoculation ofcell cultures
The isolation and characterisation of the viral isolates were carried out in ovine foetal
kidney (OFK), bovine foetal kidney (BFK) and ovine skin fibroblast (OSF) cell
cultures. All cell culture were assessed as free of bovine viral diarrhea (BVD) virus.
For comparison purposes and as positive controls reference virus strains were used
including two bovine isolates of PIV-3 (BPIV-3) and one ovine isolate of PIV-3
(OPIV-3). Cell cultures were carried out in 24 well tissue culture plates with round
coverslips and inoculated with 0.1 ml of inoculum from lung samples. Coverslips were
removed after 1,2,3,4, and 5 days p.i.
3.2.3.2 Cytopathic effect (CPE)
The CPE induced by the three ovine isolates was studied in primary and secondary
OFK BFK and OSF cell cultures. Observations by inverted tight microscopy showed
disruption of the cell monolayer with presence of large swollen round cells, as the
earliest indication of CPE. This started from 24hrs. post inoculation (p.i.) and
increased in severity through 48 hours p.i., when syncytia formation appeared. After
72 hours the virus had destroyed most of the cell culture, achieving rapidly 100%
CPE. Syncytia began to shrink, became pyknotic and eventually sloughed into the
medium (data not shown).
After 24 hrs. p.i., cell cultures stained with haematoxytin/eosin revealed the
appearance of large round refractive cells, some of them in mitosis (Fig.3.2a).
Whereas, the formation of cytoplasmic eosinophilic inclusions, irregular in shape and
2
Bovine isolate of PIV-3 kindly supplied by Dr. Neil Watt (Edinburgh University, Veterinary
Pathology Department, Field Station, Edinburgh, UK).
Bovine isolate of PIV-3 named La Pintana 84(Berrfos et al., 19) kindly supplied by Dr. Patricio
Berrios (Laboratorio de Virologfa, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de
Chile, Santiago, Chile).
Ovine isolate of PIV-3 named Moredun kindly supplied by Dr. Peter Nettleton (Moredun Institute,
Edinburgh, UK)
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size and surrounded by a halo was most frequently observed after 48 hrs. p i.
(Fig.3.2b). At this time p i. there was also syncytia formation (Fig.3.2c,d), that was
produced by isolates 392-10 and 270-7, but not by isolate 430-7. Nuclear inclusions
were rarely observed.
The CPE produced by the three isolates was similar to that observed after inoculation
with two BPIV-3 and one OPIV-3 reference viruses.
3.2.3.3 Transmission electron microscopy(TEM) of viralparticles
Material from cell cultures infected with the three ovine isolates was processed for
negative staining and observed under transmission electron microscopy (TEM).
Predominantly pleomorphic spherical viral particles of 150 to 320nm in size were
found. Nucleocapsids with the typical herringbone arrangement could be seen within
and spilling out of disrupted virus (data not shown).
Cell cultures were grown in 75 cm? tissue culture flasks and inoculated with ovine
viral isolates 270-7, 430-7 and 392-10. Cells were collected by scraping them off after
1,2, and 3 days p.i. Ultrathin sections were prepared from infected and mock-infected
cultures and observed by TEM. The first sign of progeny viral development was the
appearance of small filamentous cytoplasmic inclusions, after 24 hrs. p.i. These were
usually located in a perinuclear position (Fig.3.3a). Inclusion material in the
perinuclear region tended to be more tightly packed than the one located in other
parts of the cytoplasm. At 48 hrs. p.i. cytoplasmic inclusions were larger and more
numerous (Fig.3.3b). This material was only occasionally seen inside the nucleus (Fig.
3.3c). Other changes in the cytoplasm included an increased number of
polyribosomes, swollen mitochondria and displacement of cytoplasmic organelles by
filamentous inclusions. This was concurrent with the first signs of viral maturation
which included both presence of immature virus particles in cytoplasm and budding
and release of virus particles inside cytoplasmic vesicles (Fig. 3.3d). Then budding
was also observed at the cell membrane (Fig.3.3e). In isolated areas the cell
membrane appeared thickened with the outer aspect being covered with a fringe
(Fig.3.3f). Along the inner surface of the cell membrane lay a row of tubules cut in
cross section. Adjacent to these areas and outside the cell there were roughly
spherical particles (Fig.3.3g) completely surrounded by a similar fringed membrane
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FIGURE 3. 2 Time dependent cytopathic effect (CPE) in ovine foetal kidney (OFK)
and ovine skin fibroblasts (OSF) cell cultures inoculated with ovine isolates 270-7,
430-7 and 392-10. Cell cultures were carried out in 24 well tissue culture plates with
round coverslips and inoculated with 0.1 ml of inoculum from lung samples.
Coverslips were removed after 1,2,3,4, and 5 days p.i.
a) OFK cell culture after 24 hrs. p.i.
with an inoculum of lung sample
430-7. Formation of large round cells
which later detach from the cell
culture monolayers is observed. H/E
stain. Magnification xlOO.
c) OSF cell culture after 48 hrs. p.i.
with inoculum of lung sample 392-10.
Syncytia formation together with a
cytoplasmic eosinophilic inclusion
body are observed. H/E stain.
Magnification x200.
b) BFK cell culture after 48 hrs. p.i.
with inoculum of lung sample 270-7.
There are numerous pleomorphic
cytoplasmic eosinophilic inclusion
bodies (arrows). H/E stain.
Magnification x400.
d) OSF cell culture after 48 hrs. p.i.
with inoculum of lung sample 270-7.
Syncytia formation together with
numerous pleomorphic cytoplasmic
eosinophilic inclusion bodies are
observed. H/E stain, magnification
x200.
 
(Fig.3.3h). These particles were pleomorphic and had an overall diameter of 150 to
320 nm. They were observed first inside the cytoplasm then budding through the cell
membrane and finally detaching from the cell surface.
Cytoplasmic inclusions containing filamentous material were seen as early as 24 hours
p.i., but were larger and more numerous after 48 and 72 hours p.i. Virus buds being
most evident after 48 hours p.i. of cell cultures. Beneath the virus buds,
ribonucleoprotein appeared to follow a helical configuration or as dots in cross
section. The cytoplasmic membrane in some areas was covered with virus spikes
(peplomers).
The ultrastructure of the three reference virus particles showed similar morphological
characteristics, although BPIV-3 particles had a larger range for virus particle size of
210-520 nm (data not shown).
3.2.4 Titration of the ovine viral isolates
OFK cell cultures were infected separately with the three ovine isolates 430-7, 392-10
and 270-7. Culture fluid from the 5 th passage was used to titrate virus infectivity.
The titration considered the CPE induced in OFK cell cultures and the mean titre was
expressed as mean TCID50/0.1ml of cell culture fluid ±S.E. The haemagglutinating
activity was assessed with guinea pig erythrocytes and the titre was expressed as the
highest initial dilution of haemagglutinin causing complete agglutination of the
erythrocytes (Table 3. 1).
I
3.2.5 Viral physical and chemical properties
3.2.5.1 Sensitivity to extreme pH.
Buffers solutions pH 3.0, 7.0 and 9.0 were prepared (see section 2.2.1.4.1), then 10
fold virus dilutions were made with them to be incubated at 40°C for 15 minutes,
Anally the extreme pHs were neutralized by adding NaOH or HC1 0.25M. After being
exposed to pH 3.0 and 9.0 media conditions for 15 minutes, the three ovine viral
isolates as well as the reference virus, lost infectivity. hi contrast, they did not show
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FIGURE 3. 3 Transmission electron microscopy (TEM) of OFK and OSF cell
cultures infected after OPIV-3 infection. Cell cultures were grown in 75 cm3 tissue
culture flasks and inoculated with ovine viral isolates 270-7, 430-7 and 392-10. Cells
were collected by scraping them off after 1,2, and 3 days p.i.
a) OSF cell culture after 24 hrs. p.i.
with ovine viral isolate 392-10. There
is an accumulation of filamentous
material (arrow) in the cytoplasm close
to the perinuclear area. TEM.
Magnification x46,000.
b) OSF cell culture after 48 hrs. p.i.
with ovine viral isolate 270-7. A large
inclusion of filamentous material tightly
packed can be observed close to the
nucleus. TEM. Magnification x 16,500.
c) OSF cell culture after 48 hrs. p.i.
with ovine viral isolate 430-7. A large
inclusion of filamentous material is
observed inside the nucleus. TEM.
Magnification x 16,500.
d) OSF cell culture after 48 hrs. p.i.
with ovine viral isolate 430-7. Virus
budding in the membrane of the
cytoplasmic vesicles can be seen with
an accumulation of vims particles
inside these vesicles. TEM.
Magnification x215,000.
e) OSF cell culture after 48 hrs. p.i.
with ovine viral isolate 430-7. Vims
budding can be seen from the cell
membrane with viral particles
detaching from it. TEM. Magnification
x215,000.
f) OSF cell culture after 48 hrs. p.i.
with ovine viral isolate 270-7. An
incomplete vims particle can be seen in
an early stage of vims budding. The
vims particle is inside the cytoplasm
close to the cell membrane. The cell
membrane appears thickened at this
point with the outer aspect being
covered by a fringe. TEM.
Magnification x315,000.
g) OSF cell culture after 48 hrs. p.i.
with ovine viral isolate 270-7. A group
of pleomorphic vims particles (150-
320nm) can be seen after having been
released from the cell membrane.
TEM. Magnification x215,000.
h) OSF cell culture after 48 hrs. p.i.
with ovine viral isolate 270-7. Vims
particle surrounded by a fringed
membrane after being released. TEM.
Magnification x315,000.
 
alterations in infectivity when maintained in standard MEM culture media or exposed
to pH 7.0 media conditions for 15 minutes (Table 3. 2).
3.2.5.2 Sensitivity to tipidic solvents
The sensitivity to ether was performed according to a method described by
Andrewes & Horstman (1949). The sensitivity to chloroform was assessed following
the method described by Feldman & Wang (1961). The virus was suspended in 20%
v/v ether or 33% chloroform, in culture media (the control was suspended in 20% v/v
Puck's saline solution A). The three ovine isolates together with the reference viruses
lost their infectivity after being exposed to 20% ether for 24 hrs. and to 33%
chloroform for 10 minutes (Table 3.3).
3.2.5.3 Sensitivity to trypsin
The sensitivity to trypsin was shown using a method described by Gresser & Enders
(1961). 1%, 0.5% and 0.25% solutions of trypsin were prepared with Puck's saline
solution A. Then, 1 ml of virus suspension was mixed with 1 ml of the trypsin dilution.
Tubes were incubated at 37°C in a thermoregulated bath for 60 minutes. As control, 1
ml virus suspension was mixed with 1 ml of Puck's saline solution A. Then they
followed the same procedure.
The three ovine PIV-3 isolates along with the reference virus lost their infectivity after
being treated with high concentrations of trypsin. Virus isolate 392-10 and the
reference virus showed decreased infectivity after being treated with 0.25% and 0.5%
trypsin dilutions and lost all infectivity after 1% trypsin treatment. Isolates 430-7 and
270-7 did not show change in infectivity titre after 0.25% trypsin treatment but lost
infectivity after being treated with both 0.5% and 1 % trypsin (Table 3. 4).
3.2.5.4 Heat sensitivity
Test tubes were previously warmed up to 56°C and then 0.5ml of virus suspension
was added to each of them. They were immediately taken to a thermoregulated bath
at 56°C. Each tube was removed from the thermoregulated bath at different times
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TABLE 3. 1 Titration of both virus infectivity in ovine foetal kidney (OFK) cell
cultures and haemagglutinating activity (HA) of guinea pig erythrocytes for ovine
viral isolates.




Reference OPIV-3 5.8 512
1 Calculated according to method by Reed & Muench (19.18).
2 Tilre expressed as Logto TCIDso/lml of virus.
TABLE 3. 2 Sensitivity of three ovine viral isolates to extreme pH conditions
during 15 minutes.
Viral isolate pH Control( MEM)
3.0 7.0 9.0
392-10 0.0 6.5* 0.0 6.5
430-7 0.0 6.2 0.0 6.2
270-7 0.0 6.9 0.0 6.9
Reference OPIV-3 0.0 6.2 0.0 6.2
* Titrc expressed as Logm TCID50/I ml of virus.
I
TABLE 3. 3 Sensitivity of three ovine viral isolates of PIV-3 to lipidic solvent
exposure.
Viral isolate Ether 20 % Chloroform 33 % Control
392-10 0 0 6.5*
430-7 0 0 6.2
270-7 0 0 6.9
Reference OPIV-3 0 0 6.0
* Titre expressed as Logio TCID5(/lml of virus suspension.
TABLE 3. 4 Sensitivity the three ovine viral isolates to 60 minutes trypsin
treatment.
Viral isolate Trypsin solution Saline
solution
0.25% 0.5% 1%
392-10 ■ 5.8 2.1 0 6.5
430-7 6.5 0 0 6.2
270-7 6.9 0 0 6.9
Reference OPIV-3 5.1 2.6 0 6.1
* Titre expressed as Logio TCID50/lml ofvirus suspension
(0, 5, 10, 20 and 30 min.). The three viral isolates and the reference virus were
sensitive to exposure to 565C for 30 minutes. After this exposure they lost their
infective capacity. Virus isolate 392-10 lost its infectivity completely after 30 minutes
exposure whereas the other two lost all infectivity after 20 minutes of exposure to
56QC (Table 3. 5).
3.2.6 Antigenic relationships.
I
3.2.6.1 Comparison of three ovine isolates ofPW-3 (270-7, 392-10 and 430-7)
and reference strain of OPIV-3 by reciprocal cross inhibition of
haemagglutination.
The antigenic relationships among the three ovine isolates and reference strain of
OPIV-3 were studied by a two-way cross-inhibition of haemagglutination test. The HI
antibody titre of the serum was taken as the highest initial dilution of serum which
affected complete inhibition of haemagglutination.
Homologous titres ranged from 1280 to 640 and were higher than, or equivalent, to
those obtained with any of the heterologous strains (Table 3.6). The three ovine
isolates (270-7, 290-10 and 430-7), appeared to be closely related to each other, less
so to reference OPIV-3, although none of the differences could be considered notable.
Furthermore, there was no evidence that any of these ovine isolates was serologically
distinct from the others or from the reference strain. There was, however, a distinct
one-sided relationship between reference OPIV-3 and sera raised against the other
ovine isolates.
3.2.6.2 Comparison of three ovine isolates ofPIV-3 (270-7, 392-10 and 430-7)
and reference strains ofOPIV-3, BPIV-3 and HPIV-3 by reciprocal
cross serum-virus neutralisation test.
In view of the results of the cross-haemagglutination test using OPIV-3 reference
strain, it was considered worthwhile to investigate further the antigenic relationship
between these ovine isolates of PIV-3 (270-7, 392-10 and 430-7) and reference PIV-3
from different species. This time a two way cross serum virus neutralisation test was
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Viral isolate 0 5 10 20 30
392-10
1
6.5 5.5 3.5 1.5 0
430-7 6.2 4.5 2.0 0 0
270-7 6.9 5.6 2.0 0 0
Reference OPIV-3 6.2 5.0 2.5 0 0
* Tilrc expressed as Logio TC IDVI ml of virus suspension.
TABLE 3. 6 Comparison of antigenic relationships among three ovine PIV-3 isolates
and reference OPIV-3 (OPIV-3r) strain in a two-way cross-haemagglutination
inhibition test.
Rabbit anti-sera raised against
Viral isolate 392-10 430-7 270-7 OPlV-3r Control
392-10 640' 320 640 160 <5
430-7 640 640 320 160 <5
270-7 640 640 1280 320 <5
OPlV-3r 320 320 640 640 <5
control2 <5 <5 <5 <5 640
1 Median titre is expressed as reciprocal of serum dilution
2 BVDV-I61 kindly supplied by Dr. Patricio Berrios (Laboralorio dc Virologia, Facultad dc
Cicncias Vctcrinarias y Pccuarias, Univcrsidad dc Chile, Santiago, Chile).
used (Lehmkuhl & Gough, 1977) and reference strains including ovine P1V-3 (OPIV-
3), bovine (BPIV-3) and human (HPIV-3) strains. All samples were tested in
triplicate, using twofold dilutions (from 1:2 to 1:512). The serum-virus neutralization
titres were the highest dilution of serum in which 50% of the wells were protected
from the viral CPE.
Homologous titres ranged from 1280 to 640; however the titres in general were
higher in the SN test. Homologous titres were higher than, or equivalent, to those
obtained with any of the heterologous strains (Table 3.7). The three ovine isolates
(270-7, 290-10 and 430-7), appeared to be more closely related to each other than to
any of the reference PIV-3 strains. They appeared to be less related to HPIV-3 than to
OPIV-3 or BPIV-3. However, again none of the differences could be considered
significant. Also, there was no evidence that any of these ovine isolates was
serologically distinct from the others or from the reference strains. Similar to that
observed with HI there was a distinct one-sided relationship between reference
OPIV-3 and sera raised against the three ovine isolates. Furthermore, the same
pattern of relation was observed between the BPIV-3 reference strains and the three
ovine isolates.
3.2.7 Identification of OPIV-3 particles in infected cell cultures by
immunofluorescence and immunocytochemistry
Every staining was carried out in triplicate using the rabbit anti-sera against both the
ovine viral isolates and the reference virus. Monoclonal antibodies raised against HN
(4.795) and F (3.283) proteins of human PIV-3 and showing reactivity with bovine
PIV-3 (Klippmark et al., 1990) were also used to detect viral particles in lung lesions
of infected lambs. Previously the sera and monoclonal antibodies were titrated in
order to determine optimal dilutions for immunostaining.
I
3.2.7.1 Indirect immunofluorescence (1IF)
OFK and OSF cell cultures were infected separately with each one of the three ovine
isolates and also with the reference virus. Positive fluorescence was detected in all
these infected cultures after incubation with either homologous or heterologous rabbit
anti-sera, followed by incubation with FITC-conjugated anti-rabbit Ig. The
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TABLE 3. 7 Comparison of antigenic relationships between three ovine PIV-3
isolates and reference PIV-3 strains from different species by two-way cross serum-
virus neutralization test.





IIPIV-3 OPIV-3 392-10 430-7 270-7 Control2
392-10 3203 320 160 320 1280 640 640 <5
430-7 320 640 160 160 640 1280 640 <5
270-7 640 320 320 640 1280 640 1280 <5
BPIV-3/CH 1280 640 320 640 160 160 320 <5
BP1V-3/UK 320 640 320 320 160 160 320 <5
HPIV-3 ND ND ND4 ND ND ND ND ND
OPIV-3 640 640 160 1280 640 640 1280 <5
Control <5 <5 <5 <5 <5 <5 <5 640
1 BPIV-3/CH=antiscrum to bovine isolate of PIV-3 named La Pintana 84 (Berrios el a!., 1991)
kindly supplied by Dr. Patricio Berrios (Laboralorio dc Virologia, Facultad dc Ciencias
Veterinarias y Pecuarias, Universidad dc Chile, Santiago, Chile).
BPI V-3/UK=antiserum to bovine isolate of PIV-3 kindly supplied by Dr. Neil Watt (Edinburgh
University, Veterinary Pathology Department, Field Station, Edinburgh, UK).
HPIV 3-anliscrum to human isolate of P1V 3 used to raise monoclonal antibodies anti HPIV 3
viral proteins (Klippmark et al., 1990), kindly supplied bv Dr. Robert Rydbcck, Virology
Department, Karolinska Institute, Stockholm, Sweden.
OPIV-3=antiscrum to ovine isolate of PIV-3 named Moredun kindly supplied by Dr. Peter
Ncttlcton (Morcdun Institute, Edinburgh University, Edinburgh, UK)
2 BVDV-161 kindly supplied by Dr. Patricio Berrios (Laboratorio de Virologia, Facultad de
Ciencias Vcterinarias y Pecuarias, Univcrsidad dc Chile, Santiago, Chile).
3 Median litre is expressed as reciprocal of scrum dilution
4 Not done for this experiment. Reference titre with homologous virus=640
I
fluorescence staining pattern was of high intensity and involved botli the cell
membrane and cytoplasm (Fig.3.4a). Immunostaining of the same infected cultures
with monoclonal antibody PIN4.795 (against HPIV-3 HN protein), showed a more
scattered and discontinuous staining pattern of cell membrane and cytoplasm.
Furthermore, the intensity of staining was lower (Fig.3 .4b). On the other hand, no
reaction was observed after incubation with monoclonal antibody F3.283 (against
HPIV-3 F protein).
In general, the majority of cells in the infected cultures showed some degree of
fluorescence, particularly large round cells that were detaching from the cell
monolayers (Fig.3.4a,b). Although fluorescence was detected from 24 hrs. pi. the
fluorescence intensity was greatest at 48 hrs. p.i. Non-infected control cultures and
infected cultures incubated with normal rabbit sera did not reveal fluorescence.
The specific fluorescence seen in infected cultures first appeared in occasional cells by
24 hrs. p.i. By 48 hrs. small groups of cells were positive and by 72 hrs. p.i. most of
the cell monolayer was disrupted and the remaining cells were reacting intensely for
PIV-3 staining. Specific fluorescence first appeared in the perinuclear area, usually as
a diffuse fluorescence which spread to larger areas of the cytoplasm. In a few cells
early fluorescence appeared as bright pin-points on the nuclear membrane. At 48 to
72 hrs. p.i. the whole cytoplasm including the long cytoplasmic processes of spindle-
shaped cells was positive. Very bright fluorescence occurred occasionally at the
margins of the cytoplasm (Fig. 3.4a). No specific nuclear fluorescence was detected,
although a hazy and somewhat diffuse fluorescence was seen in some nuclei in the
later stages of infection.
3.2. 7.2 Immunocytochemistry
OFK cell cultures, infected with either the ovine isolates or the reference virus were
stained by both indirect immunoperoxidase (IIP) and indirect immunoalkaline
phosphatase (HAP) methods. These techniques were carried out using rabbit antisera
to OPIV-3 and monoclonal antibodies to HPIV-3. The virus-antibody reaction was
visualized by the appearance of a brown colour in the case of IIP and of a red colour
in the case of IIAP. The reactivity with the antibodies showed a similar pattern as for
IIF in that positive staining was achieved with anti OPIV-3 polyclonal sera and
monoclonal antibody 4.795 (anti HPIV-3 HN protein) but not with monoclonal
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antibody 3.283 (anti HPIV-3 protein F). The staining pattern was similar to that
observed after IIF. This included the staining of the cell membrane and cytoplasm but
not of nuclei (Fig.3.4c,d). After IIP and IIAP it is possible to counterstain nuclei and
observe under light microscope; this gives samples with a better morphology and
allows identification of cell types and their characteristics. Here a marked staining of
cytoplasm of large round cells was also observed. Many of these cells were
undergoing mitosis (Fig.3.4c,d). Along with the positive staining of cell membrane
and cytoplasm a number of multiple intracytoplasmic inclusion bodies were observed
(Fig.3.4c). There were no significant differences between staining with homologous
and heterologous rabbit anti-sera. Some background was detected with control
staining by IIP, but it did not interfere with interpretation of positive staining. The
staining with monoclonal antibody showed no background after either IIP or DAP
staining.
3.2.8 Reactivity of a panel of monoclonal antibodies anti-HPIV-3 with OPIY-3
isolates by flow cytometry.
Monoclonal antibody F3.283 recognizes an epitope present in protein F of both
HPIV-3 and BPIV-3 (Klippmark et ai, 1990). OFK and OSF cell cultures, infected
with either the ovine isolates or the reference OPIV-3, were incubated with this mAb
for virus detection by immunostaining (see section 3.2.7). No expression for this
epitope of protein F was detected in either cell membrane or cytoplasm. This was
thought to be due to antigenic differences between the ovine isolates and both HPIV-
3 and BPIV-3. In order to investigate if there were any further antigenic differences, a
panel of murine mAbs anti HPIV-3 proteins (see Table 3. 8) was tested with both the
three ovine isolates and the reference OPIV-3. All these mAbs have cross reactivity
with epitopes on the same proteins of BPIV-3 (Klippmark et al., 1990). Reference
BPIV-3 was also used as a control for the reactivity of the mAb panel and for
comparison.
The reactivity of this mAb panel with viral proteins expressed either on the cell
surface or cytoplasm of infected OSF cells was detected by indirect
immunofluorescence (IIF). OSF cells were cultured in 75cm3 flasks and were infected
3
Kindly supplied by Dr. Robert Rydbcck, Virology Dcpartaincnt, Karolinska Institute, Stockholm,
Sweden.
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FIGURE 3. 4 Immunostaining of OFK and OSF cell cultures infected with ovine
viral isolates 270-7, 430-7 and 392-10. Cell cultures were grown in 24 well plates
with round coverslips. After 1, 2, 3 and 5 days p.i. coverslips were removed and
immunostained by IIF, IIP or IIAP using anti OPIV-3 rabbit antisera or monoclonal
antibodies (FIN 4.795 and F3.283).
a) OFK cell culture after 48 hrs. p.i.
with ovine viral isolate 430-7. After
staining with OPIV-3 rabbit antisera
there is a high intensity of fluorescence
of the cell membrane and the
cytoplasm. Very bright fluorescence
can be observed sometimes at the
margins of the cytoplasm. IIF.
Magnification x400.
b) OFK cell culture after 48 hrs. p.i.
with ovine viral isolate 430-7. After
staining with monoclonal antibody HN
4.795 there is an intermediate intensity
of fluorescence of the cell membrane
and the cytoplasm. The photograph
was taken with the same exposure
time as in a). Magnification x400.
c) OFK cell culture after 48 hrs. p.i.
with ovine viral isolate 392-10. After
staining with rabbit antisera there is
stronger staining (brown colour) of the
cell membrane and the cytoplasm of
round cells(large arrows) than in cells
showing pleomorphic cytoplasmic
inclusions (small arrows). IIP.
Magnification x400.
d) OFK cell culture after 48 hrs. p.i.
with ovine viral isolate 270-7. After
staining with rabbit antisera there is
strong staining (red colour) of the cell
membrane and the cytoplasm of round
cells. In the other cells the staining is
seen mostly in the cell membrane
(small arrows). IIP. Magnification
x400.
 
with either of the three ovine isolates (270-7, 392-10 or 430-7) or reference strains
(OPIV-3 or BPIY-3). Cell cultures were infected with the virus at 0.5 TCID50 per cell
or mock infected 1, 2 or 3 days before immunostaining by IIF. Viral proteins
expressed on the cell surface were detected on non-fixed cells as previously described
(section 2.). IIF was carried out in rhesus tubes as described in section 2. and
analyzed by flow cytometry. OSF cells infected with the BPIV-3 reference strain
expressed all proteins epitopes detected by this mAb panel in a moderate to high
amount, according to the mean fluorescence intensity. Fig. 3.5. shows a profile with
the time dependent expression of different viral protein epitopes in OSF cultures after
infection with BPIV-3.
The reactivity of the mAb panel with OSF cell cultures infected with either of the
ovine isolates or OPIV-3 reference virus was very similar in each case. Generally no
significant differences (at p<0.05). were detected in comparing the reactivity among
the three ovine isolates with this mAb panel against HPIV-3 antigenic proteins. In
contrast, some significant differences were found when their reaction was compared
to that shown by OSF cells infected with the BPIV-3 reference strain. The expression
of the PIV-3 protein epitopes, detected by the monoclonal panel, was analysed in
OFS cultures after 3 days of infection. Table 3.8. shows the comparison of expression
between cultures infected with either of the three OPIV-3 isolates and cultures
infected with BIPV-3 or OPIV-3 reference strains.
The reactivity of mAbs HN4771 and HN 4795, against two different epitopes of HN
protein from both HPIV-3 and BPIV-3 (see Table 3.8), was tested. These two mAbs
reacted with the three ovine isolates and also with reference strains of OPIV-3 and
BPIV-3. No highly significant differences (at p<0.05) in the expression of the epitopes
detected by these mAbs were observed among the ovine isolates. However, in cells
infected with either of the ovine derived virus strains there was a significantly lower
intensity of expression for both HN epitopes 4.771 and 4795 (p<0.05 and p<0.001,
respectively) when compared to that shown by BPIV-3 infected cells (Fig.3.6).
I
Monoclonal antibodies F3263, F4503 and F4673 react with two different epitopes of
F protein from HPIV-3 and BPIV-3 (see Table 3.8). None of these mAbs reacted with
any of the ovine derived virus strains (Fig.3.7). In contrast, the reactivity of the three
mAbs against HPIV-3 F protein with reference BPIV-3 was of very high intensity.
Staining on fixed cells in PBS 80% methanol was carried out to detect
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TABLE 3. 8 Reactivity of a monoclonal antibody panel anti IIPIV-3/BPIV-3 viral
proteins with OSFa cultures alter 3 days post infection with ovine OPIV-3 isolates
(270-7, 392-10 and 430-7), by flowcytometry.
Viral MAbs Epitope OPIV-3 Virus isolates PIV-3 reference
strains
Protein Group 270-7 392-10 430-7 OPIV-3 BPIV-3
HN 4771 llb 40.5+3.8c'd 35.1+5.2d 32.7+5.5d 38.3+5. ld 49.2+4.9
4795 III 40.3+4.4" 39.3+4.5° 34.5+3.9° 43.6+3.5° 78.3+5.6
F 3263 1 0.0 0.0 0.0 0.0 65.4+4.8
4503 I 0.0 0.0 0.0 0.0 68.2+4.3
4673 11 0.0 0.0 0.0 0.0 66.3+3.9
NP 4721 L1I 40.6+4.3d 43.7+3.9d 31.2+4.5° 48.5±5.2d 57.4+5.1
4794 V 56.2+4.7 49.2+5.1 45.5±3.8d 57.3+4.4 59.3+4.6
4890 II 62.7+5.2 59.5+5.8 65.3+4.2 68.4+5.9 70.1+4.8
M 2873 III 07.5+3.5C 08.1+5.0° 12.1+3.9° 10.0+3.3° 28.4+3.5
3471 III 10.3+4.0° 13.5+3.8° 08.3+2.9° 10.2+3.3° 48.3+4.2
4877 V 0.0 0.0 0.0 0.0 30.5+4.8
a=Ovine skin fibroblasts (OSF) cultures were infected with the virus at 0.5 TCID5C/cell
b=difTcrent group indicate that the mAb recognizes different epitope (Rydbeck el a!., 1986)
c=reaclivity expressed as mean of fluorescence! SD from 5 separate experiments. Fluorescence of
negative control (NMS) has been subtracted.
d=indicales a significant difference (p<0.05) from BP1V-3 strains (Mann-Whitney non-parametric
rank test).
e=indicates a significant difference (p<0.001) from BP1V-3 strains (Mann-Whitney non-paramctric
rank test).
FIGURE 3. 5 Frequency histograms showing the time dependent reactivity of mAbs,
against distinct HPIY-3 protein epitopes, with BPIV-3 infected OSF cell cultures.
Ovine skin fibroblast (OSF) cultures were infected with BPIV-3 reference strain at
0.5 TCID50/cell. Cell cultures were infected 1, 2 or 3 days before immunostaining.
All cells were harvested and incubated with mAbs anti HPIV-3 proteins on the same
day. The profiles show the reactivity after 1 day p.i. (red line); 2 days p.i. (green line)
and 3 days p.i.(blue line). The red shaded area shows the reactivity with mock-
infected cells.
 
Reactivity of monoclonal antibodies HN4771 and HN4795












MAbs against protein HN of HPIV-3
FIGURE 3. 6 Reactivity of monoclonal antibodies HN4771 and HN4795, against
HN protein of HPIV-3, with OPIV-3 and BPIV-3 strains. Both mAbs recognize
distinct epitopes. OFS cell cultures were infected with ovine viral isolates (270-7,
430-7 and 392-10) and OPIV-3 and BPIV-3 reference strains. Cells were collected 3
days p.i. and stained with mAbs HN4771 and HN4795 and analysed by flow
cytometry. Data from five separate experiments is expressed as the mean of
fluorescence intensity ±SD with negative control fluorescence (NMS) subtracted. (*)
indicates a significant difference (p<0.05) from OPIV-3 strains; (**) indicates a
significant difference (p<0.001) from OPIV-3 strains (Mann-Whitney non parametric
rank test).
Reactivity of monocional antibodies F3263, F4503































mAbs against protein F of HPIV-3
FIGURE 3. 7 Reactivity of monoclonal antibodies F3263, F4503 and F4673, against
F protein of HPIV-3, with OPIV-3 and BPIV-3 strains. Monoclonal antibodies F3263
and F4503 recognize the same epitope. OSF cell cultures were infected with ovine
viral isolates (270-7, 430-7 and 392-10) and OPIV-3 and BPIV-3 reference strains.
Cells were collected 3 days p.i. and stained with mAbs F3263, F4503 and F4673 and
analysed by flow cytometry. Data from five separate experiments is expressed as the
mean of fluorescence intensity +SD with negative control fluorescence (NMS)
subtracted.
intracytoplasmic antigen. No reaction was detected with any of these three mAbs
against HPIV-3 F protein epitopes, after 1, 3, 5 or 7 days p.i. in cells infected with
OPIV-3 isolates(data not shown).
Monoclonal antibodies NP4721, NP4794 and NP4890 react with three distinct
epitopes of NP protein from HPIV-3 and BPIV-3 (see Table 3.8). The reactivity of
these three mAbs with the ovine derived virus strains and also with the reference
BPIV-3 was of high to moderate intensity. Cells infected with ovine isolate 430-7 and
stained with mAb NP4721 showed significantly lower (p<0.05) intensity of
fluorescence when compared to cells infected with the other ovine derived isolates.
Likewise, the staining with this mAb was significantly lower (p<0.05) in cells infected
with either the ovine derived isolates 270-7, 392-10 or reference OPIV-3 when
compared to cells infected with BPIV-3. This difference was more marked (p<0.001)
between ovine viral isolate 430-7 and BPIV-3. In general, no significant differences
(at p<0.05) were observed in intensity of fluorescence after staining with mAb
NP4794, except for the significantly lower (p<0.05) staining of cells infected with
ovine isolate 430-7 in comparison to the staining with any of the other strains tested.
Finally, the reactivity of mAb NP4890 with all strains tested was very similar in each
case (Fig. 3.8).
Monoclonal antibodies M2873, M3471 and M4877 react with two distinct epitopes of
M protein from HPIV-3 and BPIV-3 (see Table 3.8). Both mAbs M2873 and M3471
showed similar low reactivity with all ovine derived virus strains (Fig.3.9). This
reactivity was significantly lower (p<0.001) in comparison to the reactivity observed
with BPIV-3. Staining with mAb M4877 showed no reactivity with any of the ovine-
derived virus strains. In contrast, cells infected with reference BPIV-3 showed a
moderate but much higher intensity of fluorescence after staining with any of these
three mAbs against HPIV-3 M protein. A representative profile is shown in Fig. 3.10
with the reactivity of mAbs that showed major differences of staining between cells
infected ovine derived viral isolates and BPIV-3 reference strain.
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Reactivity of monoclonal antibodies NP4721, NP4794 and







MAbs against protein NP of HPIV-3
FIGURE 3. 8 Reactivity of monoclonal antibodies NP4721, NP4794 and NP4890
against NP protein of HPIV-3, with OPIV-3 and BPIV-3 strains. These three mAbs
recognize distinct epitopes. OFS cell cultures were infected with ovine viral isolates
(270-7, 430-7 and 392-10) and OPIV-3 and BPIV-3 reference strains. Cells were
collected 3 days p.i. and stained with mAbs NP4721, NP4794 and NP4890 and
analysed by flow cytometry. Data from five separate experiments is expressed as the
mean of fluorescence intensity ±SD with negative control fluorescence (NMS)
subtracted. (a),(b) and (c) indicate a statistically different group, (a) is significandy
different from (b) at p<0.05; b is significandy different from (c) at p<0.001 and (a) is
significandy different from (c) at p<0.05 (Mann-Whitney non parametric rank test).
Reactivity of monoclonal antibodies M2873, M3471







MAbs against protein M of HPIV-3
FIGURE 3. 9 Reactivity of monoclonal antibodies M2873, M3471 and M4877
against M protein of HPIV-3, with OPIV-3 and BPIV-3 strains. Monoclonal
antibodies M2873 and M3471 recognize the same epitope. OFS cell cultures were
infected with ovine viral isolates (270-7, 430-7 and 392-10) and OPIV-3 and BPIV-3
reference strains. Cells were collected 3 days p.i. and stained with mAbs M2873,
M3471 and M4877 and analysed by flow cytometry. Data from five separate
experiments is expressed as the mean of fluorescence intensity ±SD with negative
control fluorescence (NMS) subtracted. (*) indicates a significant difference
(p<0.001) from OPIV-3 strains (Mann-Whitney non parametric rank test).
I
FIGURE 3. 10 Frequency histograms showing the reactivity of mAbs against
distinct HPIV-3 viral protein epitopes (—) with OSF cultures infected with BPIV-3
or OPIV-3 isolates( 270-7, 392-10 and 430-7). The reactivity of rabbit OPIV-3
antisera is shown for comparison. Ovine skin fibroblasts (OSF) cultures were infected
with the virus at 0.5 TCID50/cell, 3 days before immunostaining. The reactivity with
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In this study, three viral isolates (270-7, 392-10 and 430-7) were obtained from field
cases of sheep pneumonia in Chile. According to characteristics of their cytopathic
effect (CPE) in OFK and BFK cell cultures; morphology under TEM;
physicochemical properties; serological relationship with PIV-3 reference viruses and
associated lung pathology, they were classified as ovine strains of PIV-3. All the
characteristics described for these viral isolates, in this study, are compatible with
those reported for PIV-3 (Kingsbury et al., 1978; Andrewes & Pereira, 1978).
The cytoplasmic inclusions found in this study, in OFK cell cultures infected with the
ovine viral isolates, are morphologically similar to those previously reported for PIV-3
isolated from sheep (Hore, 1966; Lehmkuhl & Cutlip,1982), cattle (Omar, 1965;
McLean & Doane, 1971) and humans (Porter et al., 1991). These characteristic
inclusions have been described as large, irregular but homogeneous eosinophilic and
"halo-bound" (see Fig.3.2b). Furthermore, the presence of these cytoplasmic
inclusions together with syncytia formation have been, since long ago, regarded as the
typical features of the cellular pathology of paramyxoviruses (Omar, 1965).
Intranuclear viral inclusions were rarely observed as part of the CPE produced by the
OPIV-3 isolates. This low incidence of intranuclear inclusions has been observed also
by Singh &Pathak (1977) and by Ditchfield (1966) who isolated OPIV-3, from
sheep, in BFK cell cultures. In fact these intranuclear viral inclusions may not be
observed at all in some cases. This could be explained by differences in m.o.i., type of
cell culture system used or vims infectivity properties (Lehmkuhl & Cutlip, 1982).
Also, this may be related to the origin of the vims. One the most striking differences
between bovine strains of PIV-3 and other parainfluenza vimses (included OPIV-3) is
seen in the ability of BPIV-3 to cause both abundant nuclear and cytoplasmic
inclusions (McLean & Doane, 1971). This, together with some viral morphological
characteristics, made McLean & Doane (1971) suggest setting BPIV-3 apart as a
unique member of parainfluenza vimses, closer to the antigenically unrelated measles-
rinderpest-distemper subgroup of paramyxoviruses. In contrast, OPIV-3 in its
cytopathology and morphology more closely resembles the parainfluenza vimses.
68
Ovine PIV-3 isolates 392-10 and 210-7 produced a CPE which included syncytia
formation. This effect was not observed with ovine isolate 430-7 or the bovine
reference virus, La Pintana 84 (Berrfos et al., 1990). It has been reported that there
are differences in syncytia formation capacity by different PIV-3 isolates according to
the type of cell culture used for virus replication. Thus, Ebata et al. (1991), observed
that the same PIV-3 human strain showed different fusion activity in different cell
culture systems. They attributed this to the magnitude of HN and F glycoprotein
expression. It is also possible that syncytia formation is affected by the number of
virus receptor molecules expressed on the host cell membranes.
In this study the ovine isolates induced 100% CPE in OFK and BFK cell cultures
after 3 days p.i. This agrees with the time required to achieve 100% CPE reported
by Lehmkuhl & Cutlip (1982). They also isolated ovine PIV-3 BFK cell cultures.
However, Giauffret & Russo (1972) reported that an ovine PIV-3 isolate produced
100% CPE only after 5 to 8 days p.i., in MBDK cells. Similarly, Reisinger, et
al.{ 1959) described 100% CPE after 5 days in MBDK cell culture, infected with a
bovine PIV-3 isolate. Apparently, the time required to achieve 100% CPE in infected
cell cultures by PIV-3 is variable and not only depends on the viral strain but also on
the type of cell culture inoculated.
Transmission electron microscopy (TEM) of infected OFK cell cultures, with the
ovine PIV-3 isolates, revealed the presence of virus particles budding from or
attached to the cell membrane. Similar but incomplete particles were seen in
cytoplasm. This agrees with previously reported TEM observations of PIV-3 (Bryson
et al., 1983). Likewise, aggregations of vims nucleoproteins in the cytoplasm were
observed in this study and they were similar to those described in cell cultures of lung
epithelial cells AM(|)s infected with PIV-3 (Cutlip & Lehmkuhl, 1982; Bryson, et
al., 1983). According to Elango, et al. (1986), these TEM features indicate that
PIV-3 replicates in the cytoplasm of the host cells.
The generally diffuse fluorescence pattern observed in the present study is compatible
with the manner in which the antiserum was produced. This was by using non-purified
whole vims. The antibody produced in this way is against the outer components of the
vims particles or the HN. Whereas, fluorescence with monoclonal antibody anti NP
produced discrete fluorescent foci (data not shown). The presence of strong
fluorescence at the cytoplasmic margins in some cells during the later stages of
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infection may be related to the marginal cytoplasmic virus assembly described for
PIV-3 (Chanock & Mcintosh, 1990).
The three ovine PIV-3 isolates exhibited physicochemical characteristics that have
been described for paramyxoviruses, some in particular for PIV-3. Accordingly, all of
them lost infectivity after being exposed to pH 3.0 and 9.0. This characteristic has
been previously described for paramyxoviruses (Andrewes, et al., 1978). The
sensitivity to exposure for 30 minutes at 569C has also been reported by Orfei, et
al.( 1966) and Lehmkuhl & Cutlip (1982) as an attribute of PIV-3 . The three ovine
virus isolates in this study lost infectivity after this treatment. The lipid envelope
exhibited by PIV-3 makes this virus sensitive to lipid solvents (Orfei, et al., 1966;
Lehmkuhl & Cutlip 1982). This feature was also observed when the ovine PIV-3
isolates were treated with ether and chloroform. Finally, when the isolates underwent
trypsinisation at 372C for 1 hour all of them showed sensitivity to this treatment and
lost infectivity after being treated with 1 % trypsin solutions. This has been previously
reported for bovine PIV-3 (Gresser & Enders, 1961; Berrfos et al., 1990).
The haemagglutination test with guinea pig erythrocytes along with the
haemagglutination inhibition test with rabbit anti-sera have been suggested as tests of
choice in PIV-3 identification (Leunen & Wellemans, 1966; Nguyen-Ba-Vy, 1967b;
Lehmkuhl and Cutlip, 1982). The results of these tests, for the ovine viral isolates
described in this study, implied that they are in fact strains of PIV-3. The three
isolates produced haemagglutination of guinea pig erythrocytes with different titre
when compared with the reference virus. This variability can be related to levels of the
glycoprotein hacmagglutinin, which is determined by genetic factors (Fenner et al.,
1987a).
The ovine PIV-3 isolates described in this study showed serological cross-reactivity
with bovine and human PIV-3 reference strains by the serum-virus neutralization test,
although reference anti-sera were shown to have higher reactivity with the
homologous strains. These findings are similar to other reports on antigenic
relationship between HPIV-3 and BPIV-3. This relationship has been demonstrated by
hemagglutination inhibition (HI), neutralization (NT), complement fixation and the
immunodiffusion test (Abinanti et al., 1961; Ray & Compans, 1986).
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The reactivity with a panel of monoclonal antibodies cross-reacting with HPIV-3 and
BPIV-3 viral proteins showed that the OPIV-3 strains can be distinguished from
HPIV-3 and BPIV-3. They also showed that only limited variation occurs among
OPIV-3 strains recovered at different geographical locations, in a similar fashion to
that observed with BPIV-3 (Klippmark et al., 1990). With the reagents employed
here, epitopes of viral proteins common to HPIV3 and BPIV-3 were found to be
absent or to be expressed in a lower proportion in OPIV-3 strains. Antigenic
differences were found predominantly in the F protein and to a lesser extent in the M
protein. F protein seems to have a conserved character among OPIV-3 strains. This
has also been observed in HPIV-3 and BPIV-3 strains (Rydbeck et al., 1986;
Klippmark et al., 1990). In this case three distinct epitopes of F protein that are found
in HPIV-3 and BPIV-3 strains were absent in OPIV-3.
These differences should be considered when using vaccines produced with PIV-3
from other species. Antigenic differences suggest that a bovine strain may well induce
important neutralization antibodies in sheep but a sheep strain may induce a wider
spectrum of neutralizing antibodies against OPIV-3. Production of nonfunctional
local antibodies, as well as poor antibody response to F protein, has been suggested
to explain why reinfection with PIV-3 occurs with considerable frequency during
infancy and early childhood (Chanock & Mcintosh, 1990). Furthermore,
immunopathology can result from the induction of inappropriate immune responses.
The F protein is responsible for penetration of virions into cells, spread from cell to
cell and formation of syncytia. If vaccinees fail to elicit anti-F antibodies and are
subsequently infected, they fail to control the spread of virus. This allows large
amounts of viral antigen to be produced which reacts with non-neutralising antibodies
and causes immunopathological changes (Choppin & Scheid, 1980).
On the other hand, two mAbs against two distinct epitopes of HN protein, common to
HPIV-3 and BPIV-3 strains, reacted with the three ovine isolates. These results show
that these two epitopes of HN protein seem to be conserved among PIV-3 strains
isolated from different species. Antigenic variations in HN proteins among HPIV-3
strains have been found to be limited (Van Wike Coelingh et al., 1988). In contrast, it
has been demonstrated that extensive differences are found between HN proteins from
HPIV-3 and BPIV-3 strains, although there are some epitopes in common
(Ray & Compans, 1986; Klippmark et al., 1990). It is necessary to consider that the
two monoclonal antibodies against HPIV-3 HN protein, used in this study, come
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from a group of 7 mAbs that crossreact with HPIV-3 and BPIV-3 strains. They were
selected out of 16 mAbs raised against HPIV-3 and reacting with HN protein.
Therefore, the detection of these two HN epitopes common to PIV-3 strains from
different species and from different geographical areas seems relevant. The study of
conserved epitopes could be useful for choosing mAbs for diagnostic purposes and
production or usage of vaccines.
It is necessary to carry out further antigenic characterisation with a more complete
panel of monoclonal antibodies anti-PIV-3, for further characterisation of these and
other OPIV-3 strains. This kind of studies have been accomplished so far for human
and bovine PIV-3 strains only (Klippmark et al., 1990).
The three ovine PIV-3 isolates described in this study were obtained from lungs
showing histopathological lesions that corresponded to those described as
bronchointerstitial pneumonia (Yates, 1988). In the bronchiolar epithelium there was
hyperplasia, vacuolation, necrosis and less frequently eosinophilic intracytoplasmic
inclusions. Also, in the peribronchiolar area there was lymphocyte infiltration and in
the lumen there were PMNs, along with epithelial cell debris. In alveolar walls there
was intense lymphocyte and M(J> infiltration. Proliferation of fibroblasts and
pneumocytes type II was also found at this level.
The presence of PMNs in bronchiolar lumen is a characteristic of bronchointerstitial
pneumonia and represents the combined action of virus and bacteria (Yates, 1988). In
this study PIV-3 was isolated from two field cases of sheep pneumonia (430-7 and
392-10) where Pasteurella haemolytica was found. It has been reported that
experimental and sequential infection with both PIV-3 and Pasteurella haemolytica
regularly produces pneumonia in either SPF (Sharp et al., 1978), colostrum-deprived
(Davies et al., 1986) or conventionally-reared lambs (Davies et al., 1977), regardless
of age. According to Davies et al. (1977), the lesions fall into two main categories:
necrotic lesions (demarcated by a zone of PMN infiltration) and a milder purulent
bronchopneumonia. Both types of lesion were observed in sheep 430-7 and 392-10
where Pasleurella haemolytica was isolated. The necrotic lesions appeared to
develop as a result of bacteria proliferation within the bronchial tree. A necrotising
bronchitis and bronchiolitis develop, then infection seems to spread. This occurs either
endobronchially or through the partly denuded epithelium, into the loose
peribronchiolar connective tissue. The combination of PIV-3 and Pasteurella
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haemolytica can produce a variety of pathological changes. These range from an
acute fatal bronchopneumonia with septicaemia, to a mild purulent
bronchopneumonia which resolves rapidly. The lesions produced depend both on the
degree of bacterial multiplication in the lung and the efficiency of pulmonary bacteria
clearance. The extent of virus-induced damage in the lung may be reflected in the
amount of virus recovered (Davies et al., 1986),
Some characteristics of the histopathology of these lungs, suggested that the lesions
corresponded to intermediate or late reactions against PIV-3 virus, probably around 7
days post infection. For instance, the M(j)s that predominated in inflammatory areas
were mostly of large size. These cells have been associated to late stages of this
infection (Brannen & Chandler, 1988). Also, both simultaneous epithelial cell
destruction and regeneration, observed in these lesions, have been found during
experimental infections after 7 days p.i. (Cutlip & Lehmkuhl, 1982). Furthermore,
eosinophilic cytoplasmic inclusions were rarely observed in bronchiolar epithelium.
This is normally seen during late stages of the virus replication cycle.
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CHAPTER FOUR
EXPERIMENTAL PARAINFLUENZA TYPE 3 INFECTION:
HISTOPATHOLOGY OF LUNG LESIONS AND
IMMUNOHISTOCHEMICAL DETECTION OF VIRUS PARTICLES.
4.1 INTRODUCTION
Historically, strains of PIV-3 have been identified that affect man (Chanock & Parrot,
1958) and cattle (Reisenger et ciL, 1959). They are known to produce respiratory
tract disease. The ovine species can also be affected by this virus and there are reports
of its isolation from many countries (Hore, 1966; Ditchfield, 1966; St George, 1969;
Carter & Hunter, 1970; Epstein, 1974; Davies el al., 1977; Sharp, el at., 1978;
Lehmkuhl & Cutlip, 1982).
Only minimal quantitative data on the course of PIV-3 replication in humans is
available. Pathological descriptions indicate that PIV-3 may cause bronchiolitis or
interstitial pneumonia (Aherne et at., 1970). Animal models of infection with human
PIV-3 (HP1V-3) have been proposed. Hamsters, after infection with HPIV-3, may
develop a mild bronchiolitis with occasional giant cells, but generally they show no
clinical illness or lesions of interstitial pneumonia. Whereas cotton rats seem to be
more appropriate for HPIV-3 studies as the genus Sigmodon hispidus develops
bronchiolitis and Sigmodon fulvivenler develops interstitial pneumonia (Porter el at.,
1991).
Antibody to PIV-3 may be found in deer, pigs, dogs, cats, monkeys and rats (Fenner
et al., 1987), but it is not known whether such infections cause disease or, indeed,
whether such species represent natural hosts for PIV-3 or if they have their own
distinct strains of PIV-3 (Porter et at., 1991). The cattle virus (BPIV-3) is species
specific but is quite similar immunologically and in nucleic acid sequence to HPIV-3
(Coehling et al., 1986). Infection of cattle has been associated with the respiratory
illness known as shipping fever. The sheep virus (OPIV-3) has been demonstrated to
cause bronchiolitis and interstitial pneumonia in this species (Cutlip and Lehmkuhl,
1982).
Both the inoculation of colostrum-deprived lambs with a BPIV-3 strain and the
inoculation of colostrum-deprived calves with an OPIV-3 strain resulted in
macroscopic and histopathological lesions of interstitial pneumonia (Stevenson &
Hore, 1970). However, the ovine strain of PIV-3 failed to produce clinical signs of
pneumonia in calves.
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Pathogenicity studies have been done in sheep using OPIV-3 (isolated from the upper
respiratory tract of spontaneously infected sheep), inoculated intranasally and/or
intratracheally (Lehrnkuhl & Cutlip, 1983). This was carried out in both specific
pathogen free (SPF) lambs (Sharp et al., 1978) or colostrum-deprived lambs
(Lehmkuhl & Cutlip, 1983). However, the clinical and pathological response of sheep
to experimental infection, with different OPIV-3 isolates, has been variable and
ranged from subclinical infection to severe respiratory tract disease. This may be due
to some extent to variations in virulence of different strains.
In this study colostrum-deprived lambs were inoculated with the ovine isolate 270-7
isolated and characterised as PIV-3 in this study (see Chapter 2). The pathogenicity
of this virus strain was assessed in vivo through the induction of clinical disease and
lung lesions. The relation between these lesions, corresponding to viral pneumonia
and the presence of virus particles is discussed. Virus particles were detected by
immunostaining with polyclonal and monoclonal antibodies. Finally, this allowed the
production of lung pathological material for studies on the immune cell response to





Sixteen lambs were obtained at birth and deprived of colustrum. They were divided
into two groups. The first group of eleven lambs was inoculated with 5ml tissue
culture fluid containing virus (OPIV-3 270-7); 2ml were given intranasally and 3ml
transtracheally. The second group, of five control lambs was housed separately and
mock-infected with the same amount of cell culture fluid from non-inoculated cell
cultures. The lambs were observed daily for clinical response. Three lambs were
euthanatised and necropsied on day 3 post-inoculation (p.i.), three on day 5 and five
on day 7. The control lambs were euthanatised and necropsied on day 8 p.i.
The eleven lambs inoculated transtracheally with the ovine isolate of OPIV-3 270-7,
but not the five control lambs developed clinical signs of respiratory infection that
peaked on post inoculation day 4 and 5. After 2 to 5 days p.i. the lambs developed a
biphasic febrile response, with increased respiratory rate, mouth breathing and became
lethargic. By days 4 to 5 p.i. some of them were mostly recumbent with moderate
rhinitis and showed some weight loss. The lambs either refused to suck or had
reduced milk intake after days 3 p.i. From days 6 to 7 p.i. the remaining lambs
showed some improvement in clinical signs and food intake.
4.2.2 Bacteriological findings
Neither Pasteurella haemolytica nor Mycoplasma or other pathogenic bacteria were
isolated from the nasal secretions of any of these lambs on the days preceding the
inoculation nor was it isolated after inoculation from any of the swabs collected from
animals receiving either the virus or media alone.
4.2.3 Serological findings
Antibody titres to PIV-3 were determined on paired serum samples from the lambs,
using a microtitration serum-virus neutralization test (Lehmkuhl & Gough, 1977).
I
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All lambs were seronegative at the beginning of the experiment and the three control
lambs remained seronegative. Thus, no virus neutralizing antibody was detected
before inoculation of the virus or during the first 2 days p.i. The lambs necropsied on
p.i. day 3 had reciprocal serum antibody titres ranging from 4 to 8 whereas the lambs
necropsied on p.i. days 5 and 7 had reciprocal titre ranges of 16 to 32 and 16 to 64,
respectively. Antibody titres were detected by both HI and SN (Table 4.1), higher
antibody titres were observed with SN test (Table 4.2).
4.2.4 Virus recovery
Parainfluenza type 3 virus, as confirmed by virus titration and immunocytochemistry
of infected tissue cultures with nasal secretions, was isolated from all inoculated
lambs. Virus was recovered from nasal secretions beginning on p.i. day 2. Virus
isolations from nasal secretions are summarised in Table 4.3. Titres reached their peak
at 4 to 6 p.i. At necropsy, vims was also recovered from lung tissues (Table 4.4) of
all inoculated lambs. No vfrus was recovered from nasal secretions or lungs from
control lambs.
4.2.5 Pathology
4.2.5.1 Gross pathology findings
The upper respiratory tract of the infected group showed generally nasal and turbinate
hyperaemic mucosae and contained a mucoid or mucopumlent exudate. No significant
tracheal lesions were observed in any lambs. No lesions at this level were observed in
control lambs.
In lungs of infected lambs the main lesion consisted in areas of consolidation. Initially
these areas, which were dull red, atelectatic and consolidated, showed small linear
lesions similar to the ones observed in lambs necropsied on p.i. day 3. These
consolidated areas gradually increased in size in lambs necropsied on p.i. day 5 and on
cross section of the lung they were found to be distributed extensively throughout
affected lobes and appeared to follow the smaller bronchi and bronchioles. Maximal
lesions were observed in lambs necropsied on p.i. day 7, when the consolidated areas
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TABLE 4. 1 Serum antibody conversion for PIV-3 after experimental inoculation of
lambs expressed as HI titre.
Lamb Days of experiment
Group Number 0a 3 5 7 8
















a= Pre-inoculations serum samples were all negatives at a dilution of !/4
b= Titre is expressed as median of reciprocal of serum dilution.
TABLE 4. 2 Serum antibody conversion for PIV-3 after experimental inoculation of
lambs expressed as serum-virus neutralization titre3
Lamb Days of experiment
Group Number 0 3 5 7 8
















a=The serum-virus neutralization titrcs were the highest dilution of serum
in which 50% of the wells were protected from the viral CPE. Titre is
expressed as median of reciprocal of serum dilution
TABLE 4. 3 PIV-3 recovery from nasal secretions of lambs after experimental
inoculation.
Titre3 Number Positiveb
PIDC Inoculated Control Inoculated Control
0 0 0 0/11 0/5
1 0 0 0/11 0/5
2 3.2+0.4 0 5/11 0/5
3 4.1±0.1 0 11/11 0/5
4 5.0+0.3 0 8/8 0/5
5 6.2+0.1 0 8/8 0/5
6 6.0+0.4 0 5/5 0/5
7 5.8+0.5 0 5/5 0/5
8 - 0 - 0/5
a= Mean titre expressed as mean TCID50/0.1ml of nasal secretions ±S.E.
b= Number of positive animals v/s animals tested
c= Post inoculation day
TABLE 4. 4 PIV-3 recovery from lungs at necropsy after experimental inoculation
Titre3 Number Positive6
PIDC Inoculated Control Inoculated Control
3 5.0+0.4 0 3/3 -
, 5 6.8+0.4 0 3/3 -
7 5.7+0.2 0 5/5 -
8 - 0 - 0/5
a= Mean titre expressed as mean TCID50/g of lung tissue +S.E.
b= Number of positive animals v/s animals tested
c— Post inoculation day
showed a reddish brown colour and contained small grey foci on their cut surface.
These areas were confined only to the anterior lobes of the lungs (Fig.4.1a).
The mediastinal and bronchial lymph nodes were hyperaemic and slightly enlarged
only in lambs necropsied on p.i. day 7, but looked normal in infected lambs necropsied
previously. No significant lesions were observed in the kidneys, liver or spleen.
No significant lesions were observed in lungs or other organs in control lambs.
4.2.5.2 Histopathology findings
There were focal areas of ulceration as well as erosion and neuthrophil infiltration of
the nasal and turbinate mucosae in lambs of the infected group. No significant lesions
were found in the trachea.
On p.i. day 3 the bronchi were generally normal but the bronchioles contained a small
amount of exudate. There was a slight epithelial and BALT hyperplasia in comparison
to controls where BALT structures were not usually visible (Fig.4. lb,c). Occasionally
epithelial cells showed ballooning degeneration and a moderate number of pyknotic
cells were seen in the epithelium or in the process of extrusion from the epithelium
into the lumen. In no cases was there denudation or severe damage to the epithelium
and only in one lamb was there some loss of cilia. From p.i. 3 there were scattered
PMN in and beneath the epithelium of bronchi and bronchioles. Lymphocytes
appeared in and around the walls of bronchi and bronchioles as early as 3 days p.i.
(Fig.4.1c,d) with a maximum response 6 to 7 days p.i. There were scattered foci of
interstitial pneumonia, usually around or near small bronchioles with infiltration of
lymphocytes and M<J)s and septal alveolar cell proliferation (Fig.4.2a,b), showing
scattered foci of pseudo-epithelialisation. Thickening of the alveolar walls was
minimal to moderate when compared with the lungs of non-infected animals. M(()s
were also attached to the alveolar wall, while others were found lying free in alveolar
space along with detached epithelial cells. The M())s had pale staining, oval or indented
nuclei and abundant cytoplasm which showed varying degree of vacuolation.
In lambs killed on p.i. day 5 the exudate of the bronchioles was more abundant and
exudate was also observed in bronchi. In many of the smaller bronchioles there was
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FIGURE 4. 1 Lesions of interstitial pneumonia induced by experimental inoculation
with OP1V-3 270-7 isolate. Lambs were obtained at birth and colostrum-deprived.
They were inoculated with 5ml tissue culture fluid containing the virus (OPIV-3 270-
7); 2ml were given intranasally and 3ml transtrachcally. Lung biopsies were taken
from lambs euthanised and necropsied on post-inoculation (p i.) days 3, 5 and 7.
Samples were fixed in buffered formalin and processed for staining with
hematoxylin/eosin (H/E), Giemsa's or Van Gieson's stains.
a) Photograph of a lung showing
pneumonic consolidation areas (arrow)
in the anterior lobes. These lesions are
surrounded by emphysema. This lung
was taken from a lamb that was
necropsied after 7 days of
experimental inoculation with OP1V-3
270-7 isolate.
b) Histological section of a lung from
one of the mock-infected lambs. A
bronchiole surrounded by alveoli is
shown. No accumulation of
inflammatory cells is observed around
the bronchiolar epithelium, bronchiolar
lumen, alveolar walls, alveolar space or
any other histological area. Also, there
is no BALI' visible close to the
bronchiole. H/E stain. Magnification
x40.
c) Lung section of a lamb after 3 days
p.i. with OPIV-3 270-7. There is a
moderate hyperplasia of BALL (large
arrow). Also mononuclear cell
accumulation, around the bronchiolar
epithelium, is seen. Alveoli close to the
bronchiole show a slight thickening of
their walls (small arrows). H/E stain.
Magnification x40.
d) Lung section of a lamb after 3 days
p.i. with OPIV-3 270-7. There is an
intense accumulation of lymphocytes
around the epithelium. They are
migrating towards the lumen (small
arrows). Presence of cell debris and




hyperplasia of the epithelium with foci of giant cell bronchiolitis and acidophilic
cytoplasmic inclusions (Fig.4.2c). Mitotic figures were occasionally observed. The
areas of interstitial pneumonia were larger and well established and reached their
maximal extent by day 6 to 7 p.i. They were similar in composition to those found in
lambs killed on p.i day 3 but the thickening of the alveolar walls showed a two-to-
fivefold increase (Fig. 4.2d). There was mononuclear infiltration of alveolar walls with
pseudo-epithelialisation of alveoli and small syncytia attached to alveolar walls in
some cases (Fig.4.2d). Compensatory vesicular emphysema and evidence of slight
perivascular oedema were seen in some lobules, while in others there was partial
atelectasis. Some M<(>s and occasionally some epithelial cells were free in alveolar
spaces.
By p.i. day 7 most of the above described changes had reached their maximum
expression. There was an increased amount of exudate in bronchi and bronchioles,
hyperplasia of the bronchial epithelium and less frequently acidophilic cytoplasmic
inclusions. There was a remarkable enlargement of bronchiolar associated lymphoid
tissue (BALT) in comparison to control lungs (Fig.4.3a). The interstitial reaction was
now lobular in distribution with widespread lymphocyte interstitial infiltration and
atelectasis (Fig. 4.3b). Also syncytia and pseudoepithelialisation were seen. Scattered
foci of alveolar necrosis with PMN infiltration and areas of atelectasis were present.
There was also intense hyperemia in lung blood vessels with lymphocyte perivascular
infiltration (Fig.4.3c) and interlobular oedema with lymphatic vessel dilatation
(Fig.4.3d). Increased thickness of pleura was detected in some areas due to
infiltration of lymphocytes and M<j)s and proliferation of type I collagen fibres.
There were no marked differences in the composition of the lymph nodes from
control and infected lambs. No significant changes were observed in lungs of control
lambs or in kidneys, liver, spleen, intestine, brain, and other organs studied, of any
lamb.
The histopathology findings are summarized in Table 4.5. The most noticeable lesion
found in PIV-3 infected lungs corresponded to interstitial pneumonia. The most
characteristic features were the hyperplasia of BALT and degenerative changes of
bronchiolar epithelium with lymphocyte infiltration. Other frequent lesions were areas
of atelectasis and increase in alveolar septa thickness. The latter were due to
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FIGURE 4. 2 Lesions of interstitial pneumonia induced by experimental inoculation
with OPIV-3 270-7 isolate. Lambs were obtained at birth and colustrum deprived.
'I'hey were inoculated with 5ml of tissue culture fluid containing the virus (OPIV-3
270-7); 2ml were given intranasally and 3ml transtracheal^. Lung biopsies were
taken from lambs euthanised and necropsied on post-inoculation (p.i.) days 3, 5 and
7. Samples were fixed in buffered formalin and processed for staining with
hematoxylin/eosin (H/£), Giemsa's or Van Gieson's stains.
a) Lung section of a lamb after 3 days
p.i. with OPIV-3 270-7. A slight
thickening of the alveolar walls can be
seen. Inside these walls or attached to
them it is possible to observe M<|>s
(arrows). No cells are present in the
alveolar spaces. H/E. Magnification
xlOO.
b) Histological lung section of a lamb
after 3 days p.i. with OPIV-3 270.
Intense infiltration of lymphocytes
(large arrow) is seen around the
bronchiolar epithelium. A slight
thickening of the alveolar walls and
areas of emphysema (small arrows) are
shown. Also, some cell debris can be
seen inside the bronchiolar lumen. H/E
stain. Magnification x40.
c) Lung section of a lamb after 5 days
p.i. with OPIV-3 270-7. Many mucus
cells (a) are present in the bronchiolar
epithelium. There are also some halo
bound eosinophilic cytoplasmic
inclusions (b). H/E stain. Magnification
x600.
d) Lung section of a lamb after 5 days
p.i. with OPIV-3 270-7. There is a
marked increase in the alveolar wall
thickness due to an accumulation of
lymphocytes (L), M<{>s (M) and the
presence of fibrosis (F). There are also
some groups of pneumocytes showing
epithelialisation. Van Gieson's stain.
Magnification xlOO.
 
FIGURE 4. 3 Lesions of interstitial pneumonia induced by experimental inoculation
with OPIV-3 270-7 isolate. Lambs were obtained at birth and colustrum deprived.
They were inoculated with 5ml tissue culture fluid containing the virus (OPIV-3 270-
7); 2ml were given intranasally and 3ml transtracheally. Lung biopsies were taken
from lambs euthanised and necropsied on post-inoculation (p.i.) days 3, 5 and 7.
Samples were fixed in buffered formalin and processed for staining with
hematoxylin/eosin (H/E), Giemsa's or Van Gieson's stains.
a) Lung section of a lamb after 7 days
p.i. with OPIV-3 270-7. Marked
hyperplasia of a BALT can be seen
(large arrow). Also there is alveolar
wall thickening and atelectasis (small
arrow). Van Gieson's stain.
Magnification xlOO.
b) Lung section of a lamb after 7 days
p.i. with OPIV-3 270-7. Widespread
atelectasis (A) and intense infiltration
of mononuclear cells (Y) are present.
H/E stain. Magnification x40.
c) Lung section of a lamb after 7 days
p.i. with OPIV-3 270-7. A lymphocyte
cuff around an arteriole is shown
(arrow). Giemsa's stain. Magnification
x400.
d) Lung section of a lamb after 7 days
p.i. with OPIV-3 270-7. There is
interlobular oedema and hyperemia.




proliferation of pneumocytes type II (known as epithelialisation), lymphocyte and M(|)
infiltration and later to fibrosis.
Small M(j)s were more frequent during early inflammation, while large M<|)s
predominated later. Van Gieson staining confirmed that around p.i. 7 part of the
increase in alveolar septae thickness was due to fibrosis with proliferation of type I
collagen fibres. Giemsa staining confirmed that the morphology of the cell infiltrate in
alveolar septa, around bronchi and bronchioles, pleura and blood vessels
corresponded mainly to lymphocytes and to a lesser extent M(j>s and plasma cells.
4.2.6 Identification of virus particles in situ by immunohistochemistry
After experimental infection, virus particles were detected in lung tissue by
immunohistochemistry. For this purpose, lung samples were taken simultaneously
with those for viral isolation and histopathology and stored frozen at -70°C. The
immunostaining was carried out with rabbit anti PIV-3 sera raised against both the
ovine isolates and reference virus. Also mouse monoclonal antibody anti human PIV-3
protein HN was used (mAbs HN4771 and HN4795).
Attempts were made in order to detect OPIV-3 particles in formalin fixed, paraffin
embedded tissue sections, by immunohistochemistry. Positive staining was achieved
with rabbit antisera, however the staining was less intense when compared with the
one obtained in frozen sections (data not shown). On the other hand, staining with the
monoclonal antibodies did not give positive reaction.
Antibodies were previously titrated for indirect immunostaining techniques which
included indirect immunofluorescence (IIF), immunoperoxidase (IIP) and
immunoalkaline phosphatase (IIAP). All staining was carried out in triplicate. Normal
rabbit and mouse serum (NRS and NMS) replaced primary antibodies in control
sections for rabbit antisera and monoclonal antibody, respectively. Table 4.6.
summarizes the results obtained after analyzing sections immunostained with any of
these three techniques.
Positive fluorescence staining in pneumonic lung sections, on p.i. days 3 to 5, was
detected on cell membrane and cytoplasm of a great proportion of bronchiolar and
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TABLE 4. 5 Histopathologic^ findings during experimental infection of colostrum
deprived lambs with OPIV-3 270-7.
DAYS POST INOCULATION
LESION 3 5 7 Control
BRONCHIOLAR
EPITHELIUM
degenerative changes +* ++ +++ -
lymphocyte + +++ 11(1 -
PMNs + ++ ++ -
M(j>s + ++ +++ +
BRONCHIOLAR
LUMEN
cell debris - + ++ -
lymphocyte + +++ I I M -
PMNs + ++ ++ -
M<j)S + +-r +++ +
BALT
hyperplasia + ++ i i M -
ALVEOLAR SPACE
alveolar epithelial cells + ++ +++ -
lymphocyte - + ++ -
PMNs - - - -
Mcfis + ++ +++ +
atelectasis + +++ 111) -
emphysema - ++ +++ -
ALVEOLAR WALL
t septa thickness + ++ +++ -
fibrosis - + ++ -
cpithelialisation - + ++ -
lymphocyte + ++ +++ -
PMNs - - - -
M<j>s + ++ +++ +
INTERLOBULAR SPACE
oedema - + t-t -
lymphocyte - + + -
PMNs - + + -
M<(>s - + + -
PLEURA
t thickness - + ++ -
lymphocyte - + ++ -
PMNs - + + -
M(}>s - + ++ -
fibrosis - + ++ -
VESSELS
hyperemia ++ +++ +++ -
lymphocytic cuffing - + ++ -
* Changes are expressed according to frequency of appearance as follows:
-= absent +=scarce ++++=highly frequent
++=modcrate +++=frequcnt
I
alveolar epithelial cells. Also small groups of M(|)s showed specific fluorescence (Fig.
4.4a). On p.i. day 7 fluorescent epithelial cells were far less frequent, whereas more
cells in alveolar walls, apparendy some M<j>s among them, showed a positive reaction.
In pneumonic lung sections on p.i. days 3 to 5, immunostained by IIP, there was
positive staining (brown colour) of cell membrane and cytoplasm in a great proportion
of bronchiolar and alveolar epithelial cells and in some M4>s. PIV-3 antigens were
more easily demonstrable in the cytoplasm of alveolar epithelial cells. On p.i. day 7 the
staining for epithelial cells in bronchi and bronchioles was markedly reduced, whereas
more staining was detected in alveolar walls with more M<])s showing positive
reaction Fig. 4.4b).
Immunostaining by IIAP of pneumonic lung sections on p.i. days 3 to 5, showed a
similar staining pattern to that observed with IIP. OPIV-3 antigens were
demonstrable (red colour) more frequently in cell membrane and cytoplasm in a high
proportion of bronchiolar and alveolar epithelial cells (Fig. 4.4c). On p.i. day 7 the
staining for epithelial cells was less frequent and it was detected in M(j)s and
pneumocytes, in alveolar walls. Staining of bronchiolar epithelium was not observed
at this stage of infection (Fig. 4.4d).
No reactivity was detected in endothelium, fibroblasts, lymphocytes or any other type
of lung tissue cell.
I
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TABLE 4. 6 Histological distribution of OPIV-3 particles in lung tissue, by
immunohistochemistry, after experimental infection with ovine isolate 270-7.
Histological area Days Post OPIV-3 inoculation
1 3 5 7 Control
Bronchi(oles)
epithelium +++ ++ + -
lymphocytes - - - -
M<{>s + ++ +++ -
BALT
lymphocytes - - - -
Ml}* - - - -
Alveolar wall
epithelium + ++ +++ -
lymphocytes - - - -
M<}* + ++ +++ -
Alveolar space
epithelium - + ++
lymphocytes - - - -
Mi}* - + ++ -






FIGURE 4. 4 Immunostaining of OPIV-3 virus particles in tissue sections of
pneumonic lungs taken from lambs after experimental infection with OPIV-3 270-7.
Lung biopsies were collected from lambs that were euthanised and necropsied on
post-inoculation (p.i.) days 3, 5 and 7. Samples were stored frozen at -70SC until
being processed by indirect immunofluorescence (IIF), immunoperoxidase (IIP) or
alkaline phosphatase (IIAP).
a) Lung section of a lamb after 3 days
p.i. with OPIV-3 270-7. Fluorescence
staining of a group of M<j)s present in a
peribronchiolar area. Positive staining
is observed in the cytoplasm and the
cell membrane. IIF. with rabbit
antisera. The nuclei were
counterstained with H/E.
Magnification x400.
b) Lung section of a lamb after 5 days
p.i. with OPIV-3 270-7. In an
atelectatic area, positive staining
(brown colour) is observed in the cell
lining of the alveolar walls. IIP with
rabbit antisera. The nuclei were
counterstained with H/E.
Magnification x400.
c) Lung section of a lamb after 3 days
p.i. with OPIV-3 270-7. There is
strong immunostaining (red colour) of
the bronchiolar epithelium. IIAP with
rabbit antisera. The nuclei were
counterstained with H/E.
Magnification xlOO.
d) Lung section of a lamb after 7 days
p.i. with OPIV-3 270-7. Positive
staining (red colour) of a few scattered
M(f)s attached to alveolar walls can be
seen. IIAP with monoclonal antibody







The present study confirms the pathogenicity of ovine PIV-3 strain 270-7 and shows
that this virus is able to induce clinical and pathological symptoms corresponding to
interstitial pneumonia. The pulmonary lesions observed here correspond closely to
those seen in experimental inoculation of lambs with other PIV-3 ovine strains (Hore
& Stevenson, 1969; Stevenson & Hore, 1970; Cutlip & Lehmkuhl, 1982).
Previous investigations, on experimental reproduction of interstitial pneumonia by
PIV-3, report variability in the presence of eosinophilic cytoplasmic inclusions. During
this study these viral inclusions were observed in bronchiolar epithelium in the early
stages of infection. Likewise, Dawson & Crickshanik (1965) & Omar (1966) report
similar findings in bronchiolar epithelium in cattle. In contrast, Stevenson &
Hore (1970) did not find virus inclusions in lung tissue, during experimental infection
with an OPIV-3 isolate. However, these inclusions are usually observed during in
vitro replication of OPIV-3 (Hore, 1966; Ditchfield, 1966; Singh &Pathak, 1977;
Lehmkuhl & Cutlip, 1982).
Another infrequent feature observed as a result of the experimental infection with
OPIV-3 270 strain was syncytia formation in alveolar epithelium. This has been
previously reported as being part of in vivo cell pathology induced by OPIV-3
infection both in natural and experimental infections (Hore & Stevenson, 1969;
Stevenson & Hore, 1970).
The low seroconversion rate may reflect a rather low level of enzootic infection in
these lambs as there was no maternal antibody interference. In fact, the lungs lesions
found at necropsy were confined to small portions of the anterior lobes. Furthermore,
after 7 days post infection the experimentally induced respiratory disease started to
show signs of recovery. Similar antibody seroconversion findings have been observed
in studies of naturally occurring respiratory disease, associated with PIV-3 infection in
calves (Lehmkhul & Gough, 1977). Moreover, the serological tests HI and SN, used
in this study, may have a low sensitivity and underdetect antibody titres. In fact, in
this study these tests had different sensitivities in that SN gave higher titres than HI.
Similarly, St. George (1971), in a PIV-3 serological survey, observed that HI is less
sensitive than the virus neutralization test. Furthermore, Adair (1986) compared the
sensitivity for antibody detection of HI, SN and fluorescence antibody (FA) test in
experimental infection of colostrum deprived calves, with PIV-3 and SRV. He
obtained very similar low titres for seroconversion by HI and SN. In contrast, serum
titres for the same samples detected by FA test were much higher. For example,
seroconversion after day 9 p.i., with PIV-3, was 32 according to the HI and 256
according to the FA test.
An increase in the population of fibroblasts of the alveolar walls was observed in lung
lesions of lambs inoculated with the OPIV-3 270-7 strain. This change, which has
been associated with regeneration (Crouch, 1990), partly explains the increase in
thickness of this histological structure during late PIV-3 infection. Thus, PIV-3
infection in sheep may induce pulmonary fibrosis and its severity should be related to
the extent of damage induced by the inflammatory process.
OPIV-3 particles were detected, by immunohistochemistry, in greater proportion in
alveolar septal cells and less in both bronchiolar epithelium cells and M0s. This may
be associated with the rapid epithelial regeneration and agrees with TEM observations
by Bryson et al. (1983) and Tsai (1977) in PIV-3 experimentally infected calves.
OPIV-3 particles, detected by the immunohistochemistry of infected lung tissues,
were found more frequently in areas displaying an early rather than late inflammatory
process. During the early inflammatory process these virus particles were found
mostly in bronchiolar epithelium cells. On the contrary, during intermediate to late
stages of infection the highest proportion of virus particles was found in alveolar
epithelial cells. These cells were most probably pneumocytes type II, as these are the
cells that predominate in the alveolar walls during these stages of PIV-3 infection
(Bryson et al., 1983). Furthermore, it has been demonstrated that Paramyxoviruses
infect and replicate more easily in pneumocytes type II cell cultures (Castleman et al.,
1989).
In this study no virus particles were detected in lung endothelial cells, fibroblasts or
lymphocytes, by immunohistochemistry. Similarly, Bryson et al.,(1983) did not find
PIV-3 replication in these cells by TEM.
Immunohistochemical tests are rapid and can be a sensitive and reliable method for
viral diagnosis (Haines et al., 1992), however this method is dependant upon the
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availability of a high quality antiserum that will bind to specific antigens in tissue
sections. Traditionally, polyclonal antisera have been developed for this purpose;
however, in recent years the polyconal antisera are being replaced by monoclonal
antibodies (mAbs). Both types of antibody preparations have advantages and
disadvantages for use in immunohistochemical stains. Polyclonal antisera recognize
many epitopes on the infecting virus and thus are likely to detect more isolates of the
virus and viral epitopes retained in formalin-fixed specimens. Alternatively, mAbs are
less likely to contain contaminating antibodies to other pathogens or to normal tissue
constituents that result in nonspecific staining. Also, monoclonal antibodies are
generally available in unlimited quantities, in contrast to the finite quantities of
polyclonal antisera, which enables standardization of the test methods within and
between laboratories. However, several mAbs rather than a single mAb may be
preferable for diagnostic testing because individual mAbs binding single epitopes may
fail to detect some antigenic variants of the virus.
Both the immunoperoxidase and immunoalkaline phosphatase staining methods, in
contrast to immunofluorescence, do not require a special microscope for observation
of results and the sample sections can be stored for a much longer period of time. The
sections can be counterstained for nuclei identification, thus allowing histological
details to be clearly distinguished, particularly in formalin fixed sections. However, the
fixation of tissues by formalin produces protein denaturation that may lead to a failure
in their identification by antibodies, due to alterations in the epitopes needed to be
recognized. This is particularly critical for monoclonal antibodies as they recognize
only one epitope. Thus, when using formalin fixed sections for OPIV-3 identification
by immunohistochemistry, in this study, the monoclonal antibodies (HN4771 and
HN4795) did not react, while the rabbit antisera gave a weaker reaction. In contrast,
both reagents immunostained OPIV-3 particles in frozen sections. This means that the
epitopes recognized by the monoclonal antibodies were modified by formalin fixation.
Besides, the OPIV-3 anti-serum, used in this study, seems to recognize a different
group of epitopes, some of which are modified by formalin and some are not.
One of the most striking histopathological findings in lambs inoculated with OPIV-3
270-7 strain was an intense proliferation of lymphocytes. This was most noticeable in
the resulting BALT hyperplasia. This can be associated with the immune response
elicited against OPIV-3. In the pulmonary tissue, the lung cell immune response arises
from the action of lymphocytes which are partly derived from BALT (Potgieter, 1986;
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Yates, 1988). Accumulations of lymphocyte were also seen around the
peribronchiolar walls, within the interalveolar septa and as perivascular lymphocytic
cuffing.
No vims particles were detected in lymphocytes in this study. Observations in
lymphocytes cultures in vitro infected with PIV-3 showed that despite the presence of
lymphocyte-associated vims antigen detected by direct immunofluorescence, no
increase in PIV-3 titre above baseline was seen from infected lymphocytes,
irrespective of mitogen stimulation. Likewise, lymphocytes did not contribute to the
extracellular vims pool in lymphocyte/AM<{) cultures as the increases in viral titre
above basal levels in supernatants were equal to levels released by M<J)s alone. The in
vitro expression of viral antigen on lymphocytes stimulated in the presence of PIV-3-
infected AM(|) suggests a non-productive or abortive infection of lymphocytes
mediated through contact with infected AM (Basaraba et al., 1993).
The host cell membrane receptor involved in infection by Orthomyxovirus and
Paramyxovirus is a neuraminic acid contained in a glycoprotein. These cell receptors
for PIV-3 are found in different cell types including lung epithelial cells, lymphocytes,
monocytes, M<])s and neurones (Vainionpaa et al., 1989). However, the ultimate
susceptibility of a cell to become infected by this vims is determined by the presence
of specific proteases together with characteristics of the vims structure, host cell
receptors, cell metabolism and vims replication (Potgieter, 1986).
The presence of a large number of lymphocytes, particularly on days 5 and 7 p.i.,
combined with the minimal to moderate cytolysis in antigen bearing cells, suggests
that PIV-3 induced pulmonary disease may have an important immunopathological
component. Lymphocytes were first seen at 3 days p.i. and reached a maximum after
7 days p.i., an observation consistent with a specific T-cell response to the vims




CELLULAR ASPECTS OF THE IMMUNE RESPONSE IN OVINE LUNGS
EXPERIMENTALLY INFECTED WITH PARAINFLUENZA TYPE 3 VIRUS
I
5.1 INTRODUCTION
Histopathological examination of lung lesions induced by OPLV-3 270-7 strain, (as
described in section 4.2.5.2), showed both epithelial damage and inflammatory
infiltrate. This included intense peribronchial infiltration by lymphocytes with few
PMNs; hyperplasia ofBALT; infiltration of lymphocytes and M<|)S within interalveolar
septa; perivascular lymphocytic cuffing and presence of some PMNs and cell debris in
bronchial lumen. The inflammatory cell infiltration in the alveolar space was far less
severe with some M<j>s and detached epithelial cells.
In pulmonary tissue, the lung cell defence is primarily derived from the action of
lymphocytes from bronchiolar associated lymphoid tissue (BALT). They are involved
in antibody and cell mediated immunity. The lung immune defence is complemented
by the activation of AM<j>s and the inllux of monocytes and PMNs from peripheral
blood (Potgieter, 1986).
Cytotoxic T cells are vital for effective recovery from P1V-3 infection. This is
illustrated by PIV-3 induced giant-cell pneumonia in T-cell deficiency children which
can often prove fatal (Chanock & Mcintosh, 1990). Reports of productive infection
of PIV-3 by lymphocytes are controversial (Basaraba et al., 1993). However, it has
recently been reported that T cells can be infected with PIV-3 in vitro and release
virus (Sieg et al., 1994). Apparently, the productive infection requires activation of
the T cells and results in a marked inhibition of cell proliferation. Furthermore,
exposure to PIV-3, even without overt expression of viral proteins as detected by
immunohistology, seems to alter the functional capacity of T cells profoundly. The
capacity of the virus to regulate T-lymphocyte function may play an important role in
the failure of the virus to induce lifelong immunity (Sieg et al., 1994).
It has been demonstrated that cytotoxic T cells react weakly with individual
glycoproteins HN or F, but cytotoxic activity is far more effective when both
glycoproteins are present. Furthermore, cytotoxic T cells can also react with cell lines
persistently infected with PIV-3 (Spriggs et al., 1987).
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The infection of AMc|>s has important consequences tor the pathogenesis of
respiratory tract viral disease (Stauber & Weston, 1984). These cells are critically
important in lung resistance to bacterial colonisation. This can take place after the
AM<J> has been affected as a direct consequence of the virus replication or as a result
of immune mediated cytotoxicity towards virus infected M<j)s (Davies et a!., 1986).
Pulmonary M<j>s can be classified into three different groups according to their
localization. They are: AM(J>s, interstitial M<|>s and respiratory airway M(j>s (Holian &
Scheule,1990). The AM(|>, is a phagocyte residing in the alveolar space and is in
direct contact with epithelial cell types I and II; its nucleus is lobulated and has
vacuolated cytoplasm. It is morphologically and functionally heterogeneous and its
size varies between 12 to 40pm (Pratt et a/., 1971; Cohen & Cline, 1971). There are
different AM<|> subpopulations according to membrane receptor expression,
phagocytic function and capacity of releasing mediators (Shellito & Kaltreider, 1984).
Variability has also been observed in cell morphology and may have some functional
implications. It has been observed that small AM(j>s predominate in acute diseases
while, those of a larger size predominate in chronic disease (Brannen & Chandler,
1988). AM<|>s can interact with other cells and molecules in their environment through
both numerous secretion products and expression of specific receptors on the cell
membrane (Fels & Cohn, 1986).
Interstitial M<j>s are located in the connective lung tissue in contact with fibroblasts,
lymphocytes and endothelial cells and have a great capacity for replication. They are
most efficient in stimulating the T lymphocyte response against antigens (Holian &
Scheule, 1990).
PMNs participate in both enzymatic degradation and phagocytosis events. They
contain enzymes and oxidative elements that can damage not only microbial
pathogenic agents, but also the pulmonary tissue where the inflammatory process
takes place (Welliver & Ogra, 1988). According to the lesions observed in
experimental infection with OPIV-3 in this study (section 4.2.5.2) they seem to be a
minor component of the inflammatory reaction induced in lung tissue by this virus.
The organization of the immune response is a biological event that is mounted in an
orchestrated fashion in the presence of an antigen. Different cell types and populations
are involved such as M<{)s, and apart from displaying phagocytic function, they can
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interact with other effector cells of the immune system, the lymphocytes. Therefore,
it is the aim of this work to deal with changes in proliferation and histological
distribution of M<j)s as well as lymphocyte subsets after PIV-3 experimental infection.
In the previous chapter, the presence of a large number of lymphocytes was detected,
particularly on days 7 p.i. The lymphocytic infiltrate was part of marked
bronchi/bronchiolar associated lymphoid tissue (BALT) hyperplasia and alveolar wall
thickening. This, combined with the minimal to moderate cytolysis of virus infected
cells, suggests that PIV-3 induced pulmonary disease may have an important
immunopathological component. Lymphocytes were first seen at 3 days p.i. and
reached a maximum 7 days p.i., an observation consistent with a specific T-cell
response to the virus (Porter et al., 1991).
As it has been described in the previous chapter (section 4.2.5.2) the lesions of
interstitial pneumonia had reached their maximum expression by day 7 post
experimental inoculation. In this chapter, aspects of the cell immune response against
OPIV-3, in the sheep lung, were studied by detecting changes after 7 days post
experimental inoculation with OPIV-3 isolate 270-7. The presence and proportion of
lymphocyte subsets and M(t>s were evaluated both in lung wash fluid (LWF) and in
histopathological lung lesions. Also, the association between these cell populations
and virus particles was studied. Both the detection of immune cells and virus particles
were carried out by single and double immunostaining with monoclonal antibodies.
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5.2 RESULTS
Samples of lung tissue and lung wash fluid (LWF) were collected from 5 infected
(OPIV-3 270-7) and 5 mock-infected lambs. These animals were part of the
experimental infection described in Chapter 4. Infected animals were necropsied on
day 7 p.i. and control animals on day 8 p.i. After dissecting the lungs and taking
biopsies for immunohistochemistry LWF was immediately collected. Biopsies for
immunohistochemistry were either snap frozen in liquid nitrogen and then stored at -
702C or fixed in buffered formalin. LWF was immediately processed for differential
cell counting and staining for flow cytometry.
5.2.1 Total and differential leucocyte cell count in lung wash fluid (LWF) from
experimentally infected lambs with OPIV-3 270-7.
LWF from OPIV-3-infected lambs after 7 days p.i. presented an increased cellularity
when compared with controls. OPIV-3 =4.3xl08 (range 0.2-6.3); controls =3.2xl08
(range 1.6-6.9)(values expressed as median of cells per millilitre) although this
difference was not significant at p<0.05. However, significant changes in most cell
types were observed after differential cell counts of LWF (Table 5.1). PIV-3 infected
animals had significantly increased proportion of (p<0.05) lymphocytes and PMNs
and a significantly decreased proportion of M(j>s (p<0.05), when compared with
controls. Absolute numbers showed similar changes with a significant increase of
lymphocytes (p<0.001) and PMNs (p<0.001). M(j) numbers were slightly higher but
not significantly different from the controls (data not shown).
5.2.2 Changes in lymphocyte subsets and in the CD4+/CD8+ lymphocyte ratio
in LWF from OPIV-3 experimentally infected lambs.
The different ovine lymphocyte subsets were studied by flow cytometry in LWF from
animals necropsied after 7 days p.i. with OPIV-3 270-7. Lymphocyte subsets CD4+,
CD8+, T cells and B cells were immunostained with mAbs SBU-T4, SBU-T8, ST-197
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TABLE 5.1 Differential cell count in lung wash fluid (LWF) from mock-infected and
OPIV-3 infected animals after 7 days post inoculation.
Animal Groups





Mast cells 2.3±1.9 1.5±1.4
1 Results are expressed as a median of percentages +SD.
2 Significantly different from control at p<0.05 (Mann-Whitney non-parametric rank test).
and VPM32, respectively. Using FSC and SSC parameters a gate was set on small
lymphocytes. Data was analyzed with 1% threshold set on negatively stained cells.
By using the percentage of positive lymphocytes to calculate the CD4'/CD8' ratio it
was shown that there was a statistically significant decrease in the CD4 :CD8' ratio in
PIV-3 infected lambs with lung lesions compared to non-infected lambs (Table 5.2).
Most PIV-3 infected lambs with pulmonary lesions showed a decrease in the
CD4 :CD8' ratio(<l), In contrast, the CD4 :CD8' ratio of lymphocytes from normal
control lambs was consistently higher (2.8+0.5).
In LWF of PIV-3 infected animals, the most noticeable changes were a significant
decrease (p<0.001) of CD4' lymphocytes and a significant increase (p<0.05) of CD8'
T lymphocytes ratios, leading to a significant inversion (p<0.001) of the CD4VCD8'
ratio, when compared with controls. The percentage of y6T cells and B cells in LWF
from PIV-3 infected animals did not show statistically significant variations, although
values were higher for infected animals.
5,2.3 Detection of OPIV-3 infected alveolar macrophages (AMsjis) and
lymphocytes in LWF from experimentally infected lambs by flow
cytometry immunocytochemestry.
LWF cells were obtained lfom mock-infected and OPIV-3 infected lambs after 7 days
p i. Using FSC and SSC parameters to gate on small lymphocytes or M<()s, these cell
populations were studied by How cytometry after immunofluorescence staining with
rabbit anti OPIV-3 sera. No positive lymphocytes were found in either mock-infected
or OPIV-3 infected animals (data not shown). In contrast, 18% (range=15.I2% to
36.68%) of M(j>s from experimentally infected lambs were positively stained with the
anti OPIV-3 serum. They showed a low variable intensity of virus particle staining
which ranged from 9.8 to 26.73 (with NRJS staining subtracted). Figure 5.1 shows the
flow cytometry profiles of AM(j>s obtained from the OPIV-3 infected animals. The
rabbit anti OPIV-3 serum showed no reactivity with AM<jis from mock-infected
animals (data not shown). Cytocentrifuge smears were obtained ffom LWF of mock-
infected and OPIV-3 infected animals and immunostained with rabbit anti OPIV-3
serum by indirect immunoalkaline phosphatase (IIAP). Again positive staining was
90
TABLE 5. 2 Lymphocyte subsets in lung wash fluid (LWF) from control and PIV-3
infected animals.
Markers
Groups CD4+ CD8+ y5TCR B cells CD47CD8*
ratio
Control (n=5) 60.2+09.51 21.6±08.2 6.9±3.2 17.3±08.7 2.8+0.5
PIV-3 (n=5) 28.7±10.83 31.3±09.32 4.6±2.5 29.5+10.2 0.9+0.43
1 Results are expressed as median of percentages ± SD of positively labelled cells in lymphocyte
gate.
2 Significantly different from controls at p<0.05 (Mann-Whitney non-parametric rank test)
3 Significantly different from controls at p<0.001 (Mann-Whitney non-parametric rank test)
FIGURE 5. 1 Frequency histograms showing the reactivity of OPIV-3 antisera ( )
with AM<J>s from 5 lambs (A-E) experimentally infected with OPIV-3 270-7. Lambs
were obtained at birth and colostrum-deprived. They were inoculated with 5 ml of
tissue culture fluid containing the vims (OPIV-3 270-7); 2ml were given intranasally
and 3ml transtracheally. The profiles show staining of AM(j>s in the lung wash fluid
(LWF) that was obtained from lambs euthanised and necropsied on post-inoculation
(p.i.) day 7. Negative controls of staining (incubation with NRS) is shown for
comparison ( ).
LW-AM/OPIV-3
i Log10 Fluorescence Intensity —►
observed with M0s but not with lymphocytes (Fig. 5.2). M(|>s showed variable
intensity of staining in cytoplasm. No staining of nuclei was detected.
5.2.4 Leucocytes distribution in lung lesions from normal and PIY-3
experimentally infected lambs.
The distribution of leucocytes in lungs from mock-infected animals is shown in Table
5.3. M0S were observed around the bronchial or bronchiolar epithelium; in
association with BALT; inside alveolar walls and free in alveolar space. In contrast,
lymphocytes were located mainly in peribronchial and peribronchiolar areas as part of
small BALT structures and less frequently migrating through the epithelium. They
were only rarely seen in alveolar walls or in alveolar space. PMNs were occasionally
seen inside blood vessels.
The distribution of leucocytes in lung sections from infected animals after 7 days p.i.
with OPIV-3 270-7 is shown in Table 5.3. The numbers of lymphocytes increased
considerably in peribronchial and peribronchiolar areas and heavily infiltrated the
epithelium. They also appeared in association with oedema and in lymphatic vessels of
the interlobular space. Lymphocyte cuffs were observed in many hyperemic blood
vessels. Presence of lymphocytes in bronchiolar or bronchial lumen was sporadic. M(|)s
increased around the epithelium, interlobular space and subpleural area and inside
bronchial and bronchiolar lumen, where they were occasionally seen in control
sections. Their number increased inside alveolar walls and in bronchial BALT. Inside
the alveolar space, M(|)s did not show a noticeable increase, but some degenerative
free, pneumocytes appeared. PMNs could sometimes be seen in bronchial and
bronchiolar lumen and occasionally infiltrating the epithelium. More were observed
inside hyperemic blood vessels.
5.2.5 Immunohistochemical detection of T lymphocyte subsets and
macrophages in lung lesions from PIY-3 experimentally infected lambs
T lymphocyte subsets and M(j)s were identified, by immunohistochemistry, in sections
of colostrum deprived lungs showing lesions of interstitial pneumonia, after 7 days p.i.
with OPIV-3 270-7. Serial frozen sections were cut and stained for CD4 and CD8
91
 
FIGURE 5. 2 OPIV-3 particles detection in LWF cells. Cytospin smear of LWF
obtained from a lamb 7 days p.i. with OPIV-3 270-7. Immunostaining was carried
out with OPIV-3 rabbit antisera. All four M<J)s but none of the three lymphocytes
show positive immunostaining (red colour) after incubation with OPIV-3 antisera.
IIAP. The nuclei were counterstained with H/E. Magnification x400.
TABLE 5. 3 Leucocyte cell distribution in lung sections from control1 and PIV-3
2 ...
infected lambs according to histological regions.
Leucocytes
Histological area Lymphocytes M(j)s PMNs
C PIV-3 C PIV-3 C PIV-3
Bronchi lumen O o CO 09.0+03.6 0.0 09.5106.3 03.2101.5 04.5108.6
epithel 0.0 36.5112.6 0.0 12.4103.9 0.0 03.9109.4
BALT 72.6±09.8 160.8+18.9 03.1105.4 11.4104.7 0.0 0.0
Bronchioles lumen 0.0 04.2103.6 0.0 07.5103.8 02.3101.6 03.2106.6
epithel 0.0 22.9+07.8 0.0 10.7102.9 0.0 0.0
BALT 32.8+13.9 76.2117.2 01.2103.2 08.6104.7 0.0 0.0
Alveolar space 0.0 02.8101.7 06.3104.9 19.8+07.6 01.6101.4 02.9108.7
Alveolar wall 20.4100.9 75.6118.8 05.6106.3 13.6105.8 0.0 0.0
Interlobular area 0.0 12.3107.9 0.0 05.5102.6 0.0 0.0
Subpleural area 0.0 14.6109.7 0.0 07.6103.4 0.0 0.0
Perivascular cuffs 0.0 26.9108.6 0.0 02.9108.8 0.0 01.914.6
1 formalin fixed paraffin embedded sections from five inoculated (7 days p.i.) PIV-3 positive lambs
n= 25 (5 sections from each animal taken from affected lobes). Giemsa stain
2 formalin fixed paraffin embedded sections from five control PIV-3 negative lambs n= 25(5 sections
from each animal taken from anteroventral lobes). Giemsa stain
3 Results are expressed as the mean number(±SD) of cells found in each region considering 10
random observations per histological region in every section, magnification 600x
I
lymphocyte T cell markers. M<j)s were detected by using monoclonal antibody
VPM32. Corresponding areas were compared for staining for T cell and M<j) markers.
The reactivity was detected by indirect alkaline phosphatase immunostaining. Table
5.4 shows the results with distribution of positive cells according to histological areas
in lung tissue.
In control lung sections (mock-infected lambs) BALT structures were small and
detected around a few bronchioles. Occasional peribronchiolar and peribronchial
lymphocytes were observed. Most lymphocytes in BALT, around the epithelium and
inside the alveolar walls were positive to CD4+ staining (Fig.5.3a). Fewer cells were
positive for CD8+ staining (Fig. 5.3b). This gave a CD4+/CD8+ ratio of 12.2±4.1 for
bronchial BALT and of 8.8±3.4 for bronchiolar BALT (Table 5.4).
In contrast, immunostaining of lung sections from animals 7 days p.i. with PIV-3 270-
7, showed significant differences in number and distribution of cells in interstitial
pneumonic lesions (see Table 5.4). CD4+ lymphocytes were also detectable in
BALT, around the epithelium and inside the alveolar walls in a similar number to
those found in control lambs (Fig. 5.3c,d). In contrast the numbers of CD8+ had
increased significantly (p<0.001) particularly in BALT (Table 5.4) where this
accounted for most of the BALT hyperplasia. This markedly and significantly
(p<0.001) changed the CD4+/CD8+ ratio of BALT, originally from 12.2±4.1 to 0.25±
0.03 in bronchial BALT and from 8.8±3.4 to 0.30±0.10 in bronchiolar BALT (Fig.
5.4a-c). CD8+ lymphocytes were detected in the mantle and germinal centre areas of
BALT nodes. Likewise in alveolar spaces there was a change in the CD4+/CD8+ from
2.4±0.5 to 0.97±0.01. In contrast, inside the alveolar walls the CD4+/CD8+ ratio did
not change after infection. However, there was a significant (p<0.001) increase in
absolute numbers of both CD4+ and CD8+ lymphocytes.
Immunostaining of sections from mock-infected animals, by monoclonal antibody
VPM32 showed a few scattered Mcjis located in the central areas of BALT, alveolar
walls, alveolar space and around the bronchi/bronchiolar epithelium (Fig.5.5a). In
contrast, M(J) immunostaining of lung sections from animals 7 days p.i. with PIV-3
270-7, showed that these cells increased significantly (p<0.001) in all areas (Table
5.4). Mcjis numbers increased particularly in interstitial tissue such as peribronchial and
peribronchiolar areas, surrounding the epithelial wall and migrating towards the lumen























































































































































































FIGURE 5. 3 Immunostaining of CD4+ and CD8+ T lymphocyte subsets in frozen
lung sections of interstitial pneumonic areas from lambs after 7 days p.i. with OPIV-
3 270-7. A series of frozen sections was cut and incubated with monoclonal
antibodies SBU-T4 and SBU-T8 for CD4 and CD8 sheep lymphocyte T cell markers,
respectively. The reactivity was detected by indirect immunoalkaline phosphatase
(IIAP) staining.
a) Bronchiole surrounded by
lymphocytes that showed positive
immunostaining (red colour) for the
CD4 marker. These cells are
distributed around the bronchiolar
epithelium where there is also a smaller
number of non-stained lymphocytes
(green nuclei). IIP with SBU-T4 mAb.
The nuclei were counterstained by
methyl green. Magnification x400.
c) A large BALT close to a bronchiole
can be seen where there are some
positive cells (red colour) for the CD4
marker. Most cells in this lymphoid
structure remain negative (green
nuclei). More scattered positive cells
are observed in the alveolar walls. IIP
with SBU-T4 mAb. The nuclei were
counterstained with methyl green.
Magnification xlOO.
b) Bronchiole surrounded by
lymphocytes that showed positive
immunostaining (red colour) for CD8
marker. These cells are distributed
around the bronchiolar epithelium and
the alveolar walls where there is also a
larger number of non-stained
lymphocytes (green nuclei). IIP with
SBU-T8 mAb. The nuclei were
counterstained with methyl green.
Magnification x200.
d) Closer view of figure 5.5c. Detail of
BALT node where most of the
lymphocytes are negative for CD4
marker. SBU-T4 mAb. The nuclei
were counterstained with methyl green.
Magnification x400.
 
FIGURE 5. 4 Immunostaining of CD8+ T lymphocytes in frozen lung sections of
interstitial pneumonic areas from lambs after 7 days p.i. with OPIV-3 270-7. A series
of frozen sections was cut and incubated with monoclonal antibody SBU-T8 for CD8
sheep lymphocytes T cell marker. The reactivity was detected by indirect
immunoalkaline phosphatase (IIAP) staining.
a) Two BALT nodes with marked hyperplasia can be seen. They show that most of
the lymphocytes stained for the CD8 marker (red colour). A few cells remain negative
in the periphery (green nuclei) of this lymphoid structure. IIP with SBU-T8 mAb. The
nuclei were counterstained with methyl green. Magnification xlOO.
b) A closer view of the BALT located to the right in figure 5.6a. Most of lymphocytes
in this lymphoid structure are positive (red colour) for lymphocyte marker CD8. IIP
with SBU-T8 mAb. The nuclei were counterstained with methyl green. Magnification
x400.
c) There is strong staining for the CD8 marker in lymphocytes located around the
peribronchiolar area immediately below the epithelium. Staining of the cell membrane
is noticeable. IIP with SBU-T8 mAb. The nuclei were counterstained with methyl
green. Magnification xlOO.
 
FIGURE 5. 5 Immunostaining of M<J)s in frozen lung sections of interstitial
pneumonic areas from lambs after 7 days p.i. with OPIV-3 270-7. A series of frozen
sections was cut and incubated with monoclonal antibody VPM32 for ovine tissue
M<j)s. The reactivity was detected by indirect immunoalkaline phosphatase (IIAP)
staining.
a) Scattered cells positive for VPM32
M<j) marker (red colour) can be
observed around the bronchiolar
epithelium and migrating towards the
lumen. Also there are some positive
cells in the alveolar walls which show
increased thickness. IIP with VPM32
mAb. The nuclei were counterstained
with methyl green. Magnification x200.
c) Closer view of the peribronchiolar
area from Fig. 5.7b. A large number of
M(j)s (red colour) can be observed
either in small groups in the alveolar
spaces or individually in the alveolar
walls. IIP with VPM32 mAb. The
nuclei were counterstained with methyl
green. Magnification x400.
b) Overview of an atelectatic area
around two bronchioles that show cell
debris inside their lumens. Strong
positive staining of many cells in the
alveolar walls and the alveolar spaces,
(green nuclei) can be seen. IIP with
VPM32. The nuclei were
counterstained with methyl green.
Magnification xlOO.
d) Close view of a hyperplastic BALT
structure where there are some positive
cells for M(|) marker VPM32. They are
located in the centre of this lymphoid
structure. Lymphocytes (green nuclei)
remain negative. IIAP with VPM32
mAb. The nuclei were counterstained
with methyl green. Magnification x400.
 
of BALT (Fig. 5.5d). The increment of AM(j)S was less noticeable than that of the
interstitial Mtjts.
5.2.6 Immunohistochemical detection of PIV-3 infected macrophages and
lymphocyte subsets in lung lesions from PIV-3 experimentally infected
lambs by double immunostaining.
PIV-3 infected AMtjts or lymphocyte subsets CD4+ and CD8+ were detected by
double immunostaining SA-HRP/IAP. First, sections were incubated with rabbit and
OPIV-3 sera, then with biorinylated goat anti-rabbit IgG and finally with HRP-
conjugated avidin. The enzyme substrate was 4CN which gave blue product. Then
sections were incubated with either mouse monoclonal antibody VPM32, SBU-T4 or
SBU-T8 for M(|>s, CD4+ or CD8+ T lymphocytes, respectively and then with AP-
conjugated donkey anti-mouse IgG. The enzyme substrate was Naphtol AS-MX/Fast
Red which gave a red product.
Lung sections showing interstitial pneumonia lesions after 7 days post experimental
inoculation with OPIV-3 were double immunostained with rabbit antiserum and mAbs
SUB-T4 and SBU-T8. They did not show positive staining for virus particles in cells
staining for either CD4 or CD8 markers. In contrast sections double immunostained
with rabbit anti OPIV-3 serum and mAb VPM32 showed that many cells which
stained for the ovine tissue M<[) marker (VPM32) also stained for virus particles.
In double immunostained sections viral particle staining (blue colour) appeared not
only associated with some Mtjts (red colour) but also with some epithelial septal cells
(pneumocytes) (Fig. 5.6a). In alveolar spaces large, round M<(>s appeared intensely
stained for M<j> marker VPM32. Some of these AM<j)s also showed positive staining
for virus particles (Fig. 5.6a,b). Interstitial Mtjts also showed positive staining for virus
particles. Large round cells, in alveolar spaces, which stained only for the virus (blue
colour only) were more likely to correspond to detached degenerative epithelial cells.
It was noted that in some areas there was patchy distribution of the virus particle
staining following the lobular structure. Thus some lobules showed viral particle
staining while the surrounding ones were negative (Fig.5.6c,d).
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FIGURE 5. 6 PIV-3 infected AM(j) detection by double immunostaining (SA-
HRP/IAP) in frozen lung sections of interstitial pneumonic areas from lambs after 7
days p.i. with OPIV-3 270-7. Firstly, sections were incubated with rabbit anti OPIV-3
sera as primary antibody, then with secondary antibody biotinylated goat anti-rabbit
IgG and finally with a third antibody HRP-conjugated avidin. The enzyme substrate
was 4CN for a blue product. Then sections were incubated with mouse monoclonal
antibody VPM32 as a primary antibody and then with AP-conjugated donkey anti-
mouse IgG. The enzyme substrate was Naphtol AS-MX/Fast Red for a red product.
a) Many positive cells for VPM32 M<j)
marker (red colour) can be seen in the
alveolar walls or in the alveolar spaces.
Positive staining for PIV-3 particles
(blue colour) can be seen in some
pneumocytes (small arrows) and also
in some alveolar and interstitial M(j)s
(large arrow). SA-HRP/IAP with
VPM32 mAb and OPIV-3 rabbit
antisera. Nuclei were counterstained
with methyl green. Magnification
x400.
b) Small groups of M(j)s in the alveolar
spaces (arrows) are stained for both
M<)> marker VPM32 (red colour) and
OPIV-3 particles (blue colour). SA-
HRP/IAP with VPM32 mAb and
OPIV-3 rabbit antisera. The nuclei
were counterstained with methyl green.
Magnification x200.
c) Overview of an atelectatic area
where the division between two lobules
can be distinguished (large arrow). It is
possible to observe OPIV-3 particle
staining (blue colour) in the upper
lobule, but not in the lower one.
Positive cells for M(j) marker VPM32
(red colour) can be observed in both
lobules. SA-HRP/IAP with VPM32
mAb and OPIV-3 rabbit antisera. The
nuclei were counterstained with methyl
green. Magnification xlOO.
d) Closer view of Fig. 5.8c. Detail of
the division between two lobules where
there is staining for OPIV-3 particles
(blue colour) in the lobule to the left
but not in the one to the right. SA-
HRP/IAP with VPM32 mAb and
OPIV-3 rabbit antisera. The nuclei
were counterstained with methyl green.
Magnification x400.
 
No PIV-3 particle staining was detectable in bronchial or bronchiolar epithelial cells.
Likewise, no viral particles were detected by immunohistochemistry in BALT nodes.




The results shown in this study demonstrate alterations in the normal composition of
CD4+ and CD8+ lymphocyte subsets that could play a key role in the pathogenesis of
OPIV-3 infection in the lung and could provide a better understanding of the
pathogenic mechanisms of OPIV-3 in sheep pneumonia. This viral infection is
associated with accumulation of lymphocytic cells, however the role for the different
subsets remains unknown (Crouch, 1990).
An increased interstitial cellularity and a thickening of the alveolar septa due to M<j)
and lymphocyte infiltration 7 days p.i. with OPIV-3 270-7 has been previously
described in this study (section 4.2.5.2). These findings are similar to those from other
reports on OPIV-3 experimental infection (Cutlip & Lehmkhul, 1982). Accordingly,
an increased recovery of cells in lung wash fluid (LWF) could be expected. However,
in this study the total LWF cell count in OPIV-3 infected animals, showed some
increase, but did not differ significantly (p>0.01) from the controls. This could be due
to the fact that in interstitial pneumonia most changes occur in the lung interstitial
tissue rather that at the alveolar level. Moreover the lung pathology induced by OPIV-
3 in the experimental lambs in this study were of focal distribution and restricted to
anterior lobes. Furthermore, although the total cell count for LWF cell recovery after
OPIV-3 infection was not significantly higher than in controls, there was a significant
increase (p<0.001) in the proportion and also in absolute number of lymphocytes,
when compared to controls. Also, lymphocytes were the main mononuclear cell type
found in PIV-3 lung sections in this study. On the other hand, there was a decreased
proportion of M(j)s in LWF with a non-significant low increase in absolute number.
In contrast AMcjis in LWF after 7 days p.i. with OPIV-3 showed a significant
(p<0.05) decrease in frequency. Although their absolute number was increased this
was not significant (p>0.01). AM<j)s although increased in pneumonic lung lesions
their increment was less noticeable than the one of interstitial M())s. This may reflect a
cytolytic action of OPIV-3 for AM(j)s.
Similar changes in cellularity and both lymphocyte and M(j) recovery, from
bronchoalveolar lavage (BAL), have been described after infection with MVV in
sheep (Lujan et al., 1993). This virus not only induces interstitial pneumonic lesions
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but also grows in AM<j)s (Lee, 1994). In contrast, intratracheal inoculation of PIV-3 in
guinea pigs (Folkerts et al., 1992) has been reported to induce airway hyper-
responsiveness with significantly increased cellularity and recovery of AM(|)S,
monocytes, lymphocytes and even eosinophils after 4 days p.i. However, no data is
available on the type and extent of lung pathology induced by OPIV-3 in these guinea
pigs, showing airway hyper-responsiveness, for comparative purposes.
In addition to the increase in lymphocytes there was also an increase in PMNs in LWF
from OPIV-3 infected animals. An increased secretion of Neutrophil Chemotactic
Activity (CA) factor by alveolar cells from MVV pathologically affected animals has
been reported (Cordier et al., 1990). It has also been described here (section 4.2.5.2.)
and elsewhere (Cutlip & Lehmkhul, 1982) that necrosis is one of the histopathological
findings in interstitial pneumonia induced by PIV-3. This could account for the
increased recruitment of PMNs into the affected lungs. Also the release of
granulocyte-macrophage colony-stimulating factor (GM-CSF) from AM(|)s has been
demonstrated to occur in vivo in the lung during HIV-1 infection (Agostini et al.,
1992). This cytokine has well recognized effects on granulocyte and M(j) growth and
differentiation and plays some role in the mechanisms leading to the accumulation of
M(|)s and PMNs in patients with interstitial lung disease. These histopathological
findings are concordant with many others from interstitial lung diseases in humans and
animals (Martin et al., 1983). The local overproduction of GM-CSF is likely to play a
role in the pathogenic events leading to the local accumulation of M<J>s and
recruitment of PMNs in PIV-3 infection.
The significant decrease (p<0.001) in the CD4+/CD8+ ratio of lymphocytes from LWF
of PIV-3 infected animals is due to both a significant increase of CD8+ T lymphocytes
and a significant decrease of CD4+ T lymphocytes. This pattern of immune response is
similar to that observed in murine lung lesions caused by the influenza virus (Allan et
al., 1990) and also in inflammatory meningeal exudate after lymphocytic
choriomeningitis (LCM) vims infection (Baezinger et al., 1988), where CD8+ cells
increase and largely surpass CD4+ cells. In influenza CD8+ cells promote viral
clearance, monocyte release from bone marrow and induce severe inflammation in the
absence of the CD4+ T lymphocyte response (Allan et al., 1990).
The mechanism of protection against infection varies according to the etiological
agent involved. In rats infected with the measles vims, CD4+ cells are more important
in protection than CD8+ cells. In infections with LCM vims, CD4+ cells are not
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required when CD8+ cells are present, however, after CD8+ depletion, CD4+ cells can
compensate this deficiency and play a protective role (Scott & Kaufmann, 1991).
CD8+ lymphocytes play an important role not only in viral diseases but they also are
important in many diseases produced by bacteria and parasites such Listeria
monocytogenes, Mycobacterium tuberculosis, Toxoplasma gondi, Plasmodium spp.,
Theileria parvum and Tripanosoma cruzi (Scott & Kaufmann, 1991).
The fact that CD8+ are induced to proliferate in response to PIV-3 infection as well as
in response to other viral or non-viral infectious diseases is of considerable importance
in the strategy and design of prophylactic schemes for these diseases. For example,
vaccines against these pathogens could be designed to introduce antigens into MHC
class I molecules, while recombinant bacteria could be used as carriers for vaccines
against viral infections (Scott & Kaufmann, 1991).
In this study, after 7 days p.i with OPIV-3 virus particles were detected by
histochemistry in association with pulmonary M<|)s. In contrast, no virus was
associated with CD4+ or CD8+ lymphocyte subsets. This seems to disagree with
findings by Sieg et al., (1994) who have reported that HPIV-3 readily infects T cells
in vitro; however, they also reported that T cell infection by PIY-3 may not be
detectable, by immunostaining, before 1 or 2 weeks p.i. It is possible that the short
period which had elapsed before taking the lung samples for this study (7 days p.i.)
did not give time for infected lymphocytes to express viral proteins. Besides, no data
is available on the time required to observe lymphocyte viral protein expression after
in vivo infection with PIY-3. Furthermore, Basaraba et al. (1993) have reported, from
in vitro infection of lymphocytes cultures with PIV-3, that despite the presence of
lymphocyte-associated virus antigen, detected by direct immunofluorescence, no
increase in PIV-3 titre above baseline was seen in infected lymphocytes, irrespective
of mitogen stimulation. Likewise, lymphocytes did not contribute to the extracellular
virus pool in lymphocyte-M(j> cultures as the increases in viral titre in supernatants
were equal to levels released by M(j)s alone. They conclude that the expression of viral
antigen on lymphocytes stimulated in the presence of PIV-3-infected bovine AM(f)s
suggests a non-productive or abortive infection of lymphocytes mediated through
contact with infected M(j)s. Similar findings were observed in this study and are
described in the following chapter.
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In lungs after 7 days p.i there was an increase of pulmonary lymphocytes both in the
alveolar walls and the BALT nodes. Similarly, in the alveolar walls of MVV infected
sheep lungs there was an increase of CD4+ and CD8+ lymphocytes with a CD4+/CD8+
ratio similar to control non infected animals. In regional lymph nodes of MVV
infected animals there was also an increase of CD8+ T lymphocytes (Watt et
al., 1992). This suggests that activated T lymphocytes, particularly CD8+ cells have an
important role in the pathogenesis of lymph nodes and pulmonary lesions as part of
the interstitial pneumonia induced by PIV-3 and MVV.
The accumulation of lymphocytes in the interstitial pulmonary tissue found in this
study during PIV-3 infection can be the result of retention and proliferation of
lymphocytes in response to cytokines, and/or the presence of viral antigens. In this
study a clear increase in CD8+ T lymphocytes was observed as an inflammatory
infiltrate distributed along the alveolar walls, around the bronchi and bronchioles,
around the blood vessels and in particular as the main cell component of BALT
hyperplasia. CD8+ lymphocytes were detected in the germinal centre and mantle areas
of secondary BALT nodes. This is in agreement with observations in other viral
induced interstitial pneumonia such as HIV in man and MVV in sheep (Watt et al.,
1992). However, no OPIV-3 particles were detected by immunohistochemistry in
these lymphoid structures. Similar findings has been reported in MVV infection by
Watt et al. (1992). They suggest that the reaction in these lymphoid nodes can be
driven by soluble antigens drained to this nodes or transported by cells from infected
areas.
Generalized immunosuppression is not commonly associated with PIV-3 infection.
Moreover, infected individuals often recover from the infection, if no secondary
bacterial contamination occurs. This indicates that specific immune response is not
totally obliterated. However, PIV-3 has the potential to both persist and reinfect in
vivo (Basle et al., 1986). The mechanisms for these phenomena has not been
described. HPIV-3 mediated immunoregulation of human T lymphocytes has been
suggested to play an important role in the failure of the virus to induce lifelong
immunity (Sieg et al., 1994; Ray et al., 1995).
It is likely that the equilibrium between the host and the viral parasite arises as a result
of the complex interactions between the host immune system and the virus. It has
been suggested that PIV-3 infection preferentially inhibits the establishment of specific
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anti-PIV3 memory T cells (Sieg el at., 1994). So far, the role of specific T cells in the
immune system to PIV-3 has not been thoroughly investigated. However, it seems
likely that the virus has the potential for manipulating the immune response.
T cells have the capacity to lyse virally infected cells, help B lymphocytes produce
immunoglobulins and establish long lived memory cells. Hence, the possibility that
PIV-3 mediated immunoregulation of T lymphocytes plays a role in either viral
persistence or reinfection should be clarified
The increase in both alveolar and interstitial M(|>s observed after 7 days of infection
with OPIV-3 suggests a role for these cells in the host mechanisms of defence against
infection and also in the mechanisms of lung pathology. Pulmonary interstitial M<|)s,
for instance, have a greater capacity to replicate and produce cytokines and growth
factors that are essential for proliferation of fibroblasts (Shaw, 1991). This may
contribute to the alveolar wall thickening and fibrosis observed in interstitial
pneumonia. Furthermore, they are the most effective cells in stimulating T cell
response to viral antigen (Holian & Scheule, 1990). M<()S can be activated during viral
infection (Hearst el at., 1980) and this activation, during PIV-3 infection, is
considered as an indirect effect possibly caused by the action of cytokines, in
particular to y-IFN (Babiuk et at., 1988).
A significant proportion of M<|)s showed positive immunostaining for OPIV-3
suggesting that infection of these cells occurs in vivo. This agrees with evidence of
PIV-3 replication in M<j>s detected by electron microscopy (Bryson el at., 1983; Tsai,
1977). However, it was also observed in this study that many alveolar and interstitial
pulmonary M<})s after 7 days p.i. showed no immunostaining for the virus. This could
be the result of a lytic CPE effect of the virus combined with a rapid cell turnover.
Also, it has been frequently observed in vitro (Moscona & Peluso, 1991a, 1992,
1993b) that HP1V-3 can induce a persistent viral infection with production of
defective virus particles and no CPE. These particles may not be detectable by the
monoclonal anti HP1V-3 protein HN used here to detect the virus. Therefore, it is
necessary to carry out further studies in order to determine whether a proportion of




IN VITRO INFECTION OF OVINE PERIPHERAL BLOOD DERIVED
MACROPHAGES AND PULMONARY ALVEOLAR MACROPHAGES
WITH PARAINFLUENZA TYPE 3 VIRUS
I
PART A: OPIV-3 INFECTION OF MONOCYTE/MACROPHAGE CELL
CULTURES
PART B: PHENOTYPIC CHANGES
6.1 INTRODUCTION
In the lung inhaled antigens can stimulate local and systemic primary immune
responses. Many infectious organisms that invade the body via the lung arc controlled
by immune responses elicited locally. Furthermore, antigens inhaled by immune hosts
are suspected of being responsible for triggering type I and type IV hypersensitivity
reactions that can result in disease of the lung (Dubois, 1986). Most immune
responses have been shown to require antigen presenting cells to stimulate the
appropriate T lymphocytes (Godstein et al., 1973; Toews et al., 1984). It is likely that
AM(j>s are important antigen-presenting cells and function in the initiation and
secondary elicitation of immune responses within the lung. Likewise, it has been
postulated that, in vivo, AM()s release cytokines critical for the activation of dendritic
cells (Miller et al., 1992). This would take place during the afferent limb of the
immune response. Alveolar M(|)s would respond to products of sensitized T-cells such
as y-IFN and IL-4 to interact with T-helper cells in an antigen-specific MHC-
restricted manner during the efferent limb of the response (Miller et al., 1992). Their
role, however, has not been completely investigated.
The monocyte/Mcj) lineage originates from haemopoietic stem cells which
subsequently develop into monoblasts or promonocytes in bone marrow (Godleski &
Brain, 1972; Thomas et al., 1976). By complex cytokine stimulation and regulation,
these cells differentiate into monocytes and are released into blood. Monocytes may
remain in the blood for 36 to 104 hours and then migrate into tissues. Subsequently,
monocytes differentiate and mature as resident M<|)s. These resident M(j)s have similar
morphology and basic phenotype, but still display considerable functional
heterogeneity in response to the resident environment (Beelen et al, 1989).
In pulmonary tissue, M(bs may be found i) in the interstitial connective tissue of the
alveolar wall ii) forming part of the lining epithelium of the alveolus and iii) free in
the lumen of the alveolus. Some of the latter are true M<f>s and others are free
defoliated large alveolar cells. The fine structure of free AM<j>s contains a moderate
amount of smooth endoplasmic reticulum and relatively little rough endoplasmic
reticulum. They have numerous processes and invaginations on their surfaces. Many
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inclusion bodies or lysosomes are present, often containing myelin figures or ferritin.
Occasionally these structures are paracrystalline (Carr, 1973).
I
It is not difficult to establish a short-term mixed culture containing a preponderance of
M())s but much harder is to obtain a long term pure culture. Perhaps the best way to
obtain a pure culture is by lavaging the serosal cavity, usually the peritoneal cavity or
by lung washout. When cultured on a glass surface, other cells may be present.
Polymorphonuclear- cells degenerate rapidly and lymphocytes arc non-adhesive. Only
M(j)s remain attached to glass after few hours of culture. The attached M<j>s will
change their shape and look very different from the relatively spherical cells obtained
from lavaging out cavities but not very different from the cells that lie in the tissue
spaces (Carr, 1973).
The structure of the M(j) in culture varies according to the length of time it has been
in culture and with its source of origin. The phases in its culture include 1) adherence,
2) spreading and phagocytosis of debris, 3) mitosis and 4) extended culture. With the
scanning electron microscope the shape of a peritoneal M<}> can be followed during the
process of settling on a glass surface; it changes from a spherical to a flattened round
form and then to a flat stellate form. Very fine protoplasmatic processes are extruded
during this change. During prolonged culture the shape may be flattened and virtually
circular, elongated or fully extended and may measure 15-80pm. Stellate forms may
sometimes occur with curious end knobs. When the cell is moving a broad undulating
flap-like membrane may act as the leading edge; sometimes two processes may be
seen advancing in slightly different directions, each led by a small undulating
membrane. Sometimes adjacent cells on a flat surface may apparently adhere to one
another so closely as to form a membrane which will strip off the glass.
Multinucleated giant cells may form (Carr, 1973).
The Mcj) in culture has an oval or round nucleus which is often indented and resembles
the nucleus of the blood monocyte. It contains dispersed chromatin granules but
nucleoli are absent. The cytoplasm has a varied appearance which depends on the
activity of the cell. They tend to show numerous ruffles and globules on the surface
probably associated with pinocytosis (Stuart, 1970).
Interleukin 3 (IL-3) and granulocyte-M(j)-colony-stimulating factor (GM-CSF) have a
broad specific activity on pluripotent stem cells leading to their differentiation and
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proliferation (Schrader, 1986). IL-3 acts on early progenitors which develop into
mature cells of multiple lineages (granulocytes, monocytes and megakariocytcs).
Macrophage-colony-stimulating factor (M-CSF) and GM-CSF act at a late stage to
stimulate progenitors to develop into monocytes and Mcf>s (Geissler et al., 1989;
Eischen et al., 1991; Haig el al., 1990).
The leucocyte integrins (02 integrins, CD11/CD18) are involved in mediating
important leukocyte adhesion dependent interactions, including cell to cell
communication thus imparting a significant role in host defence by mediating
inflammatory and immune responses (Haines, 1992). The molecules of leucocyte
integrins are exclusively expressed by leukocytes and are major cell surface molecules
on monocyte/M<J)s (Ross et al., 1989; Mackay & Imhof, 1993). The leucocyte
integrin family has three structurally related glycoproteins, CD1 la (LFA-1), CD1 lb
(Mac-1, CR3) and CDllc (p!50,95, CR4). Each of these three glycoproteins exist as
an a0complex in which a unique a subunit is associated with a common 0 subunit,
the 02 chain (GDI 8) (Haines, 1992) These molecules are involved in stabilizing cell
contact between M<j>s and immune effector ceils to allow antigen presentation to
lymphocytes (Krensky et al., 1983; Denning et al., 1988). Intercellular adhesion
molecules (ICAM) 1 and 2 act as ligands for CDlla. ICAM-1 is present on
endothelium, leukocytes and many epithelial cell types. ICAM-2 is constitutively
expressed by endothelial cells and leukocytes (Springer, 1990). Both CDllb and
CD lie molecules are specific for the complement component, C3b, and are involved
in phagocytosis (Myones et al., 1988; Owen et al., 1992).
Immunoglobulin Fc receptors (FcR's) are involved in phagocytosis and endocytosis
(Fridman, 1989, 1991). The expression of Fc receptors for IgG (FcyR) by M<j>s
enables them to phagocytose a variety of antigens in the presence of specific antibody
thus enhancing the range of antigens ingested by phagocytes (Jungi & Flafner, 1986;
Fanger et al., 1989; Sarmay, 1992). FcyRII (CDw32) and FcyRIII (CD16) have been
identified on monocytes and M<})s and they bind complexed IgG only (Anderson,
1987; Ravetch & Kinet, 1991; Levy et al., 1991). AH are members of the
immunoglobulin superfamily with transmembrane and cytoplasmic regions and a
variable number of extracellular domains (William & Barclay, 1988). Expression of
these molecules on M()>s is enhanced by y-IFN and IL-2 (Fanger et al., 1989; Heagy et
al, 1984; Gonwa et al., 1986; Nash et al., 1992).
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CD 14 is a myeloid differentiation antigen expressed primarily on the cell surface of
monocytes and M(j)s. The CD 14 is anchored to the cell surface via a glycosyl
phosphatidyl inositol (GPI) linkage (Goyert et al., 1989). The antigen also exists in
various soluble forms (Haziot et al., 1988; Durieux et al., 1994). Both the membrane
and soluble forms of the antigen bind lipopolysaccharide (LPS) complexed to LPS
binding protein (LBP), an acute phase protein present in serum. The binding of LPS-
LBP complex to CD 14 results in release of various inflammatory cytokines including
TNF-a, leading to the induction of endotoxic shock (Ulevitch, 1993). CD14 is down-
regulated by y-IFN (Ziegler-Heitbrock & Ulevitch, 1993).
The direct effect on surface molecule expression of M<])s after infection with PIV-3 is
not clear. Here, a study of the changes in the phenotype of sheep monocyte/M(]) cells
including fresh monocytes and cultured both monocyte-derived M(j>s (MDM(j)) and
alveolar M(j>s (AM(j)) was undertaken, before and after infection with OPIV-3.
There is often variation in monocyte/M(j) phenotype not only amongst different tissue
types but also amongst different individuals. This heterogeneity may be related to
variations in function (Lee, 1994) as well as in susceptibility to infection. Therefore, in
this study, changes in monocyte/M(|) phenotype associated with culture and induced
by OPIV-3 in vitro are analysed. The phenotype was characterised by detecting the
expression of a number of molecules associated with differentiation and/or function,
with monoclonal antibodies. They included CD4, CD8, VPM32 antigen, LFA-1,
LFA-3 and CD 14. Also, the susceptibility of different monocyte/M<j> populations and
lymphocytes to infection by OPIV-3 (270-7 strain isolated in this study) is tested.
These observations may help to explain functional changes observed both in vitro and
in vivo functional studies.
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6.2 RESULTS
6.2.1 PART A: OPIV-3 INFECTION OF MONOCYTE/MACROPHAGE
CELL CULTURES
6.2.1.1 General observations in monocyte derived macrophage (MDMty) cell
cultures during maturation in vitro.
Monocytes were collected from peripheral blood (PBMC) and cultured in gelatin-
coated flasks or plates, as previously described in section 2.2.3. The number of
monocytes in the cultures was estimated by non-specific esterase staining (NSE). The
presence of other leukocytes was detected by both Giemsa's stain and indirect
immunofluorescence. The period of time the cells were allowed to attach, before the
non-adherent cells were removed (by washing them off) seemed to affect both the cell
number and composition of adherent cells, evaluated after 3 days in culture. Thus,
when non-adherent cells were washed off after 1 or 2 hours incubation, a high
proportion of adherent monocytes (over 80%) were obtained. However, they showed
a low absolute number. Most of the contaminating cells were lymphocytes. It was
difficult to obtain cell monolayers after 5 to 7 days with this method. In contrast,
when non-adherent cells were washed off after overnight incubation (16 hrs.) the total
number of cells, after 3 days in culture, was much higher but the proportion of
monocytes was lower (70-80%), with more contaminating lymphocytes (data not
shown). Many of the contaminating cells were trapped and attached to the flasks by
strands of a material which was thought to be fibrin produced by MDM(|)S. After 5
days of culture these aggregates of contaminating cells along with strands of fibrin
became detached and were easily removed from the flasks or plates. The proportion
of monocytes obtained with this method, after 5 days of culture, was much higher
(near 95%), with a high number of cells in culture which form a continuous
monolayer (Fig.6.1a). This method was chosen for providing MDM<|)s, in the
experiments described in this chapter. Monocytes cultured for 5 to 7 days markedly
increased their size and cytoplasm/nucleus ratio and also showed very strong NSE
staining compared to fresh monocytes (Fig.6.lb). Also, cytoplasmic vacuolization,
binucleated cells and a few scattered syncytia were observed with nuclei disposition in
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the central area of the cytoplasm (Fig.6.1c). Some MDM(J)s from early cultures, that
had come off the flask surface, could be passaged to 24 well plates where they
became adherent and confluent. Contamination with fibroblasts, epithelioid and
syncytial cells occurred in some long term MDM<|) cultures, after 2-3 weeks.
Therefore, MDMtjis were infected after 5 days in culture and followed in most
instances for no longer than 2 weeks.
6.2.1.2 General observations in alveolar macrophage (AM<p) cell cultures during
maturation in vitro.
AM(|)s were collected from LWF and cultured in gelatin-coated flasks or plates, as
previously described in section 2. The presence and number of AMcj) in the cultures
was estimated by non-specific esterases staining (NSE) and immunofluorescence with
mAb VPM32. The presence of other leukocytes was observed by using Giemsa's
stain. T lymphocytes were detected by immunofluorescence staining with mAbs
SBU-T4 and SBU-T8. Large numbers of cells with a high proportion of M(J)s (80 to
90%) were obtained from LWF. The period of time the cells were allowed to attach
before the non-adherent cells were removed, did not affect either the cell number or
composition of adherent cells, evaluated after 3 days in culture. Thus, even when
non-adherent cells were washed off shortly after setting them up (1 or 2 hours
incubation), the cultures showed high proportions of M([)s. Staining with mAb
VPM32 showed always over 95% of positive cells (Fig. 6.2a). These cells formed
monolayers, after a few hours in culture (12-24 hrs.). Staining with mAbs SBU-T4
and SBU-T8 showed that most of the scarce contaminating cells were predominantly
T lymphocytes (Fig. 6.2b). After 3 to 5 days in culture AM(j)s markedly increased their
size and cytoplasm/nucleus ratio with few scattered syncytia (larger than MDM<|>s)
that showed nuclei located in the periphery of the cytoplasm (Fig. 6.2c). As well as in
MDM(f) cultures the production of a fibrin-like material was observed. Some M<j)s,
from early cultures, that had come off the flask surface, could be passaged to 24 well
plates where they become adherent and confluent. In some long term AM(J) cultures,
after 2-3 weeks, fibroblast, epithelial and syncytial cell contamination also appeared.
Therefore, cultures of AM(j), were infected after 2 or 3 days in culture and followed
for no longer than two weeks.
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FIGURE 6. 1 Monocyte-derived macrophage (MDM<j>) cell cultures. Peripheral
blood monocytes (PBMC) were collected from clinically normal healthy sheep and
cultured in gelatin-coated flasks or plates. Non-adherent cells were washed off after
overnight incubation.
a) MDM<}> after 3 days in culture are
seen forming a continuous monolayer.
H/E stain. Magnification x40.
b) MDM<{> cultured for 5 days showed
a marked increase in their size and
cytoplasm/nucleus ratio. They also
showed very strong NSE staining. H/E
stain. Magnification x400.
c) MDM<}> cultured for 7 days show some cytoplasmic vacuolization (v), binucleated
cells (b) and cytoplasmic processes (p). H/E stain. Magnification x40.
 
FIGURE 6. 2 Alveolar macrophage (AMcj>) cell cultures. AM<j> were collected from
lung wash fluid (LWF) of clinically normal healthy sheep and cultured in gelatin-
coated flasks or plates. Non-adherent cells were washed off after overnight
incubation.
a) AM<|> after 3 days in culture. It can
be seen that the majority of cells are
positive after immunostaining with
ovine tissue M<|) marker VPM32. I1F
with mAb VPM32. Magnification
x400.
b) A 24 hour AM(j> cell culture shows
the presence of a few cells positive to
the panlymphocyte marker. Low
autofluorescence of M(|>s is observed
in the background. I IF with this mAb.
Magnification x400.
c) AM<j) after 5 days in culture show a marked increase in size and cytoplasm/nucleus
ratio with a few scattered syncytia (arrows) that show nuclei located in the periphery
of the cytoplasm. H/E stain. Magnification x40.
 
6.2.1.3 Cytopathic effect (CPE) of OPIV-3 in monocyte-derived macrophage
(MDMf) cell cultures.
During OPIV-3 270-7 replication in MDiM<}>s (infection on day 5 of culture), there
were no remarkable morphological changes in the first day p i. by light microscopic
examination, compared with mock-infected controls. But after 2 days p.i. some
infected cells became small and refractive and lysed in the culture, 3 to 5 days later.
The presence of more numerous and larger syncytia than in mock-infected MDM<(>s
was observed. These syncytia had nuclei located centrally (Fig. 6.3a). From day 3 p.i.
presence of cytoplasmic, and less frequently nuclear, eosinophilic inclusion bodies
(Fig. 6.3b ) was observed in addition to more syncytia. Compared to mock-infected
controls, 40-60% of cells were lost within the first 5 days of infection. By day 7 p.i.
80% to 90% of cells were detached from the cell monolayer.
6.2.1.4 Cytopathic effect (CPE) of OPIV-3 in alveolar macrophage (AM<f) cell
cultures.
In contrast, AM(f> infected with OPIV-3 270-7 (infection on day 3 of culture) showed
CPE starting from day 1 p.i with round refractive cells detaching from the flask
surface, intense cytoplasmic vacuolation (Fig. 6.3c) and the presence of pleomorphic,
eosinophilic inclusion bodies. By day 2 p.i. there were numerous cytoplasmic, and
sometimes nuclear inclusion bodies. Also present were numerous large syncytia with
nuclei located peripherally. They showed numerous inclusion bodies. After 5 days
p.i. 40-50% of cells were lysed and detached from the surface. After 7 days 70-80%
of cells were lost from the cell monolayer. Despite some cells showing syncytia
and/or inclusion bodies the remaining cells were firmly attached to the cell surface
and showed long cytoplasmic processes.(Fig. 6.3d).
After infection with OPIV-3 270-7 syncytia were first seen from day 2 pi. in MDM<|)
and from day 1 p.i.in AM<]>. These syncytia in MDM<j> (often 4-8 nuclei) were not as
large as those seen in AM<|) (often more than 8 nuclei). Also, the nuclei arrangement
was different for the two cell types as nuclei appeared located centrally in MDM(|>s
and peripherally in AMr)>s.
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FIGURE 6. 3 Monocyte-derived macrophages (MDM(|>s) and alveolar macrophages
(AM(j)s) cultured in gelatin-coated flasks or plates were inoculated with OPIV-3
270-7 (1 TICD50/cell) after 5 days and 3 days in culture, respectively.
I
a) MDM(j) cell culture after 2 days p.i.
with OPIV-3 270-7. Some cells have
become small and rounded (arrow).
Large syncytia with nuclei centrally
located are present. H/E stain.
Magnification x200.
b) MDM0 cell culture after 3 days p.i.
with OPIV-3 270-7. A large
binucleated MDMcf) showing presence
of numerous pleomorphic cytoplasmic
eosinophilic inclusion bodies is shown
(c). Also there is an inclusion body
located inside the nucleus (n) of this
cell. H/E stain. Magnification x200.
c) AM<j) cell culture after 1 day p.i.
with OPIV-3 270-7. Some cells have
become small and rounded (small
arrows) and other show intense
cytoplasmic vacuolation (large
arrows). H/E stain. Magnification
x400.
d) MDM(|) cell culture after 7 days p.i.
with OPIV-3 270-7. Most cells have
become detached from the monolayer.
A large multinucleated AM(j) with long
cytoplasmic processes and several
pleomorphic cytoplasmic eosinophilic
inclusion bodies is observed. H/E stain.
Magnification x200.
 
There was a time-dependent loss of adherent AM<J) in infected and mock-infected
AM<j) from 0 to 5 days p.i. (Table 6.1). There was no significant difference in adherent
AM<J) numbers between OPIV-3 infected and mock-infected cultures until 5 days
p.i.(Fig. 6.4a). The viability of mock-infected AM<}) remained constant in culture. In
contrast OPIV-3 infected AM<|> showed significantly lower (p<0.05) viability than
mock-infected cells after 3 days p.i. From this this day there was a sharp decrease in
the viability of infected cells (Fig. 6.4b). There were always less adherent cells, in
infected cultures, with lower viability in comparison to mock-infected cultures
(Fig. 6.4a,b).
6.2.1.5 Recovery of infectious virus
The time course of OPIV-3 270-7 replication in MDM(|)s and AM<|)s is shown in
Fig. 6.5. No virus was detected in the supernatant of fresh MDM<j>s infected with
virus by day 1 p.i. However, virus production was seen by day 2 and peaked at day 5
p.i. In contrast, AM<j>s infected with OPIV-3, showed 10s to 106 TCIDM/ml in the
supernatant by day 1 p.i. and reached its peak at day 5 p.i. OPIV-3 replication in
MDMx|>s and AM<|>s showed a steady increase in the virus titre in the supernatant with
time. At the peak of virus production, approximately 50% of MDM<(>s and AM(j>s had
degenerated and eventually lysed in culture. AM<j> cultures released significantly more
(p<0.001) infectious virus early after infection when compared to OPIV-3 infected
MDM(J>. Equal numbers of MDMijis failed to support viral replication to the levels of
AM<|)s throughout the length of the 9 day culture period (Fig. 6.5). Viral titres in AM<j)
cultures rapidly increased from time 0 to 48 hrs. p.i., and then increased steadily to
become maximal at 5. p.i. The titre began to decrease from day 7 p.i.
Autologous lymphocyte cultures were obtained as described in section 2.9.3. and
infected with OPIV-3. No virus replication was detected. A further experiment was
carried out to assess the effect of mitogen stimulation on the susceptibility of
lymphocytes to OPIV-3 infection. Mitogens have been shown to facilitate virus-cell
surface interactions (Yamamoto et al., 1974). Cells that are not normally susceptible
to paramyxovirus-mediated cytolysis have been made susceptible by treatment with
concanavalin A (Con A) (Yamamoto et al., 1974). Also mitogen stimulation of
lymphocytes has been reported to result in increased expression of PIV-3 antigen,
detected by immunofluorescence (Adair et a/., 1986; Basaraba et al., 1993). Cell
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TABLE 6. 1 Adherence and viability of OPIV-3 infected and non-infected AM(|). A
function of time in culture.
Days Mock-infected OPIV-3 infected1
Post inoculation AdherentfxlO4 )2 Viability3 AdherentfxlO4) Viability
0 6.8±1.2 92.111.6 6.510.6 90.513.4
1 5.8+0.7 95.216.3 5.710.4 94.310.9
2 5.0+0.6 94.715.9 4.6+1.5 89.2+1.7
3 4.310.8 94.112.6 3.410.7 86.312.84
4 4.011.5 93.412.9 2.911.44 74.211.9s
5 3.910.9 92.1+3.5 1.610.45 62.312.9s
1 AM4> cultures were infected with OPIV-3 270-7 (I TICDso/cell) strain after 3 days in culture.
2 Mean adherence of alveolar M<J>s as determined by direct counting of plates; average of
five separate experiments ±SD.
3 Viability expressed as mean percentage of non-adherent cells as determined by trypan blue dye
exclusion; average of five separate experiments ±SD.
4 significantly different from non infected AM(f) at p<0.05.
5 significantly different from non infected AM(() p<0.001 ( Mann-Whitney non-parametric rank
test).
A. Effect of OPIV-3 infection on alveolar macrophage (AM)
adherence in ceil culture.
B. Effect of OPIV-3 infection alveolar macrophage (AM)





FIGURE 6. 4 Time dependent effect on adherence (a) and viability (b) of OPIV-3
infected (•) and mock-infected (o) AM<t>, after infection with OPIV-3 -270. AM<()
were inoculated with OPIV-3 270-7 (1 TCID5o/cell) after 3 days in culture. Data
(Table 6.1) represents the average cell count ±SD from five different experiments.
Time dependent release of infectious virus from
MDM and AM cultures infected with OPIV-3.
FIGURE 6. 5 Time dependent release of infectious OPIV-3 from equal numbers
(6.4xl04 cells/well) of MDM<J>s (•) and AM(|)s (o). MDM(|)s and AM<[)s were
inoculated with OPIV-3 270-7 (1 TCID5o/cell) after 5 and 3 days in culture,
respectively. Data represent the average TCID50/ml ±SD from five different
experiments.
surface receptors for paramyxoviruses arc ubiquitous and are found on many cell
types including lymphocytes (Woodruff et al., 1974). Thus, crude Con A-supernatant
generated from mesenteric lymph node lymphocytes1 was used for 3 days in order to
stimulate cell cultures (0.5mg/well). Con A stimulated lymphocytes showed no
increase in OPIV-3 titre above baseline (Fig. 6.6). Levels of infectious virus in medium
decreased steadily over time and were at the limits of being detectable after 5 days
pi.
The rate of release of infectious OPIV-3 was also evaluated from Con A-stimulated
AM(j)S or non-Con A-stimulated AM<]>s. Although the rate of virus release was always
lower in Con A stimulated cultures, this was not statistically significant (p>0.05)
(Fig. 6.7).
Direct contact of lymphocytes with AMijis is enhanced during antigenic or mitogenic
stimulation (Buono et al., 1989). These cellular interactions may be further
strengthened by the functional activity of the PIV-3 fusion (F) glycoprotein which is
expressed on the surface of virally infected cells (Moscona & Peluso, 1991a).
Expression of fusion activity on the surface of PIV-3 infected cells allows the cell to
fuse its outer membrane with that of adjacent uninfected cells resulting in intercellular
spreading of the infection (Moscona & Peluso, 1992). Thus, the possibility that
AM<j)s, after becoming infected, could induce a productive infection of lymphocytes
was also investigated. Autologous lymphocytes in lOOpl of lymphocyte complete
RPMI-1640 medium were added to AM<|)S (Lymphocyte:AM(|) = 3:1). These co-
cultures were stimulated or mock stimulated with Con A (0.5mgAvell) or medium
alone. Then they were infected with OPIV-3 270-7. The rate of release of infectious
virus from AM<j)s co-cultured with lymphocytes both Con A-stimulated and non-
stimulated, showed no significant differences (Fig. 6.8). Furthermore, they paralleled
the rate of infection of AJVtys alone. There was no significant difference in the release
of infectious virus from AM<()5 cultured alone or AMrjis co cultured with lymphocytes.
Again the release of virus was always lower in Con A stimulated cultures.
Recovery of OPIV-3 from all Con A stimulated cultures was less than non-stimulated
cells except at time 0. Yet in all cases the release of infectious vims into supernatants
treated with Con A or the rate ofvims inactivation in cell free cultures containing Con
1
Kindly supplied by Dr. Barbara Blacklaws, Veterinary Pathology Deparmcnt, University of
Edinburgh.
Effect of Con A on time dependent release
of infectious virus from lymphocyte





FIGURE 6. 6 Time dependent release of infectious OPIV-3 from lymphocytes
cultures stimulated (•) and non-stimulated (o) with Con A (0.5mg/well). Data
represent the average TCID5o/ml ±SEM from five different experiments.
Effect of Con A in time dependent release of infectious
virus from AM cultures infected with OPIV-3
Days Post Infection
FIGURE 6. 7 Time dependent release of infectious OPIV-3 from AM(j> cultures
stimulated (•) and non-stimulated (o) with Con A (0.5mg/well). Data represent the
average TCID5o/ml ±SD from five different experiments.
Effect of ConA on time dependent release of





FIGURE 6. 8 Time dependent release of infectious OPIV-3 from AM(j) (6.4
xl04/well) cultures plus lymphocytes (2xl05/well) stimulated (•) and non-stimulated (o)
with Con A (0.5mg/well). Data represent the average TCID5o/ml ±SD from five
different experiments.
A (data not shown), showed no statistically significant differences with non-stimulated
cultures.
Flow cytometry with rabbit antisera showed that a similar proportion of virally
infected AM(j>s were present in both mock-stimulated and Con A stimulated
lymphocyte co-cultures. However, in non-stimulated cultures, few lymphocytes
(15 to 22 %) expressed viral surface antigen after 3 days of co-culture with infected
AM(j)s (Fig. 6.9a). In contrast, in Con A stimulated cultures more lymphocytes (30 to
63%) were viral antigen positive (Fig. 6.9b). In mock-infected cultures, neither
mock-stimulated nor Con A-stimulated lymphocytes expressed viral antigens (data not
shown).
In Con A stimulated and OPIV-3 infected co-cultures, AM(|)S were frequently covered
and surrounded by aggregates of adherent autologous lymphocytes. These rosette
forming lymphocytes were viral antigen positive by indirect immunofluorecence.
There was a significant increase (p<0.05) in lymphocyte rosette formation in Con A
stimulated cultures when compared with non-stimulated cultures (Table 6.2). No
lymphocyte-AM(|) rosettes were found in mock-infected co-cultures (mock-stimulated
or Con A-stimulated) (data not shown). In order to investigate the distribution of
T lymphocyte subsets in these rosettes, the cultures were immunostained for CD4
and CD 8 lymphocyte markers and positive lymphocytes in rosettes were counted
(Table 6.2). In rosettes of Con A stimulated AM<t>/lymphocytes co-cultures there was
a significantly higher (p<0.001) proportion of CD8+ than CD4+ lymphocytes. In
mock-stimulated AM(j)/lymphocytes co-cultures there was no significant difference in
the proportion of CD4+ and CD8+ lymphocytes rosetting with M<})s, although there
were slightly more CD8+ lymphocytes. Fig. 6.10a,b and c show immunostaining of
T lymphocytes subsets CD4+ and CD8+ in rosettes with OPIV-3 270-7 infected
AM(j)s.
6.2.1.6 Detection of viral haemagglutinin!neuraminidase (HN) in monocyte-
derived macrophage (MDM<\>) cell cultures infected with OPIV-3.
In order to study the relationship between phenotype alterations and viral antigen
expression on MDM(J)s and AMtJis, viral antigen HN expressed on the cell surface or
within the cytoplasm was assayed using flow cytometry with mAb FIN 4795. Viral
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FIGURE 6. 9 Frequency histograms showing detection of OPIV-3 particles on
lymphocyte and AM<{) cell surfaces by flow cytometry. Autologous lymphocytes
(2xl06 cells/ml) in lOOpl of lymphocyte complete RPMI-1640 were added to AM<{)
cultures. These co-cultures were either stimulated with Con A (0.5mg/well in
lymphocyte complete RPMI-1640) or mock stimulated only with the medium. Then
they were infected with OPIV-3 270-7. Cells were obtained after 1, 2, 3, 5 and 7 days
p.i., immunostained with OPIV-3 rabbit antisera and then analyzed by flow
cytometry. The profiles show the reactivity of OPIV-3 rabbit antisera ( ) with both
Con A stimulated and mock-stimulated infected co-cultures. Analysis by flow
cytometry was carried out after setting a gate firstly in the lymphocyte area (A) and
then another one in the M<)) area (13). The staining with NRS as negative control
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TABLE 6. 2 Effect of Con A stimulation in distribution of CD4+ and CD8+
lymphocyte subsets during specific rosetting of lymphocytes to AM0 cultures
infected with OPIV-3.
OPIV-3 infected AM<{)/lymphocyte co-cultures






Con A stimulated 74±4.63 29±5.6 80±2.33 71±3.14
Non-stimulated 42±3.2 41 ±4.2 39±2.2 52±5.3
1 Specific rosetting of lymphocytes with alveolar M(J>s= lymphocytes rosettes in OPIV-3 infected
AM<)> cultures minus rosetting in mock infected AM<J> cultures. Results are expressed as median
of percentage ±SD. Data represent the average from five different experiments.
2 Specific distribution of lymphocyte subsets= immunostained lymphocytes present in rosettes of
virus infected AM(J> cultures minus immunostained lymphocytes present in rosettes of mock
infected AM<)> cultures. Results are expressed as median of percentages +SD. Data represent the
average from five different experiments.
3 Significantly different from non-stimulated cultures at p<0.05 (Mann-Whitney non-parametric
rank test)
4 Significantly different from % of CD4+ in Con A stimulated cultures at pcO.OOl (Mann-
Whitney non-parametric rank test)
FIGURE 6. 10 Immunostaining of T lymphocyte subsets CD4+ and CD8+ in
lymphocyte rosettes with OPIV-3 270-7 infected AM(j)s. Autologous lymphocytes
(2xl06 cells/ml) were added to AM(j>s (after 3 days p.i. with OPIV-3 270-7):
Co-cultures were stimulated or mock stimulated with 0.5|ig/well of a stock solution
of Con A.
a) Immunostaining of T lymphocyte
subset CD4+ in lymphocyte rosettes
with OPIV-3 270-7 infected AM(j)s.
AM(j)/lymphocyte co-culture was
stimulated with Con A. A few positive
cells (red colour) for lymphocyte CD4
marker are in contact with M(j)s (non-
immunostained cells). DAP with mAb
SBU-T4. The nuclei were
counterstained with H/E.
Magnification xlOO.
b) Immunostaining of T lymphocyte
subset CD8+ in lymphocyte rosettes
with OPIV-3 270-7 infected AM<j>s.
AM(J)/lymphocyte co-culture was
stimulated with Con A. Many positive
cells (red colour) for lymphocyte CD8
marker surround and rosette with M(j)s
(non-immunostained cells). HAP with
mAb SBU-T8. The nuclei were
counterstained with H/E.
Magnification xlOO.
c) A closer view of Fig. 6.10b. An AM(j) is shown covered and surrounded by
aggregates of adherent autologous lymphocytes. These rosette-forming lymphocytes
are positive for T lymphocyte CD4 marker. nAP with mAb SBU-T8 The nuclei were
counterstained with H/E. Magnification x600.
 
antigen expressed on the cell surface was detected on unfixed cells as previously
described (section 2.7.6). Detection of internal antigen was performed by fixing cells
in 80% methanol (Lee, 1994). The time dependent reactivity after infection is shown
in Table 6.3. and Fig. 6.11. HN antigen expression could not be detected in either the
MDJVty cell membrane or cytoplasm until 2 days p.i. with OPIV-3 270-7
(ITCIDmj/ccII). By 2 days p.i. 17% of cells showed HN expression in the cytoplasm
and 9% in the cell membrane. By 3 days p.i 38% of MDM<j>s were cytoplasmic
antigen positive and 28% membrane antigen positive. By 5 days. p.i. 62% of MDM(j>s
were positive for HN antigen detected in cytoplasm and 53% of cells also expressed
this antigen on the cell membrane. By 7 days. p.i. 82% of MDMijis expressed antigen
HN in the cytoplasm and 85% in the cell membrane. The expression of HN antigen
in the cytoplasm was always higher than in the cell membrane. However, this was
significantly higher (p<0.05) only until day 4 p.i.
6.2.1.7 Detection of viral haemagglutin in/neuram in idase (IIN) in alveolar
macrophage (AM<f>) cell cultures infected with OPIV-3.
In contrast, OPIV-3 infection of AM<J)S with 1 TCID5o/cell resulted in the detection of
OPIV-3 antigen HN within the first few hrs. p.i. The number of fluorescent positive
AM<J)s increased linearly up to 5 days p.i. stabilizing between 5 and 7 days p.i.
(Fig. 6.11). Cytoplasmic I IN antigen was detected as early as 1 day p.i. in 27% of
AM<j)s. Also 10% of AM()>s showed HN expression on the cell membrane after 1 day
p.i.. By 2 days p.i. 39% of AM(|) were positive for HN antigen in the cytoplasm and
32% also showed antigen in the cell membrane. By 3 days p.i. 52% of AM<f>s were
positive for HN antigen in the cytoplasm and 47% for HN in the cell membrane. By 5
days pi. 91% of the cells were positive for cytoplasmic HN and 85% for HN on the
cell membrane. The expression of HN antigen in cytoplasm was significantly higher
(p<0.001) than in cell membrane only until day I p.i.. After this although the
cytoplasmic expression of IIN was always higher no significant differences were
detected. By 7 days p.i. the staining pattern was virtually the same for antigen HN
expression, both at the cytoplasmic and cell membrane level. The percentage of cells
expressing HN antigen both at the cytoplasmic and cell membrane level was
significantly higher in AM<]>s than MDM<J>s until day 6 p.i. (p<0.05 until day 2 p.i.;
p<0.001 from day 3 to 6 p.i.). Representative profiles of HN expression by both
MDM(|)s and AM<j)s are shown in Figures 6.12A and 6.12B, respectively.
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TABLE 6. 3 Time dependent cytoplasmic and cell surface expression of OPIV-3 HN
antigen in MDM(j)s and AM<j)s after in vitro infection.
OPIV-3 infected cultures
Days MD M<J)S AM<))s
after infection Cytoplasm Cell membrane Cytoplasm Cell membrane
1 o1 0 27±1.93 10±2.13**
2 17±1.6 09±1.2* 39±2.23 32±1.33
3 38±1.8 28±1.6* 52±1.52 47±1.82
4 45±2.2 32±1.8* 69±1.72 58±2.42
5 62±1.5 53±2.3 91±2.32 85±2.22
6 71±2.3 65±2.7 90±2.22 84±1.42
7 82±2.5 85±1.9 92±1.8 86±2.6
1. A 1% gate was set on the negatively stained control cells and cells staining positive above this
are expressed as median of percentages of positively labelled cells (in M(|> gate) ±SD.
Data
represent the average from five different experiments.
2. Significantly different from MDM<{> same level (cytoplasm or membrane) at p<0.05 (Mann-
Whitney non-parametric rank test).
3. Significantly different from MDM<{> same level (cytoplasm or membrane) at pcO.OOl (Mann-
Whitney non-parametric rank test).
*. Significantly different from MDMtf) cytoplasm at p<0.05 (Mann-Whitney non-parametric rank
test).
**. Significantly different from AM<{> cytoplasm at pcO.OOl (Mann-Whitney non-parametric rank
test).
Time dependent expression of protein HN in OPIV-3






FIGURE 6. 11 Time dependent expression of HN antigen in OPIV-3 270 infected
MDM(|)s (•) and AM<j)s (o)detected by flow cytometry. HN expressed on the cell
surface or within the cytoplasm was detected with mAb 4795. Viral antigen expressed
on the cell surface was detected on unfixed cells. Detection of internal antigen was
performed by fixing cells in 80% methanol. Data represent the average +SD from five
different experiments.
FIGURE 6. 12 Frequency histograms showing detection of the viral antigen HN
expressed on the cell surface and in the cytoplasm, of MDM<])s (A) and AM<|)s (B)
infected with OP1Y-3 270-7, by flow cytometry. The viral antigen expressed on the
cell surface was detected on unfixed cells Detection of internal antigen was
performed by fixing cells in 80% methanol. MDM<j> and AM<]) cultures were infected
and harvested on days 1, 2, 3, 4 and 5 p.i. HN antigen was detected by
immunostaining with mAb HN4795 (—). Reactivity was analyzed by flow cytometry
and incubation with NMS ( ) was used as the negative control of the staining
Log10 Fluorescence Intensity
6.2.1.8 Transmission electron microscopy (TEM) of monocyte-derived
macrophage (MDMty) cell cultures infected with OPIV-3.
Ultrathin sections from monolayers of MDM([) cell cultures harvested at 24, 48 and
72 hours post inoculation with OPIV-3 270-7 were observed by TEM. By 24 hrs.
post infection. MDM<))s showed no major changes in cellular organelles, except for an
increase in the amount of endoplasmic reticulum, vacuolation of the cytoplasm and
swelling of mitochondria (Fig.6.13a). Noticeable morphological changes were seen in
infected MDM<j>s by 48 hrs. p.i. After 48 hrs. p.i. profound vacuolation of the
cytoplasm and swelling of mitochondria could be seen. The nuclei contained
dispersed heterochromatin margins and some infected MDM(|)s lost their surface
processes. Some small filamentous cytoplasmic inclusions, usually located in a
perinuclear position were observed (Fig.6.13b). Inclusion material in the perinuclear
region tended to be more tightly packed than that located in other parts of the
cytoplasm. After 72 hrs. p.i., the filamentous cytoplasmic inclusions were much larger
and more common (Fig.6.13c.). Further changes in the cytoplasm included an
increased number of polyribosomes, swollen mitochondria and displacement of
cytoplasmic organelles by the inclusions. Early virus budding was seen in cytoplasmic
vesicle membranes and in cell membranes. Also virions accumulated inside
cytoplasmic vesicles and in the intercellular spaces. During viral budding, an electron
dense, crescent shaped nucleoid appeared. This fused with the vesicular or
cytoplasmic membrane that appeared thickened and showed its outer aspect covered
with a fringe. Both ends of the crescent eventually met, after which, virions were
released from the membrane. They were roughly spherical pleomorphic viral particles
completely surrounded by a similarly fringed membrane. These pleomorphic particles
had an overall diameter of 150 to 320 nm. They were first observed inside the
cytoplasm then budding through the membrane and finally detaching from the cell
surface.
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6.2.1.9 Transmission electron microscopy (TEM) of alveolar macrophage (AMij>)
cell cultures infected with OPIV-3.
Similar experiments were performed with AM(j) cell cultures. OPIV-3 replication in
AM({)s was very similar to that found in MDM())s, but changes associated with viral
replication appeared much earlier in AMtJ) than in MDM((> cultures. There also seemed
to be more virus particles and larger cytoplasmic inclusion bodies in infected AM(|)s.
In contrast to MDM(j)s, by 24 hrs. p.i. AM<|)S showed changes in cytoplasm with the
presence of numerous, large vesicles, swelling of mitochondria and an increased
amount of both endoplasmic reticulum and number of ribosomes. Some small
cytoplasmic inclusions of filamentous material were seen. As with in MDM(()s these
were usually located in a perinuclear position where they tended to be more tightly
packed than those located in other parts of the cytoplasm. After 48 hrs. p.i. virus
budding was also seen more frequently along vesicular membranes than in the cell
membrane (Fig.6.13d,e.), with virus shedding inside these vesicles. Virus particles
were first observed inside the cytoplasm then budding through the membrane and
finally detaching from the cell surface (Fig.6.13f.). After 48 to 72 hrs. p.i. these
changes increased in intensity and frequency, in particular virus budding and release of
virus particles from the cell membrane.
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FIGURE 6. 13 Transmission electron microscopy (TEM) of MDM(() and AM(j) cell
cultures harvested at 24, 48 and 72 hours post inoculation with OPIV-3 270-7.
a) MDM(|) after 24 hrs. post infection
with OPIV-3 270-7. MDM(j)s showed
no major changes in cellular organelles,
except for an intense vacuolation of the
cytoplasm. TEM. Magnification
x4,600.
c) MDM(|)s after 72 hrs. p.i. with
OPIV-3 270-7. A large cytoplasmic
inclusion containing filamentous
material is seen in the cytoplasm
(arrow). TEM. Magnification x4,600.
e) AMijis after 48 hrs. p.i. with OPIV-3
270-7. Closer view of Fig. 6.13d.
Virus budding in cytoplasmic vesicle
membrane can be seen. Virions are
accumulating inside this cytoplasmic
vesicle. TEM. Magnification x215,000.
b) MDM(|)s after 48 hrs. p.i. with
OPIV-3 270-7. small filamentous
cytoplasmic inclusions (arrow), located
in a perinuclear position The inclusion
material appears tightly packed. TEM.
Magnification x 16,500.
d) AM(|)s after 48 hrs. p.i. with OPIV-3
270-7. There is displacement of
cytoplasmic organelles by a large
amount of filamentous inclusions (F).
Also there is virus budding in the
membrane of the cytoplasmic vesicles
with an accumulation of virus particles
inside these vesicles (arrow). TEM.
Magnification x 16,500.
f) AM(|)s after 48 hrs. p.i. with OPIV-3
270-7. Viral budding on the cell
membrane can be seen. The
cytoplasmic membrane appears
thickened and shows its outer aspect
covered with a fringe (arrows). TEM.
Magnification x215,000.
 
6.2.2 PART B: PHENOTYPIC CHANGES
6.2.2.1 Surface molecule expression of monocyte-derived (Ml)M<j>) and alveolar
(AMtf>) cell cultures.
Cultured MDM<J)S and AM<j>s were variable in size, so they were gated on a large FSC
and SSC area excluding lymphocytes and cell debris. They also increased in overall
size with time in culture. Changes in AM<|) size, observed during "live gating" are
shown in Figure 6.14. Analysis of the cell staining from the FACScan often uses a
1% threshold set on negatively stained cells with the antibody of interest. The
quantification of cellular constituents on AM<{)3 using flow cytometry is complicated
by two major factors. First, matching cell size and fluorescence is difficult due to the
wide variation in cell size which is found among AM<j>s. The second complication
involves the intense autofluorescence emited by AM<j)S which interferes with the
specific fluorescence of antibody-fluorophore complexes (Pankow el al., 1990). In
this study it was observed that AM()> and MDM<j) in culture showed an increase in
size and in autofluorescence of the cells. Due to these factors, it was very difficult to
separate positive and negative populations of MDM(J> and AM(j), particularly when
molecules were weakly expressed. Thus, using the percentage positive cells to express
the phenotype of MDM<j) may not reflect the actual situation, as reported by Pankow
et al., (1990). For this reason the following data is expressed as the mean of
fluorescence intensity (MF) of specific molecules, with negative control of
fluorescence staining subtracted. The staining of negative controls was obtained by
incubating with normal mouse serum (NMS, 1:400 dilution) as the primary antibody.
Fresh monocytes did not express either CD4 or CD8. After culture, they immediately
and significantly (p<0.001) began to express both molecules on their surface after
culture (Table 6.4) with maximal levels around day 7 (MF: CD4=21.5; CD8=35.6)
which began to decrease after day 10. More CD8 was expressed than CD4. Fresh
AM<|) were virtually negative for CD4 or CD8 antigens and they remained so until day
10 in culture. Figure 6.15 shows the comparison between the expression of CD4 in
either MDM<() or AM<j> cell cultures. Figure 6.15 also shows the comparison between
the expression of CD8 in either MDM<j> or AM()> cell cultures.
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FIGURE 6. 14 Flow cytometry displays for "live gating" of AM<j)s using forward
and side angle light scatter (FSC and SSC) profiles. The PMT voltage of both FSC
and SSC was optimised for each population. A time dependent increase in both size
and cytoplasm complexity is observed in culture. Cells were analyzed on days 0 (A),
3 (B), 5 (C), 7 (D) and 10 (E) of culture.
VPM32 is a monoclonal antibody which detects tissue M(J)s, but not monocytes or T
and B lymphocytes. The identity of the antigen of this mAb is not known, but is a
single 55,000 MW polypeptide. It is thought to be specific for M<(> FCyRIII
(Gonzalez, 1989). Fresh monocytes (day 0 culture) showed very low expression of
VPM32 antigen (MF=10.5); however with monocyte maturation in vitro, the
expression of VPM32 antigen by MDMtf) was greatly and significantly (p<0.001)
increased from day 3 (MF=25.3) until day 7 (MF=45.3). (Table 6.4). Figures 6.16a
and b compare the fluorescence staining with mAb VPM32 between fresh monocytes
and 7 day cultured MDM(j). AM<|) always expressed higher levels of VPM32 antigen
than MDM(j) (MF=35.4). However this was statistically significant (p<0.001) only on
days 0, 3 and 5 of culture. This is because on day 1 of culture a noticeable decrease in
VPM32 expression by AM<j) was observed. MF on day 0 was 35.4 and on day 1 was
17.6. This change was transitory and then a rapid increase took place, returning to
the initial levels by day 2. On day 5 (MF=49.4) they had reached maximum and
significantly higher levels (p<0.05) than AM<)) on day 0 of culture. Likewise, by this
time the VPM32 expression of MDM<|) had reached similar levels so no significant
differences were detected between these two cell types (Fig. 6.15).
F10-150-39 (anti-LFA-1) and L180-1 (anti-LFA-3) monoclonal antibodies stained
MDMtj) and AM<|) in a similar way. These molecules showed a tendency to increase
after culture until day 7. However, this was variable and no significant differences
were observed in the expression of these molecules during the culture of either
MDMtJ) or AM<j) (Table 6.4). The mean of fluorescence (MF) of LFA-1 and LFA-3 in
MDM<|), ranged between 46.2 to 54.4 and 50.3 to 63.5, respectively. This was
slightly lower for AM<j) with a MF ranging from 45.3 to 50.1 and 46.7 to 59.2 for
LFA-1 and LFA-3, respectively. Figure 6.17 shows a representative profile of LFA-3
expression by MDM$ in culture.
Another monoclonal antibody, VPM65, reacts with ovine CD 14, the cellular receptor
for bacterial lipopolysaccharide (LPS) and LPS-binding protein (Gupta et ai, 1993).
Both fresh monocytes and cultured MDMcJ) showed a moderately high intensity
(MF=51.4 on day 7) of staining for CD 14 without much change during culture. AM<j)
also showed a moderately high intensity, decreasing or increasing during culture but
with no significant changes (MF=45.8 on day 7) (Table 6.4).
114
TABLE 6. 4 Comparison of the phenotype of monocyte-derived macrophages
(MDMcfis) and alveolar macrophages (AM<j)s) during cell culture.
Surface Cell Time in Culture
Molecules Culture 0 days 1 day 3 days 5 days 7 days 10 days
CD4 MDM4> 0.5±0.71,5 3 55.7 11.8 3 511.7 11.9 ' 16.2 12.33'5 21.5+2.83,5 20.713.13'5
AM<|> 1.1±0.9 0.910.8 0.710.9 0.610.8 1.110.7 0.910.7
CD8 MDM<|> 0.6±0.83 3 511.212.9 ' 22.713.03' 5 30.H2.93,5 35.613.93, 5 30.612.53'5
AM<{> 1.5±1.0 0.710.6 1.210.8 0.510.7 1.511.1 1.210.9
VPM32 MDM<)> 10.5±3.23 17.513.54 3 525.313.6 29.915.03'3 45.316.25 47.716.55
AM<}> 35.4±2.9 17.614.55 32.114.2 49.413.94 47.514.14 51.513.94
LFA-1 MDM<|> 46.2±3.4 50.114.7 47.813.9 48.314.5 54.415.9 50.114.6
AM<|> 45.3±4.2 42.113.9 48.714.2 49.313.7 50.114.5 47.213.9
LFA-3 MDM<)> 50.3±4.6 52.614.1 50.414.5 57.113.9 63.515.2 59.214.8
AM(|) 46.7±4.8 49.315.2 54.714.3 60.115.0 59.214.7 52.315.7
CD14 MDMif) 43.5±5.2 45.714.9 50.614.7 54.215.2 51.416.3 50.315.7
AM() 40.314.7 37.514.1 45.613.9 47.3+4.4 45.815.9 39.214.6
CD1 MDM(() 0.0810.53 1.310.93 1.911.53 0.0910.73 1.210.53 1.510.83
AM<1> 26.612.9 20.713.7 15.213.54 6.212.15 4.011.55 3.811,75
1 Data (meaniSD) are expressed as mean fluorescence intensity (MF) where negative control
fluorescence (NMS) has been subtracted. Data was collected from 5 separate experiments.
2.Significandy different from AM((> on the same day of culture at p<0.05 (Mann-Whitney non-
parametric rank test).
3.Significantly different from AM<f> on the same day of culture at p<0.001 (Mann-Whitney non-
parametric rank test).
4. Significantly different from cells day 0 of culture at p<0.05 (Mann-Whitney non-parametric rank
test).
5. Significantly different from at cells day 0 of culture p<0.001 (Mann-Whitney non-parametric rank
test).
FIGURE 6. 15 Frequency histograms showing MDM(j) and AM<|) phenotypic
changes in culture. MDM<j) cell cultures were obtained by collecting peripheral blood
monocytes (PBMC). AM(j)s were collected from the lung wash fluid (LWF). All cells
were obtained from clinically normal healthy sheep. They were cultured in gelatin-
coated flasks or plates. Non-adherent cells were washed off after overnight
incubation. Cells were analyzed by flow cytometry for the expression of cell markers
on days 0, 1, 3, 5, 7 and 10 of culture. These cell marker included CD4, CD8 and










FIGURE 6. 16 Expression of ovine tissue M<|> marker by monocyte-derived
macrophages (MDM(|)s) in culture. Peripheral blood monocytes (PBMC) were
collected from clinically normal healthy sheep and cultured in gelatin-coated flasks of
plates. Cell were incubated with mAb VPM32 for ovine tissue M<)>s. Reactivity was
detected by indirect immunofluorescence (IIF) and cell were observed under UV
microscope and analyzed by flow cytometry.
a) All MDM(J)s after 12 hrs. in culture express a very low intensity of VPM32
macrophage marker. The insert shows a corresponding flow cytometry chart
including the negative control of the staining with normal mouse serum (NMS). IIF
with mAb VPM32. Magnification x200.
b) All MDM(|)s after 7 days in culture express VPM32 M<J) marker with high
intensity. Insert shows corresponding flow cytometry chart including negative control
of staining with normal mouse serum (NMS). IIF with mAb VPM32. Magnification
x200.
 
FIGURE 6. 17 Frequency histograms showing changes in LFA-3 expression ( )
by MDM(|)s in cell culture. MDM(j>s were obtained by collecting peripheral blood
monocytes (PBMC). They were cultured in gelatin-coated flasks or plates. Non¬
adherent cells were washed off after overnight incubation. Cells were analyzed by
flow cytometry for the expression of cell markers on days 0, 1, 3, 5, 7 and 10 of
culture. Staining with NMS as the negative control is shown for comparison ( ).
 
Dendritic cells have been reported to be present in both lung sections
(Holt et al., 1992) and LWF (Havenith et al., 1993) in the rat. Their presence in sheep
LWF was investigated with monoclonal antibody VPM5 that reacts with ovine CD lb
(Budjoso et al., 1989). It stains Langerhans cells, dendritic (veiled) cells in afferent
lymph and dendritic cells within the paracortical areas of the lymph nodes. MDM(|) did
not show specific staining for this marker either before or after culture (Table 6.4). In
AM<() suspensions there was always a small, variable, well defined subpopulation of
cells expressing CD1 antigen that decreased noticeably after day 5 in culture and
showed stronger intensity before culture than after (Fig. 6.18). The average
percentage of cells in this population of AM(j) cell suspensions was 18% in fresh AM<j)
(MF=26.55); 16% on day 1 of culture (MF=20.74); 13% on day 3 of culture
(MF=15.2); 10% on day 5 of culture (MF=6.15); 9% on day 7 of culture (MF=4.04).
Crude Con A-supematant generated from cultured mesenteric lymph nodes
lymphocytes was used to activate cultures of both MDM(|) and AM<j> in concentration
of 50%v/v for 3 days. Then cells were harvested for phenotypic analysis according to
protocol described by Lee, (1994). Con A treatment did not have a significant effect
(p>0.05) on the expression of CD8, CD4, LFA-1, LFA-2 or VPM32 antigens on
these cells, in five different experiments (data not shown).
6.2.2.2 Effect ofOPIV-3 infection on surface molecule expression.
MDMtj) and AMcf) were infected with OPIV-3, ITCID50 per cell, on day 5 and 3 of
culture, respectively. Then virus infected and mock-infected (control) cells were
harvested for phenotype analysis on days 1, 2, 3, 5, and 7 p.i. In infected MDM(t>
cultures the expression of most surface molecules including CD4, CD8, LFA-1,
LFA-3, CD 14 and VPM32 was not significantly different from mock-infected cells up
to 5 days post-infection (Table 6.5). After 5 days p.i., expression of most surface
molecules was lower on the cell membrane of infected cells, however significant
differences (p<0.05) were detected only for CD4, CD8 and VPM32 cell markers.
In infected AM(|) cultures (Table 6.6) the expression of CD4 and CD8 molecules was
considered negative and it was similar to mock-infected controls. The expression of
LFA-1, LFA-3 and CD 14 was variable. Although it was either slightly higher or
lower, no significant differences were detected after infection in comparison to mock-
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FIGURE 6. 18 Frequency histograms showing changes in CD1 expression ( )
by AM(|>s in cell culture. AM<j)s were collected from the lung wash fluid (LWF). They
were cultured in gelatin-coated flasks or plates. Non-adherent cells were washed off
after overnight incubation. Cells were analyzed by flow cytometry for the expression
of cell markers on days 0, 1, 3, 5, 7 and 10 of culture. Staining with NMS as the
negative control is shown for comparison ( ).
AM
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infected controls. The expression of VPM32 antigen followed the same pattern in
infected and mock-infected cells. Although it was slightly higher in mock-infected
cells this was noticed from day 0 p.i. No difference was detected on day 7 as the
control also showed decreased VPM32 expression in tissue culture by that time. CD1
expression decreased with time both in culture and after infection. However, on day 3
p.i. there was a significantly higher (p<0.05) expression in infected cultures when
compared to mock-infected cells.
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TABLE 6. 5 Comparison of the phenotype of monocyte-derived macrophages
(MDM(j)s) in culture in the presence or absence of infectious OPIV-3.
Surface Group Time Post Inoculation
Molecules Treatment1 0 day 1 days 3 days 5 days 7 days
CD4 Mock infected 15.0±1.22 17.4±4.9 14.2±5.5 17.3+6.0 18.6±4.2
OPIV-3 infected 14.9+3.1 18.9±3.1 13.6+5.2 12.1±4.73 14.3±5.23
CD8 Mock infected 32.4±6.1 28.7±7.9 30.0±8.0 35.4±4.3 31.4±5.6
OPIV-3 infected 29.7±6.9 25.5±5.8 29.4±4.9 30.1±6.03 23.4±5.93,4
VPM32 Mock infected 29.9±6.9 34.5±8.9 37.4±8.4 45.3±5.94 43.2+7.94
OPIV-3 infected 30.2±5.0 32.4±6.7 36.3±4.6 38.5±6.23'4 35.8±6.13
LFA-1 Mock infected 52.0±6.9 50.9+6.2 51.9±6.9 46.2±7.9 47.3±5.2
OPIV-3 infected 47.4±9.3 49.5±5.9 52.6±7.1 41.5±7.8 40.8±6.9
LFA-3 Mock infected 54.5+8.6 55.5+5.1 51.3±7.0 45.8+8.9 50.6±5.8
OPIV-3 infected 52.4±6.0 53.8±8.3 55.7+7.6 50.2+7.9 49.4+8.2
CD14 Mock infected 53.5±7.3 52.1±6.2 48.4+6.8 50.9+8.2 53.1±7.9
OPIV-3 infected 50.4±6.9 53.6±7.4 49.6±8.4 49.2±8.7 46.318.1
1 Cultured MDMcj) were infected on day 5 culture with OPIV-3 ITCID50 per cell and cells were
harvested on day 1,2,3,5 and 7 p.i.
2 Data (mean±SD) are expressed as mean fluorescence intensity (MF) where negative control
fluorescence (NMS) has been subtracted. Data was collected from 5 separate experiments.
3. Significantly different from mock-infected cells at p<0.05 (Mann-Whitney non-parametric rank
test).
4. Significantly different from cells day 0 of culture at p<0.05 (Mann Whitney non parametric rank
test).
TABLE 6. 6 Comparison of the phenotype of alveolar macrophages (AM(j)s) in
culture in the presence or absence of infectious OPIV-3.
Surface Group Time Post Inoculation
Molecules Treatment1 0 day 1 days 3 days 5 days 7 days
CD4 Mock infected 1.0±1.22 1.410.9 2.210.5 3.210.5 2.510.3
OPIV-3 infected 1.9±0.7 1.410.9 1.510.4 2.410.8 1.710.5
CD8 Mock infected 2.4±0.5 1.710.9 2.Q10.8 1.410.7 0.910.3
OPIV-3 infected 2.7±0.9 1.210.6 1.910.3 2.010.4 1.110.6
YPM32 Mock infected 47.916.9 50.519.9 52.418.4 50.115.3 42.617.9
OPIV-3 infected 45.415.0 48.118.2 51.516.3 45.617.4 41.817.0
LFA-1 Mock infected 47.016.9 50.116.7 48.916.9 46.218.9 49.317.3
OPIV-3 infected 47.419.3 48.917.8 47.217.5 42.117.7 43.418.5
LFA-3 Mock infected 57.518.6 55.515.1 58.317.1 56.819.9 46.718.64
OPIV-3 infected 61.416.0 58.718.4 56.917.9 51.719.04 50.917.84
CD14 Mock infected 51.718.9 50.617.5 49.615.9 43.916.24 42.518.54
OPIV-3 infected 52.417.7 51.918.2 48.016.8 41.617.94 37.116.74
CD1 Mock infected 5.813.4 5.712.9 5.312.1 5.212.4 4.611.9
OPIV-3 infected 6.013.6 5.413.2 7.614.23 4.313.1 3.912.24
1 Cultured AM<)> were infected on day 3 culture with OPIV-3 ITCID50 per cell and cells were
harvested on day 1,2,3,5 and 7 p.i.
2 Data (mean±SD) are expressed as mean fluorescence intensity (MF) where negative control
fluorescence (NMS) has been subtracted. Data was collected from 5 separate experiments.
3. Significantly different from mock-infected cells at p<0.05 (Mann-Whitney non-parametric rank
test).
4. Significantly different from cells day 0 of culture at p<0.05 (Mann-Whitney non-parametric rank
test).
6.3 DISCUSSION
Macrophages obtained from different anatomic locations differ in their ability to
support viral replication (Stauber & Weston, 1984). In this study it has been shown
that OPIV-3 infects ovine AM (J) in vitro and in vivo. The in vitro infection is
productive and characterised by the release of high titres of infectious virus. These
findings agree with previous reports of PIV-3 infection of bovine AM(|) (Tsai, 1977;
Bryson et al., 1983; Hesse & Toth, 1983; Toth & Hesse, 1983; Basaraba et al.,
1993). Infectious OPIV-3 virus titres increased in AMcj) and AM<j)/lymphocyte culture
supernatants equally in a time dependent manner, a finding suggesting that
extracellular virus was primarily M<)) derived. This was further supported by the
inability to recover infectious virus, above base line levels, from supernatants of
infected lymphocyte cultures.
Recently Sieg et al.( 1994) suggested that BPIV-3 causes a productive infection in
bovine lymphocytes in vitro. This productive infection seems to require T cell
activation by using anti-CD3. However, BPIV-3 vims particles on lymphocyte cell
surface were not detected by immunofluorescence before one week of infection. In
this study some lymphocytes of OPIV-3 270-7 infected AM<j)/lymphocyte co-cultures
were found to show vims particles on cell surface after 3 days p.i. The presence of
these particles on lymphocytes surface may be the result of the interaction of these cell
with infected M(j)s. In fact, a high proportion of lymphocyte rosette formation with
infected AM(j) was observed in AM^/lymphocyte co-cultures. Basaraba et al., (1993)
also failed in recovering infectious PIV-3 from both Con A stimulated and mock-
stimulated bovine lymphocyte cultures. Furthermore, they suggested a possible
interaction between Con A and PIV-3 as they found a significant decrease in the
recovery of infectious vims from culture supernatant of AM(f>, lymphocyte and
AM<j)/lymphocyte Con A stimulated cultures. In this study the recovery of OPIV-3
was lower from all Con A stimulated cultures. The reason for this observation is
unclear. Binding of Con A to surfaces of virally infected cells may inhibit the release
of vims through extensive mitogen cross linking similar to the action of antibody
directed to cell associated viral antigens (Poste et al., 1974; Basaraba et al., 1993).
Alternatively, Con A may be toxic to PIV-3 or it may cross link PIV-3 through
recognition of mannose rich regions on the vims envelope, thus decreasing the
117
number of infectious viral particles when measured by infectivity (Basaraba et
al., 1993).
In this study a non-productive or abortive type of infection was observed in
lymphocyte cultures. This agrees with the absence of infected lymphocytes found in
both LWF and in tissue sections obtained from pneumonic lungs after 7 days post
experimental infection. PIV-3 infection is considered to be restricted primarily to
epithelium and M(J)s of the respiratory tract (Brysson et al., 1983; Chanock &
Mcintosh, 1990; Li & Castleman, 1991). However, more research is necessary to
investigate the conditions both in vivo and in vitro which may lead to productive
infection of lymphocytes. Also the susceptibility of the different lymphocytes subsets
to PIY-3 infection should be clarified.
PIV-3 infections are often accompanied by depressed proliferation of mitogen
stimulated peripheral blood lymphocytes (Ghram et al., 1989; Sieg et al., 1994), with
prolonged viral shedding and incomplete immunity to viral proteins (Van Wyke-
Coelingh et al., 1990). Reinfection by PIV-3 is common and like initial infection, virus
is restricted primarily to the respiratory tract where both alveolar M<|>s (AM())) and
respiratory epithelium are infected (Chanock & Mcintosh, 1990). PIV-3 infection of
AM(J) results in altered M(j) function which is thought to contribute to the pathogenesis
of this respiratory disease (Basabara et al., 1993). AM(j) and lymphocytes are
important cellular constituents of the pulmonary host defence system. As well as the
direct effects virus interactions have on M<j)s and lymphocytes, secondary lymphocyte
dysfunction may be mediated through infected M<})s. Virally infected AMcj) may be an
important source of infectious virus or soluble mediators which can enhance or
suppress lymphocyte functions. The mechanism of vims induced suppression of
lymphocyte activation in the pathogenesis of PIV-3 infections and the role of the
virally infected AM(j) remain unknown (Basabara et al., 1993).
In this study, OPIV-3 in vitro replication in AM<j) was found to be more rapidly lytic
than in MDMcj). The differentiation and maturation state of M<|)s may affect replication
of PIV-3 with the virus being produced earlier and in higher levels in mature well
differentiated AM(j) than in less mature and differentiated MDM<|) (5 days in culture
before infection). These findings also support previous reports that AM<{> is superior
to peripheral blood monocytes (PBMC) and monocyte-derived-M<j)s (MDM<{)) in
supporting PIV-3 growth in vitro (Rosenstreigh et al., 1976; Ghram et al., 1989;
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Basaraba et al., 1993). This has also been previously shown for MW (Gendehnan
et al., 1986; Narayan et al., 1983; Lee, 1994). A similar phenomenon has also been
reported for HIV replication in fresh and mature monocytes (Potts et al., 1990), The
results here suggest that MDM<t) do not support P1V-3 replication as productively as
mature AM<j), However, these results may be variable depending on the viral isolate
and type of M<|> culture used.
Low levels of expression of CD4 molecules by human monocytes and cultured
MDM<|> have been reported (Collman el al., 1990). This molecule acts as a receptor
for HIV particles allowing infection of M<j>s (Kazazi et al., 1989; Collman et al., 1990;
Crowe et al., 1992). Expression of CD4 on sheep monocytes and cultured MDM<J)
has not been studied in depth. The experiments reported here show that fresh sheep
monocytes and AM<|)S did not express CD4 molecules on their surface, but low
intensity staining was seen after short term culture of MDM<J>s. Perhaps the ovine
CD4 expression is different to that seen in humans. Also ovine monocyte may contain
internal CD4 and/or newly synthesized CD4 is expressed on the surface after culture.
Moderate intensity staining for CD8 molecules was seen on MDM<|>s with similar
kinetics of expression as CD4, but the biological significance of CD8 expression on
MDM<j)s is not clear. A similar percentage (10%) of fresh human monocytes
expressing CD8 has been reported (Moebious, 1989). An inverse expression ofMHC
class II and CD 14 on AM<t> and peritoneal M<jis has been reported (Andreesen et al,
1990). Some molecules such as FcyRID (CD 16), a-chain of fibronectin (CD51),
Maxl and Max3 are not expressed on fresh human monocytes, but are expressed on
mature M<J>s (Eischen et al., 1991). This is similar to the pattern of expression of
VPM32, CD4 and CD8 expression on cultured MDM<j) observed in this study.
Three day cultured monocytes underwent phenotypic changes and expressed CD4,
CD8 and VPM32 antigen. They were, therefore, considered to be MDM(J>s and were
used for infection with OPIV-3. OPIV-3 replication in these MDM<|)s was found to
be slower and less productive than in AM(j»s. Furthermore, phenotypic changes seen
after infection were variable and it was difficult to say whether they were caused by
OPIV-3 infection, restriction of OPIV-3 infection or further differentiation of the cell
with time in culture. Immature monocytes limit MW replication and so monocyte
cultures are not productively infected with MVV until they have differentiated
(Narayan et al, 1983; Lee, 1994).
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Seven day cultured MDM<j) had completely differentiated into M<|)s as defined by
morphology, NSE staining and stable surface antigen expression. There was no
significant difference in surface molecule expression on OPIV-3 infected and mock-
infected MDM<{) up to 5 days of infection. However, in some cultures there was
enhanced expression of surface antigen early after viral infection. MDM<j) may
therefore increase their functional and biological activities in response to viral stimuli
early in infection , but these changes were not further amplified by a cascade reaction
due to the lack of lymphocytes in the culture. The interaction of infected M<f>s and
lymphocytes may produce y-IFN and enhance surface antigen expression as seen
in vivo (Lairmore et al, 1988a; Kennedy et al., 1985). A similar phenomenon of
enhanced antigen expression has been seen in MDM(|) infected with MVV
(Lee, 1994). There was no loss of surface antigen from MDM<]) or AM<]> up to 5 days
post infection with OPIV-3; but since then, degenerative changes including a
decrease in surface antigen expression were seen. This is probably due to productive
replication of the virus as this is supported by the detection of viral antigen both in the
cytoplasm and cell membrane (Fig.6.6). The kinetics of the changes also coincide with
surface changes seen in OPIV-3 infected MDM(f> observed under TEM.
Fc receptors are important surface molecules for monocytes and M<|> function. These
receptors participate in phagocytosis, antibody-dependent cell mediated cytotoxicity
(ADCC) and superoxide production (Jungi et al., 1990; Sarmay, 1992). VPM32
which is thought to be specific for FcyRIII (Gonzalez, 1989) showed no decrease in
M<{> surface expression before 5 days p.i.
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CHAPTER SEVEN
IN VITRO INFECTION OF MONOCYTE DERIVED MACROPHAGES AND
PULMONARY ALVEOLAR MACROPHAGES WITH PARAINFLUENZA
TYPE 3 VIRUS
PART A: EFFECT ON MAJOR HISTOCOMPATIBILITY COMPLEX
(MHC) MOLECULE EXPRESSION
PART B: EFFECT ON PHAGOCYTOSIS.
7.1 Introduction
Macrophages function as the principal cellular, non-specific effector mechanism in the
protection against microorganisms (Nathan, 1986). In addition they act to induce the
immune response by presenting antigens to antigen-specific T cells (Harding et al.,
1988; Weaver & Unanue, 1990; Unanue, 1992). Mcjts exist throughout the body, but
their functions are somewhat heterogeneous, depending on the microenvironment in
which they are found (Brain, 1992).
Within the lungs the AM(J) plays a fundamental role in both defence and homeostasis,
particularly in inflammatory response and tissue repair. They take part in depurative
processes through phagocytic function and in immunological surveillance through
their capacity of antigen processing and presentation. M(j)s are also involved in
immune regulation and some non-specific effector mechanisms of cell mediated
protection (Holian & Scheule, 1990).
AM(j)s contribute to primary non-specific defence mechanisms against invading
pathogens in the lung. Many viral infections of the respiratory tract result in changes
in the phagocytic and bactericidal activity of AM()s which may lead to concurrent
bacterial infection (Fuentes & Piojan 1986: Boschert et al., 1988; Kang et al., 1992).
PIV-3 initiates infection in respiratory tract epithelial cells, but can also infect alveolar
M(j>s. This can lead to important pathological consequences during the pathogenesis
of this respiratory tract viral disease (Stauber & Weston, 1984). The AM<j) can be
affected by different mechanisms, such as direct damage caused by viral replication or
as a result of immune mediated cytotoxicity directed towards the virus infected M<]).
Not only can the number of M<j)s be reduced by the viral infection, but also the
function of the remaining cells can be altered. Some reports suggests that such M$s
have suppressed immunological and non-immunological activities. These activities
include membrane receptor binding, phagocytic ingestion mediated by Fc receptor
(FcR), non-receptor specific phagocytosis, phago-lysosome fusion, intracellular killing
and bacterial degradation ( Hesse & Toth, 1983; Davies et al., 1986; Slauson et al.,
1987).
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After infection of AMs by PIV-3, a reduction in receptor-mediated phagocytosis and
antibody dependent cellular cytotoxicity (ADCC) can take place. PIV-3 can inhibit
M<t> phagocytosis, mediated by Fc receptors, through the interaction with
immunocomplexes (Jakab & Warr, 1981; Babiuk et al., 1988; Brown & Ananaba,
1988). Furthermore, the inhibited phagocytosis, intracellular degradation and
intracellular killing induced by the virus, can alter the antigen processing and
presenting functions of these cells (Horohov & Rouse, 1986).
Chemotactic, phagocytic and microbicidal activities are basic functions of monocytes
and M<J)s migrating into inflammatory areas against invading microorganisms.
Receptors for immunoglobulin G (FcyRI, II and III) and for iC3b (CD1 lb/18) are the
principal mediators of opsonized phagocytosis and phagocyte activation (Hed &
Stendahl, 1982; Anderson, 1987; Fanger et al., 1989; Jungi et al., 1990; Sarmay,
1992). Monocytes and M<j)s have been shown to express FcyRII (CDw32) and Fcry
RIII (CD16) (Anderson, 1987). Expression of these molecules on M<|)s is enhanced by
y-IFN and IL-2 (Fanger et al., 1989; Heagy et al, 1984; Gonwa et al., 1986; Nash et
al., 1992).
After antigen phagocytosis AMcjts also activate T cells and induce the production of
IL-2 (Elias et al., 1990). Thus, AM0S can modulate the tissue response during the
inflammatory process. Therefore, analysis of Fc receptors and phagocytosis is
commonly used to study the effector function of M(j>s and their contribution to the
pathogenesis of disease.
Other M(j) functions are related to the expression of major histocompatibility complex
(MHC) class I and class II antigens. The MHC class II molecules play a central role
in the induction of the immune response (Unanue & Allen, 1987). Among these
functions the presentation of soluble antigens to T helper lymphocytes and the
stimulation of alloreactivity are included. The induction of immune response towards
antigenic proteins depends on recognition by T cell receptors associated to MHC
class II molecules.
Over 90% of circulating human monocytes express HLA-DR, whereas, only 25-60%
express HLA-DQ and DP (Gonwa et al., 1986). MHC class II on monocytes is
closely linked to antigen presentation (Unanue & Cerottini, 1991). It has been
reported that there is a decrease in HLA-DR expression in monocytes from HIV-
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infected patients with AIDS (Heagy et al, 1984; Roy et al., 1987). In addition, AM<))s
from AIDS and AIDS related complex (ARC) patients did not express the normal
levels of class II and LFA -1 antigen on their surface when compared to the normal
controls (Roy et al., 1987; Bray et al., 1993). Documentation shows that there is a
great reduction in MHC class II expression and function of dendritic cells and
Langerhan's cells in HIV-infected patients with ARC and AIDS (Eales et al., 1988;
Belsito et al., 1984). In vitro, studies using the human promonocytic cell line U937
as a monocyte model have shown an increase in the expression of mature monocyte
surface markers, except for HLA class II antigens, after infection with HIV (Pettit et
al., 1987). It is thought that this contributes to the immunosuppression of HIV
infection.
Tlie expression of MHC class II molecules on M(j)s is transitory. In vitro eventually all
class II+ Mds become class II", and therefore lose their properties as APC (Unanue,
1984; Unanue & Allen, 1987). However, they can be rapidly reactivated to synthesize
class II molecules after antigen uptake or stimulation with y-IFN (Lucas & Epstein,
1985; Gonwa et al., 1986; Elias et al., 1990).
Viral infections can also induce the release of cell soluble factors. PIV-3 infection is
an efficient y-IFN inducer in peripheral blood mononuclear cells (Towsend et al.,
1988). This virus is also involved in induction of other molecules of biological
importance such as tumoral necrosis factor-alfa (TNF-a) (Vainionpaa et al., 1989;
Bienhoff et al., 1992). Parainfluenza-3 virus/endotoxin combinations stimulated
higher TNF-a release when compared with other virus/endotoxin combinations
(Bienhoff et al., 1992).
The well-known inducers of y-IFN are generally effective for inducing M(f> y-IFN
production. These inducers include viruses, endotoxin, synthetic polyribonucleotides,
pyran and statolon (Lucas & Epstein, 1985). A variety of viruses are effective
inducers of M(|) y-IFN production including viruses which cause respiratory infections
such as PIV-3.
y-IFN has a wide range of antiviral effects such as decreased RNAm translation, the
defective transmission of viral message and inhibition of the final events of the viral
replicative cycle. In contrast to other classic patterns of action, the inhibition
produced by y-IFN in PIV-3 infection is not due to a decrease in viral RNA or viral
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protein synthesis. On the contrary it is due to an interference with the process of virus
maturation during late stages of viral replication. This can lead to defective virus
assembly and virus budding, as well as release of virus particles with low infectivity
due to a deficiency in glycoproteins (Unanue & Allen, 1987).
It has been pointed out that y-IFN is the main inductor of MHC class II molecules
(Watanabe & Jacob, 1991). y-IFN is a biologically active molecule produced by T
lymphocytes during antigen presentation. y-IFN binds to M(j)s inducing new
expression of RNAm for MHC class II molecule synthesis (Unanue & Allen, 1987). y-
IFN-treated M(j>s also exhibit cytocidal functions upon their interaction with other
stimuli (called "second signals") of which bacterial products like endotoxin are the
most prominent (Adams & Hamilton, 1984).
On the other hand, TNF-a, acts as a potent stimulator of monocyte differentiation in
myeloid leukemia cell lines, but TNF-a acts as an antagonist to y-IFN to decrease
MHC class II expression on mature monocytes (Watanabe & Jacob, 1991; Gonwa et
ai, 1986). This raises the question of whether MHC class II production by M([>s might
be altered during PIV-3 infection and whether this has functional consequences.
The direct effect on surface MHC molecules of M(}>s after PIV-3 infection in vitro is
not clear. This can lead to alterations in the antigen presenting function of these cells.
Therefore, a study of the changes of both phagocytic capacity and surface MHC




7.2.1 PART A: EFFECT ON MAJOR HISTOCOMPATIBILITY COMPLEX
(MHC) MOLECULE EXPRESSION.
7.2.1.1 Kinetics ofMHC molecule expression in monocyte-derived macrophage
(MDM<j>s) cell cultures.
Peripheral blood monocytes (PBMC) were collected and cultured to obtain MDMtf).
AM())s were collected from lung wash fluid (LWF). All these cells were obtained from
clinically normal healthy sheep and cultured in gelatin-coated flasks or plates. Non¬
adherent cells were washed off after overnight incubation. These cells were harvested
every 24 hours and immunostained for MHC class I and II molecule expression on
cell surface. The reactivity was analyzed by flow cytometry. Table 7.1 shows the
results of MHC molecule expression by MDM(J)s before (day 0) and after cell culture
(days 1 to 7).
VPM19 is a monoclonal antibody specific for a monomorphic region of MHC class I
molecules that is expressed on most nucleated cells (Hopkins & Dutia, 1990). Fresh
monocytes were found to express class I molecules with high intensity (MF=99.5) and
they continued to express these molecules in culture during their in vitro
differentiation towards MDM(j)s. However, the intensity of fluorescence staining,
therefore density, of MHC class I on the surface started to decrease from day 1 of
culture. It became significantly lower (p<0.05) on day 3 of culture in comparison to
fresh monocytes (day 0 of culture). After 5 to 7 days of culture, although the
expression was variable they stabilized in intermediate ranges of intensity of
fluorescence (MF=68.5 and 67.2, repectively).
VPM 36 and VPM 38 are monoclonal antibodies specific for MHC class II DQ and
DR a chains, respectively (Dutia et ai, 1990). The expression of MHC class II DQ
antigen was of high intensity (MF=85.6) on fresh monocytes. However, after culture
the expression of DQ started to decrease on day 1, being significantly (p<0.001)
reduced by day 3 (MF=6.7). After day 5 the expression of DQ was almost at
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background level (MF=2.3). The pattern of MHC class II DR expression was very
similar to DQ (Table 7.1).
7.2.1.2 Kinetics ofMHC molecule expression in alveolar macrophage (AM<})) cell
cultures.
Table 7.2 shows the results obtained by flow cytometry of MHC molecule expression
by AM0S before (day 0) and after cell culture (day 1 to 7). Fresh AM(J)s also
expressed class I with high intensity (MF=95.3) and they also continued to express
this molecule in culture. However, the intensity of fluorescence staining decreased
significandy (p<0.001) and temporarily on day 1 after culture (MF=32.4). After day 2
of culture the level of MHC class I expression increased stabilizing to an intermediate
level of expression.
Fresh AM(j)s were also positive for expression of MHC class II molecules DQ and
DR, although this was somewhat lower than in fresh monocytes. After 1 day in
culture the expression of MHC class II DQ molecule was significantly decreased
(p<0.001) in comparison to fresh AM<|)s. The expression continued to decrease
thereafter to minimal levels after days 5 to 7 (MF/DQ=2.7 and 3.6, respectively). No
significant differences were observed between expression of MHC class II molecule
DQ and MHC class II DR, either in fresh AM(|)s or in AM<j>s in culture (Table 7.2).
MDM(|)s and AM<J)s were cultured on round coverslips set up in 24 well cell culture
plates. Coverslips were removed from day 0 to 7 of cell culture and immunostained
for MHC class II antigens DQ or DR by alkaline phosphatase (Fig. 7.1a). After 3 days
of cell culture MHC class II staining in both MDMtjis and AM<j)s was not detected by
this technique. However in AM(f) cultures the presence of a few scattered highly
positive and pleiomorphic cells, showing long cytoplasmic processes was observed
on many occasions. They were in close contact with and surrounding AM0S
(Fig. 7.1b,c). These cells remained highly positive for MHC class II antigens after the
AM(j)s became negative (7-10 days). They are thought to be dendritic cells according
to their morphology and MHC class II expression.
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TABLE 7. 1 Time dependent expression of MHC molecules by monocyte derived
macrophages (MDMfos) in cell culture.
Surface
Time in cell culture
Molecules 0 day 1 days 3 days 5 days 7 days
MHC class I 99.5±5.31 87.2±4.9 61.8±6.12 68.5±4.92 67.2±6.32
MHC class II DO 85.6±7.4 65.2±4.5 6.7±3.33 2.3±2.13 3.9±2.83
MHC class II DR 90.1±6.8 73.6±4.0 10.6±4.53 12.3±5.13 10.1±4.33
l.Data (mean±sd) is expressed as mean fluorescence intensity (MF) where non-specific control
fluorescence (NMS) has been subtracted. Data was collected from 5 separate experiments.
2.Significantly different at p<0.05 (Mann-Whitney non-parametric rank test) from day 0 of culture
(fresh cell).
3.Significantly different at pcO.OOl (Mann-Whitney non-parametric rank test) from day 0 of culture
(fresh cell).
TABLE 7. 2 Time dependent expression of MHC molecules by alveolar
macrophages (AMtjis) in cell culture.
Surface
Time in cell culture
Molecules 0 day 1 days 3 days 5 days 7 days
MHC class I 95.3+6.31 32.4±7.13 59.7±5.82 73.5±6.2 71.4±5.9
MHC class H DO 68.5±6.9 11.5±4.53 6.1±1.33 2.7±1.23 3.6±1.73
MHC class II DR 71.4±7.3 15.6±5.43 12.6+5.23 8.0±3.73 09.5+3.23
l.Data (mean±sd) is expressed as mean fluorescence intensity (MF) where non-specific control
fluorescence (NMS) has been substracted. Data was collected from 5 separate experiments.
2.Significandy different at p<0.05 (Mann-Whitney non-parametric rank test) from day 0 of culture
(fresh cell).
3.Significantly different at pcO.OOl (Mann-Whitney non-parametric rank test) from day 0 of culture
(fresh cell).
FIGURE 7. 1 Expression of MHC class II molecules in AM0S in tissue culture.
AM<})S were collected from the lung wash fluid (LWF) of clinically normal healthy
sheep and cultured 24 well plates (gelatin-coated) with round coverslips. Non¬
adherent cells were washed off after 4 hours of culture. Coverslips were removed
after 4, 24, 72 and 120 hours of culture. Cells were incubated with a 1:1 mixture of
mAbs VPM36 and VPM38 for MHC class II molecules DQ and DR, respectively.
Their reactivity was detected by indirect immunoalkaline phosphatase staining (IIAP).
a) AM(|)s after 4 hours in culture. Most cells show a strong positive staining (red
colour) for MHC class II molecules. IIP with mAbs VPM36/38. Magnification x200.
b) AM(j)s after 120 hours in culture.
All AM(j)s are negative for MHC class
II molecule staining. A cell in close
contact with an AM(j) (arrow) shows
a strong positive staining (red colour)
for MHC class II molecules. This
positive cell has long cytoplasmic
processes and is contacting other
AM(j)s with them. IIP with mAbs
VPM36/38. Magnification x200.
c) AM<|)s after 120 hours in culture.
All AM<|)s are negative for MHC class
II molecule staining. Two pleomorphic
cells are surrounding AM<J)s (arrows).
These cells show strong positive
staining (red colour) for MHC class II
molecules. IIP with mAbs VPM36/38.
Magnification x200.
 
7.2.1.3 y -IFN induction of MHC class II expression
We were interested in looking at the effect of OPIV-3 infection on MHC class II
expression by M<}>s in vitro. Hence, the loss of these cell surface molecules during
culture was unfortunate. It was therefore decided to see if MHC class II expression by
MDM(j)s and AM(j)s could be induced in vitro. So, MDM<|)s and AM(j)s were cultured
and then treated with y-IFN (100U/ml)on day 3. The expression of MHC molecules
on y-IFN and mock treated MDM<j>s and AM(j)s was then analyzed from day 0 to day
7 of culture by flow cytometry.
Table 7.3. shows changes of MHC molecule expression in MDMtjis cultures after 2
and 4 days of y-IFN treatment. y-IFN significantly enhanced (p<0.05) class I molecule
expression from an intermediate intensity of expression (MF=62.8) to a high intensity
after 2 days of treatment (MF =91.2). y-IFN also significantly enhanced (pcO.OOl)
MHC class II expression from minimal levels (MF/DQ=07.1; MF/DR=12.6) to a
much higher expression after 2 days of treatment (MF/DQ=37.6; MF/DR=54.8).
Representative profiles of two day y-IFN treated MDM<|)s are shown in Fig. 7.2.
Treatment of MDM(|)s with y-IFN for 1 day only slightly enhanced MHC molecule
expression. Treatment for 3 or 4 days did not greatly increased MHC expression.
y-IFN treatment had very similar effects on AM(|)s (Table 7.4). Representative
profiles of two day y-IFN treated AM(j)s is shown in Fig. 7.3.
7.2.1.4 Effect of ri\r-3 infection on major histocompatibility complex (MHC)
molecule expression by monocyte-derived macrophages (MDMfys).
Individual cultures of MDMtjis were infected with OPIV-3 270-7 (1 TCIDso/cell) on
days 3, 5, 7 and 9 of culture. MHC molecule expression on OPIV-3 and mock
infected MDM<j)s was then analyzed on the same day (day 10 of culture). Only y-IFN-
treated M<j>s expressed MHC class II molecules. Untreated cells were negative for
class II expression.
MHC class I molecules were highly expressed on cultures of OPIV-3 infected
MDM(j)s and this expression was not significantly altered during the 7 day p.i. period
studied. Although some experiments showed a tendency for surface expression to
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TABLE 7. 3 Time dependent effect of y-IFN treatment on MHC molecule
expression by monocyte-derived macrophages (MDM(j)s) in cell culture.
Surface
Time in cell culture/y-IFN treatment (days)
Molecules Treatment 0 2 4
MHC class I Mock treated1 62.8±6.52 64.5±5.8 62.8±6.3
y-IFN 62.8±6.5 91.2±6.93 92.3±6.13
MHC class H DQ Mock treated 7.1±3.5 6.2±4.3 5.9±4.8
y-IFN 7.1±3.5 37.6±4.54 38.5±4.94
MHC class II DR Mock treated 12.6±3.5 15.4±4.1 14.2±3.9
y-IFN 12.6±3.5 54.8±5.34 59.215.34
1. y-IFN treatment (100U/ml) was given on day 3 of cell culture.
2. Data (mean±SD) is expressed as mean fluorescence intensity (MF) where non-specific
control fluorescence (NMS) has been subtracted. Data was collected from 5 separate
experiments.
3. Significantly different at p<0.05 (Mann-Whitney non-parametric rank test) from
mock-treated cells same day of culture.
4. Significantly different at p<0.001(Mann-Whitney non-parametric rank test) from
mock-treated cells same day of culture.
TABLE 7. 4 Time dependent effect of y-IFN treatment on MHC molecule
expression by alveolar macrophages (AM<}>s) in cell culture.
Surface
y-IFN treatment (days)
Molecules Treatment1 0 2 4
MHC class I Mock treated 64.2±5.82 62.3±6.1 64.1±5.9
y-IFN 64.2±5.8 102.4±7.53 105.3±6.93
MHC class H DQ Mock treated 6.2±2.3 6.2±1.9 5.9±2.1
y-IFN 6.2±2.3 57.5±4.64 59.8±5.84
MHC class II DR Mock treated 10.3±3.8 10.3±2.9 11.5±2.8
y-IFN 10.3±3.8 69.8±6.54 68.3±7.14
1 .y-IFN treatment (lOOU/ml) was given on day 3 of cell culture.
2.Data (meaniSD) is expressed as mean fluorescence intensity (MF) where non-specific
control fluorescence (NMS) has been subtracted. Data was collected from 5 separate
experiments.
3.Significantly different at p<0.05 (Mann-Whitney non-parametric rank test) from mock-
treated cells same day of culture.
4.Significantly different at p<0.001 (Mann-Whitney non-parametric rank test), from
mock-treated cells same day of culture.
FIGURE 7. 2 Frequency histograms showing the effect after 2 days of y-EFN
treatment on the MHC molecule expression of MDM<{>s in culture. Peripheral blood
monocytes (PBMC) were collected and cultured in gelatin-coated flasks or plates to
obtain MDM<{)s. After 3 days of culture they were fed 100 U. of y-IFN/ml. After 2
days 7-IFN treated and mock-treated cells were harvested and incubated with mAbs
VPM19, VPM36 and VPM38 ( )in order to detect MHC class I, class II DQ and
class II DR molecules on the cell surface by flow cytometry. Staining with NMS as
the negative control ( ) is shown for comparison.
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FIGURE 7. 3 Frequency histograms showing the effect after 2 days of 7-EFN
treatment on the MHC molecule expression of AMfs in culture. AM<|)s were collected
from lung wash fluid (LWF) and cultured in gelatin-coated flasks or plates. After 3
days of culture they were fed 100 U. of 7-IFN/ml. After 2 days 7-EFN treated and
mock-treated cells were harvested and incubated with mAbs VPM19, VPM36 and
VPM38 ( ) in order to detect MHC class I, class II DQ and class II DR molecules
on the cell surface by flow cytometry. Staining with NMS as the negative control
( ) is shown for comparison.
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increase slightly after 5 days p.i. (Table 7.5). After y-IFN treatment for 2 days MHC
class I molecule expression was significantly increased (p<0.05) in infected cells as
well as in mock infected cells, in comparison to non-y-IFN treated infected and mock
infected cultures. These findings were similar to those observed in MDMtj) cultures of
non-infected cells (Tables 7.1 and 7.3) and showed no effect on MDM<{) class I
expression after OPIV-3 infection. Futhermore, y-IFN MHC class I enhancement
was not impaired (Table 7.5). A representative profile, of class I expression of
MDM(j)s after 5 days of OPIV-3 infection and two days y-IFN treatment, is shown in
Fig. 7.4. MHC class II molecule expression after infection remained almost
undetectable and very similar in fashion to that observed during culture of non-
infected MDMcj)s (Table 7.1). Furthermore, after two days of y-IFN treatment no
significant increase in expression of either DQ or DR MHC class II molecules was
observed in OPIV-3 infected cultures. In contrast mock infected control cultures
showed a significant increase (p<0.001) in both DQ and DR MHC class II molecules,
indicating a suppressive effect after OPIV-3 infection (Table 7.5). Representative
profiles of class II expression of MDM<j)s after 5 days of OPIV-3 infection, and two
days y-IFN treatment, are shown in Fig. 7.4.
7.2.1.5 Effect of PIV-3 infection on major histocompatibility complex (MHC)
molecule expression by alveolar macrophages (AM§s).
Two methods were used to examine the effect of OPIV-3 infection on AM(j) MHC
phenotype. In the first experiment individual cultures of AM<()s were infected with
OPIV-3 270-7 (1 TCIDso/cell) on days 3, 5, 7 and 9 of culture. MHC molecule
expression on OPIV-3 and mock infected AM(J)s was then analyzed on the same day
(day 10 of culture).
AM(j) cultures after OPIV-3 infection showed a similar pattern of MHC molecule
expression to that observed in infected MDM(J) cultures and also a similar response to
y-IFN treatment for 2 days (Table 7.6). MHC class I molecules were highly expressed
on cultures of OPIV-3 infected AM(j)s and this expression was not significantly
altered during the 7 days p.i. period studied. As well in MDM({> cultures, here there
was also a tendency for surface expression to increase slightly after 5 days p.i.;
however no significant differences were detected due to variability in expression.
After y-IFN treatment for 2 days MHC class I molecule expression was significantly
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TABLE 7. 5 Comparison of the MHC molecules expression by 10 day cultured
monocyte-derived macrophages (MDM<S)s) after OPIV-3 infection with or without 2
days y-IFN treatment.
MHC
Time Post OPIV-3 Infection1
Mock
molecules Treatment 1 day 3 days 5 days 7 days infected2
Class I mock-treated 64.2±6.53 63.114.8 65.714.8 64.517.9 62.315.0
ylFN4 ND 99.315.2 96.314.55 98.916.55 102.314.85
Class II DO mock-treated 5.310.9 5.211.5 6.111.3 5.911.6 5.611.8
ylFN ND 11.513.6 7.112.2 6.911.8 57.514.56
Class II DR mock-treated 10.711.8 9.612.0 12.313.8 14.013.5 9.312.3
7-IFN ND 16.814.1 14.613.1 14.212.7 69.814.26
1.Cultured MDM were infected on days 3, 5, 7 and 9 of culture with OPIV-3 ITCID50 per cell.
Cells were harvested on day 10 of culture.
2.Mock infected cells on day 3 and harvested on day 10 of culture as controls.
3.Data (mean±SD) is expressed as mean fluorescence intensity (MF) where non-specific control
fluorescence (NMS) has been subtracted. Data was collected from 5 separate experiments.
4.y-IFN treatment (lOOU/ml) was given 2 days before harvesting the OPIV-3 infected or mock
infected cells.
5.Significantly different at p<0.05 (Mann-Whitney non-parametric rank test) from non-y-IFN treated
cells.
6.Significantly different at p<0.001 (Mann-Whitney non-parametric rank test) from both non-y-IFN
treated cells and OPIV-3 infected-y-IFN treated cells.
FIGURE 7. 4 Frequency histograms showing the effect after 2 days of y-IFN
treatment on the MHC molecule expression of MDM<j)s infected for 5 days with
OPIV-3. Peripheral blood monocytes (PBMC) were collected and cultured in gelatin-
coated flasks or plates to obtain MDM<{>s. After 3 days of culture they were either
infected with OPIV-3 270-7 at 1 TCIDso/cell or mock-infected only with medium.
Three days later they were fed 100 U. of y-EFN/ml. After 2 days y-IFN treated and
mock-treated cells were harvested and incubated with mAbs VPM19, VPM36 and
VPM38 ( ) in order to detect the cell surface expression of MHC class I, class II
DQ and class II DR molecules, respectively. Staining with NMS as the negative
control (... ) is shown for comparison.
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increased (p<0.05) in infected cells as well as in mock infected cells, in comparison to
non-y-IFN treated infected and mock-infected cultures ( Table 7.2.). These findings
were similar to those observed in AM(j) cultures of non-infected cells (Table 7.2 and
7.4). OPIV-3 infection showed no effect on either class I expression by AM(j)s or 7-
IFN MHC class I enhancement (Table 7.6). A representative profile of class I
expression of AM<|)s after 5 days of OPIV-3 infection and two days y-IFN treatment,
is shown in Fig. 7.5.
MHC class II molecule expression after infection by AM(j)s (Table 7.6) remained
almost undetectable and very similar to that observed during culture of non-infected
AM<j)s and infected MDM<|>s (Table 7.2). After two days y-IFN treatment, no
significant increase in expression of either DQ or DR MHC class II molecules was
observed in OPIV-3 infected AMtj) cultures. In contrast mock-infected control
cultures showed a significant increase (pcO.OOl) in both DQ and DR MHC class II
molecules, indicating a suppressive effect after OPIV-3 infection (Table 7.6.). A
representative profile, of class II expression of AMtfis after 5 days of OPIV-3 infection
and two days y-IFN treatment, is shown in Fig. 7.5.
In the second experiment, AM0s were infected with OPIV-3 1 TCID50 per cell, on
day 3 of culture. Then after 2 days p.i. cells were either treated with y-IFN
(100U/ml)or mock-treated with medium. AM(j>s were harvested for phenotypic
analysis on days 1, 3, 5 and 7 p.i. with OPIV-3 which were also days 0, 1, 3 and 5
post y-IFN treatment, respectively (Table 7.7). Mock infected cells as well OPIV-3
infected cells showed high expression of class I molecules after day 3 post infection
(day 1 post y-IFN treatment). On days 5 and 7 p.i. which were also days 3 and 5 post
y-IFN treatment, respectively, there was a significant increase (p<0.05) in class I
molecule expression in both infected and mock-infected cells. This illustrates that
OPIV-3 infection does not affect MHC class I expression.
In contrast, OPIV-3 infection totally abrogates the effect of y-IFN in its induction of
both MHC class IIDR and DQ. Mock infected AM(j)s showed very low levels of both
MHC class II DQ and DR molecules without y-IFN treatment or after 1 day
treatment, however, after 3 and 5 days of y-IFN treatment they showed a significant
increase (p<0.05) in both molecules. OPIV-3 infected AMtjis also showed very low
levels of both MHC class II DQ and DR molecules but in contrast to mock-infected
cells they did not increase the expression of these molecules after y-IFN treatment.
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TABLE 7. 6 Comparison of the MHC molecules expression by OPIV-3 infected
alveolar macrophages (AM<j)s) in culture with or without 2 days of y-IFN treatment.
MHC
Time Post OPIV-3 Infection1
Mock
molecules Treatment 1 day 3 days 5 days 7 days infected2
Class I mock-treated 62.1±7.13 64.515.8 67.915.7 70.918.2 66.614.3
ylFN4 ND 95.415.9 93.216.25 105.917.55 97.213.85
Class II DO mock-treated 4.611.4 5.111.7 5.310.9 6.011.8 6.211.2
ylFN ND 9.712.8 6.111.8 7.912.1 37.613.56
Class II DR mock-treated 14.712.4 15.312.1 16.713.0 16.112.8 15.412.0
y-IFN ND 19.613.2 17.212.9 16.913.4 54.814.26
1. Cultured AM were infected on days 3, 5, 7 and 9 of culture with OPIV-3 ITCID50 per cell. Cells
were harvested on day 10 of culture.
2. Controls are mock infected cells on day 3 and harvested on day 10 of culture.
3. Data (mean±SD) is expressed as mean fluorescence intensity (MF) where nonspecific control
fluorescence (NMS) has been subtracted. Data was collected from 5 separate experiments.
4. y-IFN treatment (lOOU/ml) was given 2 days before harvesting the OPIV-3 infected or mock
infected cells.
5. Significantly different atp<0.05 (Mann-Whitney non-parametric rank test) from non-7-IFN
treated cells.
6. Significantly different at p<0.001 (Mann-Whitney non- parametric rank test) from both non-7-IFN
treated cells and OPIV-3 infected-7-IFN treated cells.
FIGURE 7. 5 Frequency histograms showing the effect after 2 days of 7-IFN
treatment on the MHC molecule expression of AM<|)s infected for 5 days with OPIV-
3. AM<f)s were collected from lung wash fluid (LWF) and cultured in gelatin-coated
flasks or plates. After 3 days of culture they were either infected with OPIV-3 270-7
at 1 TCrD50/cell or mock-infected only with the medium. Three days later they were
fed 100 U. of y-EFN/ml. After 2 days, 7-IFN treated and mock-treated cells were
harvested and incubated with mAbs VPM19, VPM36 and VPM38 ( ) in order to
detect the cell surface expression of MHC class I, class II DQ and class II DR
molecules, respectively. Staining with NMS as the negative control ( ) is shown
for comparison.
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TABLE 7. 7 Comparison of the effect of y-IFN treatment on MHC molecules
expression by alveolar macrophages (AM(|)s) in culture, in the presence or absence of
OPIV-3 infection.





T reatment 1/0 3/1 5/3 7/5
Class I Mock infected 68.3±4.12 70.1±5.2 97.913.93 93.214.73
OPIV-3 infected 59.8±5.7 65.1±4.3 98.215.13 95.413.93
Class H DO Mock infected 6.2±2.6 9.812.8 55.114.7 48.612.9
OPIV-3 infected 7.1±2.8 6.512.5 5.112.2 5.413.3
Class H DR Mock infected 11.5+3.3 19.313.6 71.215.34 67.514.94
OPIV-3 infected 9.4±3.0 8.912.8 10.613.7 9.113.2
1. Cultured AM were infected on day 3 of culture with OPIV-3 ITCID50 per cell. Cells were
harvested on day 1,3,5, and 7 p.i. y-IFN treatment (lOOU/ml) was given on day 2 p.i. with OPIV-
2. Data (mean±SD) is expressed as mean fluorescence intensity (MF) where nonspecific control
fluorescence (NMS) has been subtracted. Data was collected from 5 separate experiments.
3. Significantly different at p<0.05 (Mann-Whitney non-parametric rank test) from non-y-IFN
treated cells.
4. Significantly different at pcO.OOl (Mann-Whitney non-parametric rank test) from both non-
y-IFN treated cells and OPIV-3 infected-y-IFN treated cells.
7.2.2 PART B: EFFECT ON PHAGOCYTOSIS.
In order to study functional alterations in MDM<))s and AM(J>s after PIV-3 infection,
these cells were cultured in 24 well plates and the erythrocyte rosetting and
phagocytosis of opsonized sheep red blood cells (SRBC) were assayed by flow
cytometry. Individual cultures of MDMtjis and AM<|)s were infected with OPIV-3
270-7 (1 TCID50/cell) on days 3, 5, 7 and 9 of culture. Erythrocyte rosetting and
phagocytosis of opsonized SRBC were assayed on OPIV-3 and mock-infected
MDM(|>s and AMcjts on the same day (day 10 of culture).
7.2.2.1 Effect ofOPIV-3 infection in SRBC rosetting
Table 7.8 shows that OPIV-3 infection of MDM(|)s had no significant effect on Fc
rosetting. In mock-infected MDM(j> cultures 96.1±2.3% cells formed FcR rosettes.
Following viral infection, the percentage of MDM(j)s forming FcR rosettes did not
drastically differ from that of the controls. The lowest values were observed on day 7
of the virus infection, a time when 89.3+4.5 MDM(|)s demonstrated positive FcR
rosettes. At all assay periods, incubations of normal M<|)s and virus infected ones with
non-opsonized erythrocytes failed to demonstrate any non-immunologic binding.
Thus, any interaction between M<j)s and opsonized erythrocytes was specific for the
ligand and cell receptor.
FcR expression on the surface of OPIV-3 infected AM(|)s (Table 7.8), assayed by
erythrocyte rosetting, showed a significant decrease (p<0.05) in immune complex
FcR activity after 5 and 7 days p.i. when compared to mock-infected AM(j)s (Table
7.8). The lowest values were observed on day 5 of the virus infection, a time when
80.1±5.2 AM(j)s showed positive FcR rosettes. In mock-infected AM<j)s cultures
92.5±6.4% cells formed FcR rosettes.
7.2.2.2 In vitro phagocytic activity of OPIV-3 infected monocyte-derived
macrophages (MDMtJw) and alveolar macrophages (AM<j).vj.
Using FITC-labelled SRBC as targets for phagocytosis, it is possible to use flow
cytometry to analyse phagocytic activity. The time of incubation and the
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TABLE 7. 8 Effect of OPIV-3 Infection on rosetting of cultured monocyte-derived
macrophages (MDM(j)s) and alveolar macrophages (AM"(j)s) with opsonized SRBC.
Time Posl Infection
Cells Control 1 day 3 days 5 days 7 days
MDMtJ) % 96.1+6.31 95.3±6.5 96.4±5.9 92.7±6.1 89.3±4.5
AM<f> % 92.5+6.4 90.8±5.7 88.5±6.3 80.6+5.92 80.1+5.22
1 Data is expressed as percentage of positive cells with 1% gate set on the negative control of the
staining (incubation with NMS). Data was collected from 5 separate experiments.
2.Significantly different (p<0.05) from mock-treated cells same day of culture (Mann-Whitney
non-parametric rank test).
concentration of antibody coated and FITC-labelled SRBC used in phagocytic assays
were titrated in preliminary experiments (data not shown) according to the protocol
described in section 2. Phagocytosis of SRBC is affected by opsonization as well as
different concentrations of antiserum, and the fluorescence of the MDM(|)s and AM<j)s
is related to the number of FITC-particles which are ingested by the cells (Oda &
Maeda, 1986; Bjerknes et ai, 1989; Buschmann & Winter, 1989; Lee, 1994).
Individual cultures of MDM<j)s and AM<}>s were infected with OPIV-3 270-7 (1
TCID50/cell) on days 3, 5, 7 and 9 of culture. Phagocytosis of SRBC was assessed on
both OPIV-3 and mock infected cells by flow cytometry on the same day (day 10 of
culture). Previously, cells were fed with 50|il of opsonized FITC-SRBC and incubated
for 1 hr. at 37SC.
In the early phase of viral infection (before 2 day p.i.), both OPIV-3 infected and
mock-infected cells showed very high phagocytic activity, with 90.7% of cultured
MDM<j)s having high erythrocyte resetting and phagocytic activity (MF=85.5) (Table
7.9). However, the phagocytic capacity of OPIV-3 infected MDM(j)s was decreased to
67.2% (MF=65.3) by 3 days post infection. By day 5 p.i. phagocytic cells had further
decrease to 47.2% (MF=58.5). There was a statistically significant difference between
OPIV-3 infected and mock-infected MDM(j)s at this time (p<0.05) (Table 7.9). By
day 7 there was a recovery in both the percentage of phagocytic cells (67.4 %) and
the fluorescence intensity (MF=65.5). Figure 7.6 shows representative profiles of
these experiments.
The ability of AM({)s from virus infected cultures to ingest the surface bound IgG-
coated erythrocytes progressively decreased until day 5 p.i. In the early phase of viral
infection (before 2 day p.i.), AM<j>s showed a very high percentage of phagocytosis,
with nearly 85.7% positive cells, although phagocytic activity (MF=76.9) was
slightly lower in comparison to that of MDM<j)s (Table 7.9). The phagocytic capacity
of OPIV-3 infected AM<j)s by 3 days post infection was decreased to 60.2% positive
cells with not a decrease in phagocytic intensity (MF=63.3). By day 5 p.i. phagocytic
cells had significantly decreased to 48.1% or less with a much lower phagocytic
intensity (MF=58.2). There was a statistically significant difference between OPIV-3
infected and mock-infected MDM<j)s at this point in time (p<0.001) (Table 7.9). By
day 7, there was a recovery in both the percentage of phagocytic cells (67.4 %) and
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the phagocytic intensity (MF=70.5) similar to that seen in the experiments with
MDM<J>s. Figure 7.6 shows a representative profile of these experiments.
Treatment with 7-IFN did not result in significant changes in either rosetting or
phagocytic capacity of MDM(j>s or AM(j>s between mock infected and OPIV-3
infected cells (data not shown).
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TABLE 7. 9 Effect of OPIV-3 infection on SRBC Phagocytic capacity of Cultured
Monocyte-derived macrophages (MDM<j>s) and Alveolar Macrophages (AM<j)s).
Time Posf Infection
Cells Control 1 day 3 days 5 days 7 days
MDM<j) % 90.7±4.2 83.7±5.1 67.2±5.4 47.2±9.23 67.4±7.3
MF 85.5±6.3 75.5±6.1 65.3±5.2 58.514.42 65.5±4.7
AM<|> % 85.7±6.3 82.9±5.9 60.2+4.1 48.1±3.93 67.4±4.6
MF 76.914.51 77.6±5.3 63.3±4.9 58.2±4.22 70.5±5.1
-1 Data is expressed as specific mean fluorescence intensity (which is MF with FITC SRBC minus
MF without FITC SRBC) and as percentage of positive cells. Data was collected from 5 separate
experiments.
2.Significantly different (p<0.05) from mock-treated cells same day of culture (Mann-Whitney
non-parametric rank test).
3.Significandy different (pcO.OOl) from mock-treated cells same day of culture (Mann-Whitney
non-parametric rank test).
FIGURE 7. 6 Frequency histograms showing the effect of the OPV-3 infection on
the SRBC-phagocytic capacity of MDM<j)s and AM<|)s. Individual cultures of MDMfs
and AM(j)s were infected with OPIV-3 270-7 (1 TCID5o/cell) in a series on days 3, 5,
7 and 9 of culture. Phagocytosis of SRBC was assessed on both OPIV-3 and mock
infected cells by flow cytometry on the same day (day 10 of culture). Previously, cells
were fed with 50(0.1 of opsonized FITC-SRBC ( ) and incubated for 1 hr. at 37SC.
Data was obtained by flow cytometry. Staining with NMS as the negative control
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7.3 DISCUSSION
The migration of monocytes into tissues results in the generation of organ specific
populations of resident M<j)s which show different phenotypes and functions
(Andreesen et al., 1990). For example, AM<j>s express high MHC class II levels, but
low levels of CD 14, whilst peritoneal M<))s show low MHC class II levels but high
CD14 expression (Andreesen et al., 1990). The factors attributing to these differences
in vivo may be intrinsic differentiation pathways of monocytes influenced by organ
specific microenvironments. In vitro, it is possible to alter culture conditions (by the
addition or absence of serum, growth factors or cytokines) to grow monocytes in
different differentiation states and showing different levels of surface antigen
expression and function (Geissler et al., 1989; Eischen et al, 1991; Kreutz et al.,
1992). The in vitro states are therefore comparable to different organ specific M(|)s
seen in vivo.
Serum contains many factors important for monocyte differentiation in vitro. In fact
monocytes cultured in the absence of serum cannot mature and die rapidly in culture.
They can however, be rescued by the addition of growth factor (Geissler et al, 1989;
Eischen et al., 1991; Kreutz et al., 1992). Indeed, GM-CSF will increase surface
antigen expression of CR3 and FcyllR, phagocytic ability, cytotoxicity and TNF-a
secretion of M<})s (Eischen et al, 1991). GM-CSF treated human MDM(|>s exhibit low
grade proliferation (Elliot et al., 1989), but GM-CSF stimulates mouse MDM(|>
proliferation (Chen et al., 1988).
Other factors which are also present in serum are cytokines. 7-IFN is a very important
cytokine which can activate M(j)s and increase class II DR, MHC class I and LFA-1
surface expression (Gonwa et al., 1986; Watanabe et al., 1991; Nash et al., 1992),
but it restricts monocyte maturation (Andreesen et al., 1990). Another cytokine,
TNF-a, acts as a potent stimulator of monocyte differentiation in myeloid leukemia
cell lines, but TNF-a acts as an antagonist to y-IFN to decrease MHC class II
expression on mature monocytes (Watanabe et al., 1991; Gonwa et al., 1986).
In the experiments shown, monocytes were grown in high serum concentrations
(10%FCS and 10%NLS) to allow the growth and the differentiation of the monocytes
in vitro. However, these serum concentrations were not enough to overcome the loss
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of MHC class II expression in vitro. A similar result in cultured human monocytes has
been reported (Sztein et al, 1984). However, cultured human monocytes in teflon
bags (suspension) in the presence of GM-CSF persistently expressed MHC class II
DR for 2 weeks (Eischen et al., 1991), suggesting that adherence to plastic may down
regulate MHC class II expression. In vivo activated T-helper cells secrete IL-2 which
is thought to be the primary stimulus causing y-IFN release from immune T-cells
(Torres et al., 1982). y-IFN could then act on monocytes to allow MHC class II
expression. In vitro, cultured MDM<j)s do not come into contact with activated
lymphocytes. In this experiment y-IFN enhanced the expression of MHC class II
(both DR and DQ) molecules. This has also been observed with human monocytes
where y-IFN causes an induction of specific mRNA (Nash et al, 1992).
AM(j)s lost MHC class II molecules in culture as assessed by both by flow cytometry
and immunohistochemistry. However, in the same cultures there were a few scattered
highly MHC class II positive cells found in close contact with M<j)s. These cells are
thought to be dendritic cells (DC) according to morphology and class II molecule
expression. Furthermore, staining of AM(|) cultures with anti-CD lb mAb VPM5
showed a positive population that decreased in proportion from 18% on fresh cells to
9% after 7 days in culture. This mAb not only reacts with afferent lymph dendritic
cells but also with dendritic cells in the skin and paracortical T cell areas of lymph
nodes (Budjoso et al., 1989). Immunohistochemical analysis of frozen sections of rat
lung tissue (Holt et al., 1992) identified a widely distributed population of highly
pleiomorphic Ia+ cells in alveolar septal walls, which are negative for the pan-Mtj)
marker ED4 and the related markers EDI, ED2 and ED9. They were also identified
as DC. Furthermore, flow cytometric parameters, density fractionation, and a series of
ED monoclonal antibodies raised against rat M(f) antigens showed that both AM<|)s and
DC cells are present in LWF and that they are diverse populations (Havenith et al.,
1993).
This small population of CDlb+ cells was detected in AM<[) but not in MDMtj)
cultures. CD1 proteins are generally not expressed on circulating monocytes however,
they can be induced in vitro using GM-CSF (Porcelli et al., 1992) or IL-3 (Porcelli et
al., 1993). Apparently this involves transcriptional activation of CD1 and new protein
synthesis. This in vitro cytokine induction is inhibited in the presence of human serum
or plasma and the CD1+ monocyte-derived do not appear obviously dendritic in
morphology (Porcelli et al., 1995). It should be pointed out that there is evidence for
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expression of human CD1 proteins on a subset of tissue M<|>s. However, these M<j>s
are found in inflammatory or infectious lesions in vivo (Modlin et al., 1983).
Furthermore, these molecules have by no means been found on all tissue macrophages
in situ. For example, one study reported no detection of CD la on a variety of
different tissue macrophages in normal and diseased tissues (Wood et al., 1983). The
existence of CD1' macrophages in chronic infectious and inflammatory lesions may be
a consequence of in situ generation of cytokines that could induce CD1 during the
process of monocyte migration and differentiation in tissues. This may reflect the
complex regulation of CD1 on monocyte-derived cells that could restrict the
expression to a limited subset of macrophages in a restricted spectrum of pathologic
states (reviewed by Porcelli et al., 1995).
In HIV-infected MDM(j>s, HLA-DR increased, HLA-DQ decreased and HLA-DP was
unchanged (Mann et al., 1990a). A different study has shown that simian
immunodeficiency virus (SIF) infected H9 cells had increased MHC class II antigen
expression. This was caused directly by viral infection and not mediated by y-IFN
activity (Kannagi et al., 1987). In MVV infection, an increase in MHC class II
molecule expression by AM<j>s has been reported to occur in vivo (Lujan et al., 1993;
Lee, 1994) and in vitro (Lee, 1994). In contrast, in this study the in vitro infection of
both MDM<j)s and AM<|)s with OPIV-3 showed a suppressive effect on MHC class II
molecule expression. The difference between results seen here with OPIV-3 and those
with HIV, MVV and SIF may be due to the chronic (non-lytic) infection seen with
these Ientiviruses, whilst PIV-3 causes a lytic infection of Mc|>s. Furthermore, in MVV
infection y-IFN is elevated whereas TNF-a is unaffected (Ellis et al., 1991). In
contrast in PIV-3 infection both y-IFN and TNF-a are also elevated (Towsend el al,
1988). PIV-3 virus/endotoxin combinations have been shown to stimulate higher
TNF-a release when compared with other virus/endotoxin combinations (Bienhoff et
al, 1992).
Further research should be directed to elucidate the potential association between
suppressed M({> MHC class II molecule expression and impaired lymphocyte
proliferation after PIV-3 infection. Experiments have been carried out with
lymphocytes stimulated with concanavalin A (Con A) in the presence of bovine
parainfluenza virus type 3 (P1V 3) infected bovine alveolar M<|)s (BAM) or monocytes
(Basaraba et al., 1993). Lymphocytes showed depressed [3H]thymidine
incorporation. This failure of lymphocytes to proliferate occurred only in the presence
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of live virus. It was also time dependent and most pronounced when BAM(})S were
infected 48 hr. before the addition of lymphocytes. The rate of infection of AM(J)S and
the release of infectious virus into culture supernatants paralleled suppression of
lymphocyte mitogenesis by PIV-3. However, the peak titre of exogenous, live or
inactivated virus was not suppressive when added to lymphocyte M<]> cultures just
prior to Con A stimulation. Neither the loss of viable AM0S nor a shift in antigen or
mitogen dose response in virally infected cultures could account for the deficit in
[3H]thymidine incorporation by these lymphocytes. In this study despite the presence
of lymphocyte-associated virus antigen detected by flow cytometry, no increase in
PIV-3 titre above baseline was seen from infected lymphocytes, irrespective of
mitogen stimulation. Likewise, lymphocytes did not contribute to the extracellular
virus pool in lymphocyte-M(j) cultures as the increases in viral titre above basal levels
in supernatants were equal to levels released by M<|>s alone. The expression of viral
antigen on lymphocytes stimulated in the presence of PIV-3-infected BAM<j)s suggests
a non-productive or abortive infection of lymphocytes mediated through contact with
infected M<|>s. PIV-3 has been reported to cause impairment in lymphocyte
proliferation. This is thought to be associated with PIV-3 induced M(f) malfunction
(Basaraba et al., 1993).
Different approaches to determining phagocytosis and Fc receptor expression have
been developed. In general, the assay most frequendy used to quantify phagocytosis
directly counts the number of cells containing ingested particles under a microscope
(Boschert et al., 1988; Washburn et al., 1985). However, this procedure is very
tedious and time consuming, and is subject to operator error due to personal
perception and the accuracy of counting large numbers of cells by eye. More
automated assays include measurement of ingested RBC by a colorimetric assay using
haemoglobin as the substrate (Jungi et al., 1990); the total fluorescence intensity of
ingested FITC-labelled particles in lysates of the phagocytic cells is detected by
spectrofluorometry (Oda et., 1986; Ragsdale et al., 1989); and radioactive counting
of 5 Chromium-labelled particles instead of FITC-labelled particles are all employed in
phagocytic assays (Salmon et al., 1984). However, these methods have some
limitations which include: equivalence of the phagocytic cell number in parallel wells,
harvesting errors and labeling levels with radiations as well as operator safety. Flow
cytometry (Bjerknes et al., 1989; Buschmann et al., 1989, Tuijman et al., 1990) is the
best and simplest approach for the phagocytic assays. It can not only quantitatively
analyze the number of cells with phagocytic activity, but can also qualitatively analyze
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the number of ingested RBC in each phagocyte by fluorescence intensity. Moreover, it
can count more than 5,000 cells within specific parameters in a couple of minutes.
Therefore, it was a an affective and convenient method to approach the phagocytic
assays in this study.
Compared to yeast and bacteria, RBC are the best targets in phagocytic assays, as
external RBC can easily be lysed with distilled water. The assay then only measures
those cells which have internalized RBC. Bacteria and yeast cannot be removed from
the surface by this method and so some labelled particles still bind to the cell surface.
Therefore, results with yeast and bacteria are the sum of surface binding and
internalization (Lee, 1994). When crystal violet was used to quench external
fluorescence (Hed & Stendahl, 1982), it was found that all fluorescence was
interfered with and so this method could not be used in flow cytometry. A method for
stripping the external particles from the cell surface is therefore necessary (e.g. protein
digestion) before surface binding and internalization of yeast and bacteria can be
separated. However, treatment with trypsin to remove externally bound Pasteurella
haemolytica has been reported as being unsuccessful (Lee, 1994).
Both Fcry and C3b receptors are very important surface molecules which mediate
phagocytosis on M<j)s and PMNs (Sarmay, 1992; Jungi et al., 1990; Anderson, 1987;
Hed & Stendahl, 1982). The C3b receptor primarily promotes attachment so that the
particle is bound onto the membrane, whereas the FcR mediates ingestion (Hed &
Stendahl, 1982). The ingested microorganism in phagosomes may be killed by the
peroxidase-hydrogen peroxidase system (Locksley et al., 1987). Internalized particles
may also be partially degraded and peptides derived can become associated with
MHC class II molecules. Antigen breakdown and re-expression on the surface of M<j)s
play a major role in initiating an immune response (Brodsky & Guagliardi, 1991).
During this study, FcyR expression on AM<J)s and their phagocytic activity were
decreased, after OPIV-3 infection. This agrees with experiments reported previously
(Davies et al., 1986; Slausson et al., 1987); furthermore, modulation of the FcryR
associated with a functional phagocytic impairment has been reported (Fleit et al,
1982). The percentage of MDM<j)s with immune complex FcR activity was not greatly
changed during the course of the infection. However, they had a significantly reduced
capacity of SRBC phagocytic activity on days 3 (p<0.05) and 5 (p<0.001) after
infection. In contrast AM(j>s showed both a significantly lower (p<0.05) proportion of
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immune complex FcR activity on day 3 and 5 p.i. and a significantly reduced capacity
of SRBC phagocytic activity on days 3 (p<0.05) and 5 (p<0.001) after infection. Not
only less MDM<J)s and AM<f>s ingested particles attached to Fc receptors, but those
M(J)s that were still phagocytic ingested fewer particles as suggested by the mean of
fluorescence intensity. This virus-associated defect was more marked on day 3 to 5 of
the infection and correlates with the increased susceptibility of the host to secondary
bacterial pneumonia (Jakab, 1982; Jakab & Warr, 1983). After day seven the FC-
mediated phagocytic activity of M<))S started to recover slowly.
The results here suggest that direct infection of M({)s by OPIV-3 leads to the
suppression of both phagocytic activity and MHC class II molecule expression.
However, the mechanisms of suppression in both cases remain to be elucidated. Viral
infections interrupt the functions of infected cells and generally produce cell
disruption and death (Jakab, 1982). Also, the incorporation of OPIV-3 particles into
the cell membrane may alter membrane fluidity and permeability. This may be of
importance after the infection has been established and when a large amount of viral
proteins are present in the cell membrane.
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CHAPTER EIGHT
GENERAL DISCUSSION AND CONCLUSIONS
8.1 Roie of PiV-3 infection in ovine respiratory disease
Viral involvement is important in ovine respiratory disease, however the relative
contributions of different viruses as causative agents are unclear. Ovine parainfluenza
type 3 (PIV-3), a paramyxovirus, was first associated with ovine respiratory disease in
the UK in 1969 (Hore & Stevenson, 1969). It has been isolated from sheep with
respiratory disease in many countries (Ditchfield, 1966; St.George, 1969; Carter &
Hunter, 1970; Epstein, B. 1974; Lehmkhul & Cutlip, 1982). In this study, three
OPIV-31 isolates (270-7, 392-10 and 430-7) were obtained from three field cases of
sheep pneumonia in the South of Chile (Berrfos et al., 1991). In two of these cases,
Pasteurella haemolytica was isolated. No previous isolations of this virus from field
cases of sheep pneumonia had been reported before. However, according to
serological data, the frequency of infection by PIV-3 virus in sheep from this area had
been reported to be very high. Furthermore, this was thought to be the cause of
severe cases of pneumonia in association with Pasteurella haemolytica (Beirfos et
al., 1987; Riedemann et al., 1990).
The precise relationship of this virus to ovine respiratory disease has been considered
as unclear (Sharp et al., 1978). The association of bovine and ovine PIV-3 virus with
respiratory disease has been carried out with a number of laboratory tests. The most
commonly reported technique is the demonstration of the induction of serum
antibodies to PIV-3 antigens (Adair, 1986). This test is often inconclusive because
seroconversion to PIV-3 may be associated with clinical disease in some animals
(Bryson et al., 1979) and may be asymptomatic in others (Allan et al., 1978).
Another means of implication has been the isolation of the virus from tissues or body
fluids of animals with respiratory disease. However, virus has been isolated from
healthy animals (Dawson & Cruikshank, 1963) as well as from respiratory disease
cases.
The uncertainty concerning the role of PIV-3 in cases of ovine respiratory disease
may result, in part, from the failure to detect and evaluate accurately the location of
the virus in tissues of affected animals. A more recent technique for associating
viruses with disease is direct microscopic demonstration of virus in infected tissues
using immunohistochemistry. Immunoenzyme stains are permanent preparations
visible with ordinary light microscopy and may be simultaneously counterstained for
optimal demonstration of the histologic lesions, which may assist in establishing the
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pathogenicity of the agent. This advantage may be particularly important in assessing
the role of the PIV-3 virus to the pathology of ovine respiratory disease.
In this study OPIV-3 virus was not only isolated from clinical cases of ovine
respiratory disease and characterised by traditional methods but was also detected by
immunohistochemistry in lesions of natural occurring viral interstitial pneumonia. On
the other hand, the isolated PIV-3 ovine strain, 270-7, was susccessfully used in
reproducing clinical and pathological signs of interstitial pneumonia in colostrum
deprived lambs. The virus was recovered, seroconversion was detected and the virus
was demonstrated in association with lung lesions of interstitial pneumonia.
Moreover, the virus induced phagocytic and immunological alterations in AM after
infection in vitro. This demonstrates the pathogenicity of this OPIV-3 isolate and
points out a role for OPIV-3 in predisposing sheep to acquiring secondary bacterial
pneumonia. It should be considered that although under some circumstances no
clinical signs are apparent after infection with PIV-3 the virus may interfere with
AM functions, allowing concurrent or subsequent infections by other viruses and
bacteria.
8.2 Antigenic differences between OPIV-3 and BPIV-3 or HPIV-3.
Little was known about the antigenic relationship between OPIV-3 and BPIV-3 or
HPIV-3. Studies had been carried out so far to determine antigenic variations only
between BPIV-3 and HPIV-3 (Ray & Compans, 1986; Klippmark et al., 1990). Three
human and six bovine PIV-3 strains were examined by the use of 60 mAbs. Fifty-three
mAbs to the human C243 strain (Rydbeck et al., 1986) were directed against six,
four, nine and seven epitopes of the haemagglutinin-neuraminidase (HN), fusion (F),
nucleocapsid (N) and matrix proteins, respectively. Seven mAbs to the bovine strain
were directed against three epitopes of the HN protein and three epitopes of the F
protein. Each strain was characterized in ELISA and immunofluorescence tests with
all mAbs and in a haemagglutination inhibition assay with the anti-HN mAbs. There
were marked differences between human and bovine viruses, primarily in the HN
protein where five epitopes differed. One epitope of the F and one of the N protein
also differed. BPIV-3 was found to be a homogeneous subtype and distinct from
HPIV-3 (Klippmark et al., 1990).
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From this panel of 53 mAbs, against C243 strain of HPIV-3 (Rydbeck et al., 1986),
11 which showed cross reactivity with BPIV-3 were selected to be used in this study.
They would help in establishing the antigenic relationship between OPIV-3 and both
BPIV-3 and HPIV-3. The reactivity of these mAbs showed that the three Chilean
OPIV-3 strains isolated in this study together with the British OPIV-3 reference strain
can be distinguished from HPIV-3 and BPIV-3. They also showed that only limited
variation occurs among OPIV-3 strains recovered at different geographical locations,
in a similar fashion to that observed with BPIV-3 (Klippmark et al., 1990). With the
reagents employed here, epitopes of viral proteins common to HPIV3 and BPIV-3
were found to be absent or to be expressed in a lower proportion in OPIV-3 strains.
Antigenic differences were found predominantly in the F protein and to a lesser extent
in the M protein. F protein seems to have a conserved character among OPIV-3
strains. This has also been observed in HPIV-3 and BPIV-3 strains (Rydbeck et al.,
1986; Klippmark et al., 1990). In this case three distinct epitopes of protein F that are
found in HPIV-3 and BPIV-3 strains were absent in OPIV-3.
These differences should be considered when using vaccines produced with PIV-3
from other species. Antigenic differences suggest that a bovine strain may well induce
important neutralization antibodies in sheep but a sheep strain may induce a wider
spectrum of neutralizing antibodies against OPIV-3
8.3 Interaction of macrophages and PIV-3
The research undertaken here looked at the interaction of OPIV-3 and macrophages
with 3 main aspects: OPIV-3 replication in macrophages; the effect of OPIV-3
infection on the phenotype of immune related receptors and effect on functional
capacities (phagocytic and MHC class II expression for antigen presentation) of
macrophages.
In this study it has been shown that AM are infected by OPIV-3 in vivo and in vitro.
The virus induces extensive CPE and finally cell lysis in vitro. This led to defects in
the phagocytic capacity of AM. Likewise, PIV-3 has been associated with defects in
the bactericidal capacity of macrophages, chemotaxis and phagocytosis in cattle
(Brown & Ananaba, 1988) and humans (Henricks et al., 1994) in vitro. Loss of
macrophage functions may contribute to infection by opportunistic pathogens. Indeed,
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concurrent bacterial infections are often found in OPIV-3 infected sheep with
pneumonia. This was also observed in two cases of sheep pneumonia, reported during
this study, from where OPIV-3 isolates were obtained (3.2.3.3). Other examples from
field cases (Lehmkuhl & Cutlip, 1982) and experimental cases (Sharp et al., 1978 )
have been previously reported.
In this study it has been shown that in vitro infected AM not only show loss of
phagocytic functions but also ability to express MHC class II molecules upon
stimulation with y-EFN. The expression of class II molecules is direcdy related to AM
immunological functions. When macrophages are maintained in standard culture
media both class II molecule expression and accessory cell function are lost. The
accessory cell function can be recovered upon stimulation with y-IFN and is related
quantitatively to the level of class II molecule expression (Belles, 1984).
Anger & Ross (1992) have pointed out the criteria which must be fulfilled for the
macrophage to be capable of presenting antigen to T-cells for the initiation of an
immune response. The macrophage must be able to:
1) Internalize antigen by phagocytosis, to allow processing to occur;
2) process antigen by proteolysis, the primary mode of antigen degradation;
3) transcribe the products of MHC class II (and/or Class I) genes and express these at
the cell surface in sufficient quantity;
4) associate the processed peptide fragments, several amino acids long, with the MHC
molecules and express these on the cell surface; and
5) provide the necessary regulatory signals in the form of cytokines to responding
cells.
According to this at least two steps, which are necessary for the AM to be capable of
presenting antigen to T-cells, are impaired after infection with OPIV-3. They are
steps 1 and 3 associated with phagocytosis (for antigen internalization) and expression
of class II MHC antigens (at the cell surface in sufficient quantity), respectively.
This shows that some viruses can down-regulate MHC antigens. There is also
evidence that the infection of cells with hepatitis virus inhibits IFN-induction of MHC
class II antigens (Onji et al, 1987). Such effects may be more widespread than has
hitherto been recognized, leading to the subversion of immune responses by viruses.
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T cells recognize proteolytic fragments of antigenic proteins that are presented at the
cell surface by either major histocompatibility complex (MHC) class I or class II
molecules. CD4+ T cells recognize peptides presented by MHC class II molecules
(Grey et al., 1989). This implies that CD4+ T cells which help in eliciting an antibody
response may not be appropriately stimulated during PIV-3 infection. This may help
explain why humoral immunity against PIV-3 seems to be limited. It has been
reported and demonstrated that infection recurs within short time intervals (Well et
al., 1976; Lehmkuhl & Cutlip, 1983; Morein et al., 1983; Ray et al., 1985). It appears
that infection with PIV-3 does not result in the establishment of a state of long-lasting
protective immunity (Sieg et al., 1994).
CD8+ T cells recognize peptides presented by MHC class I molecules (Grey et al.,
1989). The expression of these molecules on AM surfaces was not altered after
OPIV-3 infection. This agrees with the noticeable accumulation of lymphocytes in
both lesions of interstitial pneumonia and LWF obtained from animals after 7 days p.i.
with OPIV-3. In these lesions as well as in LWF there was a predominance of CD8+ T
cells.
Mammals have both non-specific (NK cells, PMNs and macrophages) and specific
(cellular and humoral immunity) defences against invading pathogens. During the
early phase of primary infection viruses rapidly replicate in target cells and cause
lesions with a large progeny being produced and spread. It is at this first stage that
non-specific effector mechanisms are important in limiting the amount of virus
produced. Once sufficient inflammation and antigen have been produced the host
develops specific immunity which is important in eliminating these pathogens and
allowing recovery from infection. However, for patients with defects in immunity,
infection may result in death. This basic model is normally seen in most viral infections
(Sissons & Oldstone, 1980).
8.4 Cellular immune response
The complexity of the role of CD8+ (cytotoxic, Tc) and CD4+ (helper, Th) T-cell
subsets continues to emerge as more virus systems are examined. Adoptive transfer
studies using cloned lines of CD8+ class I MHC-restricted Tc have demonstrated the
beneficial role of these cells in certain virus infections, such as influenza, where Tc are
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able to protect against lethal infection and to clear the virus more rapidly from the
lung (Mackenzie et al., 1989). In other viral infections, such as lymphocytic
choriomeningitis vims (LCMV), the role of Tc depends on the type and site of
infection. Following intracerebral infection Tc are detrimental to the host and increase
pathology, for example by their direct effect on the infected cells in brain tissues
(Baezinger et al., 1988). These Tc cells can cause damage without the need for
recruited inflammatory cells. Studies with respiratory syncytial vims (RSV) specific
Tc lines or clones have shown that viral clearance is accompanied by an enhanced
pathology, unless low Tc cell numbers (> 106) are transferred (Canon et al., 1988).
Proliferation of CD8+ T lymphocytes is a common feature in many viral infections
(McMichael et al., 1983) and PIV-3 is not an exception. A great increase in CD8+
lymphocytes in lung wash as well as in BALT was seen after infection during this
study (section 5.2.2). An increase in CD8+ lymphocytes is also seen in
bronchoalveolar lavage, CSF or synovial fluid from MVV infected sheep, particularly
those sheep which have developed lesions (Harkiss et al., 1991; Torsteinsdottir et al.,
1992; Lujan et al., 1993). There is no significant alteration in lymphocyte phenotypes
in PBMC and good antibody and cellular mediated immune (CMI) responses appear
to be present in MVV infected sheep. However, there are significant changes in
CD4+:CD8+ lymphocyte ratios and lymphocyte and macrophage phenotypes in lung,
synovium and CSF (Cordier et al., 1992; Torsteinsdottir et al., 1992; Lujan et al.,
1993), suggesting that the situation in blood may not really reflect the situation in
organs targeted by MVV infection. No information is available on changes of
distribution of lymphocytes subsets in peripheral blood during PIV-3. However, it has
been reported that no major changes in differential leucocyte counts are observed in
peripheral blood during PIV-3 infection (Stauber & Weston, 1984). Also, PIV-3
infection is restricted primarily to the respiratory tract (Chanock & Mcintosh, 1990).
Concurrent infection with pasteurellosis is a common feature in PIV-3 infection,
especially in field cases (Davies et al., 1977). Pulmonary defence against infection is
very complex and consists of local humoral (IgG and IgA) and cellular immunity,
complement, ciliary activity, mucus production and phagocytosis (Burrels, 1985;
Christensen & Mousing, 1992). The major immunoglobulin generated in the
respiratory tract particularly in the upper respiratory tract is secretory IgA which can
efficiently agglutinate invading bacteria; this may enhance mucociliary clearance of
pathogens and inhibit bacterial colonization of the mucosa. However, significant
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amounts of IgG and complement components are also found in the lower respiratory
tract (Burrels, 1985). These plasma components mainly enter the respiratory system
by transduction, although small amounts may be produced locally (Kaltreider, 1976).
IgG and complement components are an important source of opsonins in the
pulmonary environment therefore act together in destroying invading pathogens
(Kaltreider, 1976). In PIV-3 lungs lesions from naturally occurring and experimental
disease the alveolar walls are greatly thickened wich may decrease the trasduction of
plasma into the lung, as has also been suggested in MVV infection in sheep (Lee,
1994). This would reduce the amount of opsonins in the respiratory system available
for action with AM, allowing the replication of gram negative bacteria (which require
opsonization for phagocytosis) entering alveolar areas. These together with
macrophage functional alterations in phagocytosis and antigen presentation would
lead to bacterial pneumonia.
8.5 Immune mechanisms of Pathology
It has been reported that proliferation of bacteria occurs more frequently, and hence
pneumonia develops more often, when animals are inoculated with P. haemolytica
6 days after PIV-3 than when they were inoculated earlier in the course of the virus
infection or when they are inoculated with P. haemolytica alone (Davies et al., 1977;
Sharp et al., 1978; Davies et al., 1986). This maximun impairment of pulmonary
clearance coincided with declining virus titres in the lung and the first detectable
evidence of the host's immune response to the virus observed in this study. A similar
impairment of pulmonary clearance at the time that the host's immune response is first
detected has been reported previously (Davies et al., 1982; Jakab & Warr, 1983).
This impairment of clearance can be prevented by immunosuppression with
cyclophosphamide (Jakab & Warr, 1981a) or anti-lymphocyte serum (Jakab, 1982).
Thus the deffect is likely to be immunologically mediated and is not due to the direct
effect of the virus replication on host cells. Similar impairment of phagocytosis was
produced by exposing virus-infected AM to antiviral antibody and complement or
sensitised lymphocytes in vitro (Jakab & Warr, 1981b).
It was observed during this study (Chapter 4) that the presence of a large number of
lymphocytes, particularly on days 5 and 7 p i., combined with a minimal to moderate
cytolysis in antigen bearing cells. This, suggests that PIV-3 induced pulmonary
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disease may have an important immunopathological component. Lymphocytes were
first seen at 3 days p i. and reached a maximum 7 days p i., an observation consistent
with a specific T-cell response to the virus (Porter et al., 1991).
Pathology accumulated during PIV-3 infection seems to be mediated by immune
responses. It is not known however, if this is through PIV-3 antigens or responses to
autoimmune antigens. Persistent, small amounts of viral antigen being produced in
target organs which continously stimulate immune responses and cytokine production
(low levels) have been suggested to be the cause of chronic inflammation in MW
interstitial pneumonia (Nathanson et al., 1976).
During interactions between PIV-3 infected alveolar macrophages and lymphocytes,
activation of some lung T-cell populations takes place (Basaraba et al., 1993; Sieg et
al., 1994). As a consequence, it is likely that several cytokines with immunoregulatory
activities are simultaneously produced. These cytokines could play a major role in
pathogenesis of PIV-3 infection, probably being the main component of the
inflammatory nature of the viral lesions. Some of those cytokines, such as TNF-a, IL-
1, IL-6 or GM-CSF, could induce the accumulation of immunocompetent cells
(including T lympocytes) in the lung interstitium (potentiating lung tissue damage)
and migration of these cells into the bronchoalveolar milieu. Whether or not cytokines
have any indirect effects that lead to proliferation of CD8 cytotoxic T cells and
inhibition of CD41 helper T cells is not known (Narayan et al., 1985). Increased
levels of cytokines in PIV-3 infection have been reported. PIV-3 virus/endotoxin
combinations had been shown to stimulate higher TNF-a release when compared with
other virus/endotoxin combinations (Bienhoff et al, 1992). IFN-y is also elevated in
alveolar macrophages following infection with PIV-3 (Towsend et al, 1988). y-IFN
also elevated in MW that is also associated with interstital pneumonia (Narayan et
al, 1985); however, TNF-a release is not (Ellis et al., 1991).
In vitro studies (Kennedy et al., 1985; Narayan et al., 1985) have demonstrated the
contribution of an ovine lentivirus-induced IFN (LV-IFN) to the pathogenesis of
MW infection. LV-IFN induces MHC class II antigen expression on alveolar
macrophages and as a result, the infected cell remains in a state of continuous or
chronic antigen presentation. LV-IFN inhibits maturation of infected monocytes to
macrophages, and thus, indirectly restricts completion of the virus life cycle. It also
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causes reduction in the number of transcripts of viral RNA in infected macrophages,
giving rise to the phenomenon of "slow replication".
Likewise, PIV-3 infection is associated with y-IFN production (Towsend et al.,
1988). However, the role of y-EFN in the pathogenesis of this respiratory infection
remains to be investigated. In vivo, the lung is exposed to complex mixtures rather to
individual cytokines, and cytokines in combination have quantitatively different
effects than they have individually (Elias et al., 1990; Kelley, 1990).
Macrophages were productively infected with OPIV-3 in vitro (Section 6.2.1). The
studies on phagocytosis and MHC class II expression in these cells have shown
functional defects (Chapter 7). In vivo there are low percentages of productively
infected macrophages (Section 5.2.3). However, a decrease in phagocytosis and
killing of bacteria has been reported to occur in vivo (Brown & Ananaba, 1988).
Cytokines produced from lymphocytes interacting with these activated macrophages
(TNF-a and IL-1) may also enhance expression from the viral LTR and increase viral
antigen products as it has been suggested in MVV (Clements et al., 1979). If this
occurs, free viral antigen may interfere with uninfected cell functions. Free virus
antigen may also add to the general immune activation, if macrophages take it up and
present it to lymphocytes. In MVV the gag p25 antigen has been seen in efferent
lymph plasma (Bird et al., 1993). So free viral antigens may be present in the body
fluids of MVV infected sheep. Cells infected with paramyxoviruses release soluble
material such as viral envelope glycoproteins (Vainionpaa et al., 1989). However,
little is known about the pathogenic effect of individual paramyxovirus proteins.
Further studies are necessary to determine whether there is any connection between
infected pulmonary macrophages and level of expression of MHC class II molecules
in vivo. Also, it is necessary to investigate the possibility of persistent infection of
pulmonary macrophages as the activation of these cells, chronically infected, could
trigger the transition from latency to active viral replication. Infection of pulmonary
macrophages apart from leading to the production of cytokines, might contribute to
perturbation of the cellular pulmonary immune response by some other mechanisms.
In this study it has been shown that cells of the macrophage lineage can be major host
cells for replication of PIV-3 in vivo and in vitro. If the cells involved in the non¬
specific cellular defence system of the host via viral presentation, are at the same time
the source of viral replication and are possibly damaged., this could result in
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disruption of the immune system and incapability of responding efficiently to the
infecting virus. Additionally, infected macrophages, by remaining in this state of
continuous antigen presentation may mediate immunopathologic disease.
In summary the pulmonary macrophage acts as a major reservoir for PIV-3.
Pulmonary lesions rather than the result of the direct effect of the virus per se will
result from the response of diverse elements of the immune response to viral infection.
During natural and experimental PIV-3 infection the pulmonary immune response is
characterised by proliferative response of interacting macrophages and lymphocytes
which should lead to production of cytokines. This interaction involves a series of
immunological phenomena associated with lung tissue damage and immune
dysfunction which, in some instances, may lay the ground for bacterial colonization,
pneumonia and eventually death. In other cases, lesions are confined to restricted
anteroventral lung areas where in the presence of highly specialised effector and
immune surveillance mechanisms, the progress of the disease will remain under
control.
Research has focused on the suppressive effect of AM, via nitric oxide, on pulmonary
immunity (Mills, 1991; Holt, 1986). Nitric oxide is functional against microorganisms
and tumour cells (Liew and Cox, 1991), but also suppresses pulmonary DC function
and lymphocyte responses (Holt et al., 1986,1993). One hypothesis suggests that the
suppressive effect of AM is necessary for the control of the non-specific activity of
AM. AM frequently come into contact with foreign antigens from air or the upper
respiratory tract which may non-specifically trigger AM to release accessory cell
factors leading to immnopathological lesions. The major physiological function of AM
is thought to be the release of chemotactic factors, ingestion and degradation of
antigen and microbicidal activity (Brain, 1992) rather than an antigen presenting
function for lymphocytes. Therefore, the increase in the number of lymphocytes and
AM and their activation in PIV-3 infection is not only responsible for the induction of
the active chronic inflammation seen, but also may cause a suppressive state in local
immunity. This may contribute to the concurrent infections seen in PIV-3 infected
lungs in field cases.
8.6 SUMMARY AND CONCLUSIONS
In this study three isolates (270-7, 392-10 and 430-7) of OPIV-3 were obtained from
field cases of sheep pneumonia in Chile. The reactivity of a monoclonal antibody panel
cross-reacting with HPIV-3 and BPIV-3 viral proteins showed that these OPIV-3
strains can be distinguished from HPIV-3 and BPIV-3 strains. They also showed that
only limited variation occurs among OPIV-3 strains recovered at different
geographical locations. With the reagents employed here, epitopes of viral proteins
common to HPIV3 and BPIV-3 were found to be absent in the OPIV-3 strains.
Antigenic differences were found predominantly in the F protein and to a lesser extent
in the M protein. Three distinct epitopes of F protein and one of M protein, that are
found in HPIV-3 and BPIV-3 strains, were absent in OPIV-3.
The present study confirmed the pathogenicity of ovine PIV-3 strain 270-7 and
showed that this virus is able to induce clinical and pathological symptoms
corresponding to interstitial pneumonia. One of the most striking histopathological
findings in lambs inoculated with OPIV-3 270-7 strain was an intense proliferation of
lymphocytes. This was most noticeable in the resulting BALT hyperplasia. This could
be associated with the immune response elicited against OPIV-3
The results shown in this study demonstrate alterations in the normal composition of
CD4+ and CD8+ lymphocyte subsets in the lungs of animals experimentally infected
with OPIV-3. This could play a key role in the pathogenesis of the interstitial
pneumonia associated with this infection. There was a significant decrease (p<0.001)
in the CD4+/CD8+ ratio of lymphocytes due to both a significant increase of CD8+ T
lymphocytes and a significant decrease of CD4+ T lymphocytes. In this study a non¬
productive or abortive type of infection was observed in lymphocyte cultures. This
agrees with the absence of infected lymphocytes found in both LWF and in tissue
sections obtained from pneumonic lungs after 7 days post experimental infection.
However, more research is necessary to investigate the conditions, both in vivo and in
vitro which may lead to productive infection of lymphocytes. Also the susceptibility of
the different lymphocytes subsets to PIV-3 infection should be clarified.
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The increase in both alveolar and interstitial M(j)s observed after 7 days of infection
with OPIV-3 suggests a role for these cells in the host mechanisms of defence against
infection and also in the mechanisms of lung pathology. A significant proportion of
Mc|)s showed positive immunostaining for OPIV-3 proving that infection of these cells
occurs in vivo. It has also been shown that OPIV-3 infects ovine AM<{> in vitro. The
in vitro infection is productive and characterised by the release of high titres of
infectious virus.
In this study, OPIV-3 in vitro replication in AMtj) was found to be more rapidly lytic
than in MDM<{>. The differentiation and maturation state of M<|)s may affect replication
of PIV-3 with the virus being produced earlier and in higher levels in mature well
differentiated AM(j) than in less mature and differentiated MDM(|) (5 days in culture
before infection).
The culture of sheep monocytes from blood induced the expression of some cell
markers, such as CD4, CD8 and VPM32 antigen which were not expressed on fresh
monocytes.
Seven day cultured MDM<|) had completely differentiated into M<{)s as defined by
morphology, NSE staining and stable surface antigen expression. There was no
significant difference in surface molecule expression on OPIV-3 infected and mock-
infected MDMtj) up to 5 days p.i.. There was no loss of surface molecules (such as
CD8, VPM32, or CD 14) from MDM(|) or AM<|) up to 5 days p.i.; but after day 5 p.i.,
degenerative changes including a decrease in surface expression of these molecules
were seen. Tins is probably due to productive replication of the virus as this is
supported by the detection of viral antigen in both the cytoplasm and cell membrane.
The kinetics of these changes also coincides with surface changes seen in OPIV-3
infected MDM<)> observed under TEM.
In the experiments shown, monocytes were grown in high serum concentrations
(10%FCS and 10%NLS) to allow the growth and the differentiation of these cells in
vitro. However, these serum concentrations were not enough to overcome the loss of
MHC class II expression in vitro. y-IFN treatment restored the expression of MHC
class II (both DR and DQ) molecules although, at a lower level in comparison to the
expression in fresh cells.
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AM<j)s also lost MHC class II molecules in culture as assessed by both flow cytometry
and immunohistochemistry. However, in the same cultures there were a few scattered
highly MHC class II positive cells found in close contact with M(j)s. These cells were
thought to be dendritic cells (DC) according to morphology and class II molecule
expression. Also, staining of AM<j) cultures with anti-CD 1 mAb VPM5 showed a
positive population that decreased in proportion from 18% on fresh cells to 9% after
7 days in culture.
In this study the in vitro infection of both MDM())s and AMiJts with OPIV-3 showed a
suppressive effect on y-IFN induction of MHC class II molecule expression.
During this study, FcyR expression on AM(|)s and their phagocytic activity were
decreased after in vitro OPIV-3 infection. The percentage of MDM<j>s with immune
complex FcR activity was not greatly changed during the course of the infection.
However, they had a significantly reduced capacity of SRBC phagocytic activity on
days 3 (p<0.05) and 5 (p<0.001) after infection. In contrast AM<f>s showed both a
significantly lower (p<0.05) proportion of immune complex FcR activity on day 3 and
5 p.i. and a significantly reduced capacity of SRBC phagocytic activity on days 3
(p<0.05) and 5 (pcO.OOl) after infection. Not only less MDM(J)s and AM<{)s ingested
particles attached to Fc receptors, but those M(j)s that were still phagocytic ingested
fewer particles as suggested by the mean of fluorescence intensity. This virus-
associated defect was more marked from day 3 to day 5 of the infection. After day
seven the Fc-mediated phagocytic activity of M<()s started to recover slowly.
The results here show that direct infection of M<])s by OPIV-3 leads to the
suppression of both phagocytic activity and MHC class II molecule expression.
However, the mechanisms of suppression in both cases remain to be elucidated.
Infected macrophages are targets for immunosurveillance (CTL and NK/LAK cells)
and the low levels of infected cells and antigen seen in vivo may be, in part, due to
clearance from the host. Also mechanisms for evasion of the immune response may
exist and include latency or restricted replication in immature macrophages. Future
work should focus on the production of sheep monocyte/macrophage cell lines or the
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